10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10–Q

(Mark One)

ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2019

OR

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number: 000-50976

HURON CONSULTING GROUP INC.

(Exact name of registrant as specified in its charter)

Delaware	01-0666114
(State or other jurisdiction of incorporation or organization)	(IRS Employer Identification Number)

550 West Van Buren Street

Chicago, Illinois

60607

(Address of principal executive offices)

(Zip Code)

(312) 583-8700

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ý    No  o

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  ý    No  o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company”, and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer	ý	Accelerated filer	o
Non-accelerated filer	o	Smaller reporting company	o
		Emerging growth company	o

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  o    No  ý

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

As of April 23, 2019, 22,883,027 shares of the registrant’s common stock, par value $0.01 per share, were outstanding.

Huron Consulting Group Inc.

HURON CONSULTING GROUP INC.

INDEX

		Page
Part I – Financial Information
Item 1.	Consolidated Financial Statements (Unaudited)
	Consolidated Balance Sheets	1
	Consolidated Statements of Operations and Other Comprehensive Income	2
	Consolidated Statements of Stockholders’ Equity	3
	Consolidated Statements of Cash Flows	4
	Notes to Consolidated Financial Statements	5
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	23
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	36
Item 4.	Controls and Procedures	37
Part II – Other Information
Item 1.	Legal Proceedings	37
Item 1A.	Risk Factors	37
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	37
Item 3.	Defaults Upon Senior Securities	38
Item 4.	Mine Safety Disclosures	38
Item 5.	Other Information	38
Item 6.	Exhibits	39
Signature		40

PART I - FINANCIAL INFORMATION

ITEM 1. CONSOLIDATED FINANCIAL STATEMENTS

HURON CONSULTING GROUP INC.

CONSOLIDATED BALANCE SHEETS

(In thousands, except share and per share amounts)

(Unaudited)

	March 31, 2019			December 31, 2018
Assets
Current assets:
Cash and cash equivalents	$	8,526		$	33,107
Receivables from clients, net	104,674			109,677
Unbilled services, net	86,504			69,613
Income tax receivable	3,209			6,612
Prepaid expenses and other current assets	13,596			13,922
Total current assets	216,509			232,931
Property and equipment, net	38,359			40,374
Deferred income taxes, net	1,302			2,153
Long-term investment	54,038			50,429
Operating lease right-of-use assets	53,805			—
Other non-current assets	38,345			30,525
Intangible assets, net	43,461			47,857
Goodwill	645,541			645,263
Total assets	$	1,091,360		$	1,049,532
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable	$	7,469		$	10,020
Accrued expenses and other current liabilities	16,611			17,207
Accrued payroll and related benefits	53,966			109,825
Accrued contingent consideration for business acquisitions	10,014			9,991
Current maturities of long-term debt	245,569			243,132
Current maturities of operating lease liabilities	10,293			—
Deferred revenues	30,023			28,130
Total current liabilities	373,945			418,305
Non-current liabilities:
Deferred compensation and other liabilities	25,886			20,875
Accrued contingent consideration for business acquisitions, net of current portion	1,115			1,450
Long-term debt, net of current portion	79,722			53,853
Operating lease liabilities, net of current portion	60,280			—
Deferred lease incentives	—			13,693
Deferred income taxes, net	759			732
Total non-current liabilities	167,762			90,603
Commitments and contingencies
Stockholders’ equity
Common stock; $0.01 par value; 500,000,000 shares authorized; 25,275,901 and 25,114,739 shares issued at March 31, 2019 and December 31, 2018, respectively	247			244
Treasury stock, at cost, 2,392,531 and 2,568,288 shares at March 31, 2019 and December 31, 2018, respectively	(126,983		)	(124,794		)
Additional paid-in capital	457,748			452,573
Retained earnings	199,410			196,106
Accumulated other comprehensive income	19,231			16,495
Total stockholders’ equity	549,653			540,624
Total liabilities and stockholders’ equity	$	1,091,360		$	1,049,532

The accompanying notes are an integral part of the consolidated financial statements.

1

HURON CONSULTING GROUP INC.

CONSOLIDATED STATEMENTS OF OPERATIONS AND OTHER COMPREHENSIVE INCOME (LOSS)

(In thousands, except per share amounts)

(Unaudited)

	Three Months Ended March 31,
	2019			2018
Revenues and reimbursable expenses:
Revenues	$	204,445		$	193,679
Reimbursable expenses	18,617			17,619
Total revenues and reimbursable expenses	223,062			211,298
Direct costs and reimbursable expenses (exclusive of depreciation and amortization shown in operating expenses):
Direct costs	137,780			132,786
Amortization of intangible assets and software development costs	1,117			1,218
Reimbursable expenses	18,669			17,549
Total direct costs and reimbursable expenses	157,566			151,553
Operating expenses and other losses (gains), net
Selling, general and administrative expenses	50,749			47,078
Restructuring charges	1,275			712
Other losses (gains), net	(456		)	830
Depreciation and amortization	7,172			8,803
Total operating expenses and other losses (gains), net	58,740			57,423
Operating income	6,756			2,322
Other income (expense), net:
Interest expense, net of interest income	(4,258		)	(4,986		)
Other income (expense), net	2,217			(145		)
Total other expense, net	(2,041		)	(5,131		)
Income (loss) from continuing operations before taxes	4,715			(2,809		)
Income tax expense	1,365			413
Net income (loss) from continuing operations	3,350			(3,222		)
Loss from discontinued operations, net of tax	(46		)	(42		)
Net income (loss)	$	3,304		$	(3,264	)
Net earnings (loss) per basic share:
Net income (loss) from continuing operations	$	0.15		$	(0.15	)
Loss from discontinued operations, net of tax	—			—
Net income (loss)	$	0.15		$	(0.15	)
Net earnings (loss) per diluted share:
Net income (loss) from continuing operations	$	0.15		$	(0.15	)
Loss from discontinued operations, net of tax	—			—
Net income (loss)	$	0.15		$	(0.15	)
Weighted average shares used in calculating earnings per share:
Basic	21,868			21,592
Diluted	22,311			21,592
Comprehensive income (loss):
Net income (loss)	$	3,304		$	(3,264	)
Foreign currency translation adjustments, net of tax	316			34
Unrealized gain on investment, net of tax	2,657			2,166
Unrealized gain (loss) on cash flow hedging instruments, net of tax	(237		)	432
Other comprehensive income	2,736			2,632
Comprehensive income (loss)	$	6,040		$	(632	)

The accompanying notes are an integral part of the consolidated financial statements.

2

HURON CONSULTING GROUP INC.

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(In thousands, except share amounts)

(Unaudited)

	Three Months Ended March 31, 2019
	Common Stock			Treasury Stock					Additional Paid-In Capital			Retained Earnings		Accumulated Other Comprehensive Income		Stockholders’ Equity
	Shares	Amount		Shares		Amount
Balance at December 31, 2018	24,418,252	$	244	(2,671,962	)	$	(124,794	)	$	452,573		$	196,106	$	16,495	$	540,624
Comprehensive income												3,304		2,736		6,040
Issuance of common stock in connection with:
Restricted stock awards, net of cancellations	254,550	3		27,612		2,196			(2,199		)					—
Exercise of stock options	10,000	—							234							234
Share-based compensation									7,140							7,140
Shares redeemed for employee tax withholdings				(94,500	)	(4,385		)								(4,385		)
Balance at March 31, 2019	24,682,802	$	247	(2,738,850	)	$	(126,983	)	$	457,748		$	199,410	$	19,231	$	549,653

	Three Months Ended March 31, 2018
	Common Stock			Treasury Stock					Additional Paid-In Capital			Retained Earnings			Accumulated Other Comprehensive Income		Stockholders’ Equity
	Shares	Amount		Shares		Amount
Balance at December 31, 2017	24,098,822	$	241	(2,591,135	)	$	(121,994	)	$	434,256		$	180,443		$	10,370	$	503,316
Comprehensive income												(3,264		)	2,632		(632		)
Issuance of common stock in connection with:
Restricted stock awards, net of cancellations	198,546	2		34,177		1,443			(1,445		)						—
Exercise of stock options	10,000	—							234								234
Share-based compensation									5,280								5,280
Shares redeemed for employee tax withholdings				(75,832	)	(2,684		)									(2,684		)
Cumulative-effect adjustment from adoption of ASC 606												1,956					1,956
Balance at March 31, 2018	24,307,368	$	243	(2,632,790	)	$	(123,235	)	$	438,325		$	179,135		$	13,002	$	507,470

The accompanying notes are an integral part of the consolidated financial statements.

3

HURON CONSULTING GROUP INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

	Three Months Ended March 31,
	2019			2018
Cash flows from operating activities:
Net income (loss)	$	3,304		$	(3,264	)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization	10,710			10,021
Lease impairment charge	740			—
Share-based compensation	5,366			4,483
Amortization of debt discount and issuance costs	2,618			2,615
Allowances for doubtful accounts and unbilled services	59			201
Change in fair value of contingent consideration liabilities	(391		)	830
Changes in operating assets and liabilities, net of acquisitions:
(Increase) decrease in receivables from clients, net	5,129			(4,452		)
(Increase) decrease in unbilled services, net	(16,850		)	(15,991		)
(Increase) decrease in current income tax receivable / payable, net	3,490			(805		)
(Increase) decrease in other assets	(2,554		)	(3,753		)
Increase (decrease) in accounts payable and other liabilities	2,396			901
Increase (decrease) in accrued payroll and related benefits	(54,151		)	(23,633		)
Increase (decrease) in deferred revenues	1,845			(3,416		)
Net cash used in operating activities	(38,289		)	(36,263		)
Cash flows from investing activities:
Purchases of property and equipment, net	(2,349		)	(1,369		)
Investment in life insurance policies	(3,645		)	(1,455		)
Purchases of businesses, net of cash acquired	—			(215		)
Capitalization of internally developed software costs	(2,093		)	(728		)
Net cash used in investing activities	(8,087		)	(3,767		)
Cash flows from financing activities:
Proceeds from exercise of stock options	234			234
Shares redeemed for employee tax withholdings	(4,385		)	(2,684		)
Proceeds from borrowings under credit facility	40,500			91,500
Repayments of debt	(14,627		)	(58,124		)
Payments for debt issuance costs	—			(1,385		)
Net cash provided by financing activities	21,722			29,541
Effect of exchange rate changes on cash	73			16
Net decrease in cash and cash equivalents	(24,581		)	(10,473		)
Cash and cash equivalents at beginning of the period	33,107			16,909
Cash and cash equivalents at end of the period	$	8,526		$	6,436
Supplemental disclosure of cash flow information:
Non-cash investing and financing activities:
Property and equipment expenditures and capitalized software included in accounts payable and accrued expenses	$	1,913		$	1,937
Contingent consideration related to business acquisitions	$	—		$	212

The accompanying notes are an integral part of the consolidated financial statements.

4

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

1. Description of Business

Huron is a global consultancy that helps clients drive growth, enhance performance and sustain leadership in the markets they serve. We partner with clients to develop strategies and implement solutions that enable the transformative change our clients need to own their future.

2. Basis of Presentation and Significant Accounting Policies

The accompanying unaudited consolidated financial statements reflect the financial position, results of operations, and cash flows as of and for the three months ended March 31, 2019 and 2018. These financial statements have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission ("SEC") for Quarterly Reports on Form 10-Q. Accordingly, these financial statements do not include all of the information and note disclosures required by accounting principles generally accepted in the United States of America (“GAAP”) for annual financial statements. In the opinion of management, these financial statements reflect all adjustments of a normal, recurring nature necessary for the fair statement of our financial position, results of operations, and cash flows for the interim periods presented in conformity with GAAP. These financial statements should be read in conjunction with our consolidated financial statements and notes thereto for the year ended December 31, 2018 included in our Annual Report on Form 10-K. Our results for any interim period are not necessarily indicative of results for a full year or any other interim period.

On January 1, 2019, we adopted Accounting Standard Update ("ASU") 2016-02, Leases. Below is an update to our lease accounting policy as a result of the adoption. Refer to Note 3 "New Accounting Pronouncements" for additional information on the adoption of ASU 2016-02.

Leases

We determine if an arrangement contains a lease and the classification of such lease at inception. As of March 31, 2019, all of our material leases are classified as operating leases; we have not entered into any material finance leases. For all operating leases with an initial term greater than 12 months, we recognize an operating lease right-of-use ("ROU") asset and operating lease liability. Leases with an initial term of 12 months or less are not recorded on the balance sheet; we recognize lease expense for these leases on a straight-line basis over the lease term.

Operating lease ROU assets represent our right to use an underlying asset for the lease term, and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at lease commencement date based on the present value of lease payments over the lease term. As our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at lease commencement date and provided by Bank of America, N.A., the administrative agent for our senior secured credit facility, in determining the present value of lease payments. The operating lease ROU asset excludes lease incentives.

Certain lease agreements contain variable lease payments that do not depend on an index or rate. These variable lease payments are not included in the calculation of the operating lease ROU asset and operating lease liability; instead, they are expensed as incurred. Certain lease agreements contain lease and nonlease components, which are accounted for separately. We separate the contract consideration between lease and nonlease components based on the relative standalone price of each component. Our leases may contain options to extend or terminate the lease, and we include these terms in our calculation of the operating lease ROU asset and operating lease liability when it is reasonably certain that we will exercise the option.

Operating lease expense is recognized on a straight-line basis over the lease term and recorded within selling, general and administrative expenses on our consolidated statement of operations. In accordance with our accounting policy for impairment of long-lived assets, operating lease ROU assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset group to which the operating lease ROU asset is assigned may not be recoverable. We evaluate the recoverability of the asset group based on forecasted undiscounted cash flows. See Note 5 "Leases" for additional information on our leases, including the lease impairment charge recorded in the first quarter of 2019.

3. New Accounting Pronouncements

Recently Adopted

In March 2016, the Financial Accounting Standards Board ("FASB") issued ASU 2016-02, Leases, as a new Topic, ASC 842, which superseded ASC Topic 840, Leases, and sets forth the principles for the recognition, measurement, presentation, and disclosure of leases for both lessees and lessors. ASU 2016-02 requires lessees to classify leases as either finance or operating leases and to record on the balance sheet a right-of-use asset and a lease liability, equal to the present value of the remaining lease payments, for all leases with a term greater th

5

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

an 12 months regardless of the lease classification. The lease classification will determine whether the lease expense is recognized using an effective interest rate method or on a straight-line basis over the term of the lease. In July 2018, the FASB issued ASU 2018-11, Leases (Topic 842): Targeted Improvements, which provides an optional transition method that allows entities to initially apply ASC 842 at the adoption date and recognize a cumulative-effect adjustment to the opening balance of retained earnings on the adoption date. We adopted ASC 842 effective January 1, 2019 on a modified retrospective basis for existing leases using the transition method allowed by ASU 2018-11, which had no impact on our consolidated financial statements in the prior periods presented. The new lease standard has a material impact on our consolidated balance sheet upon adoption, but does not impact our consolidated statement of operations. The most significant impact to our consolidated balance sheet is the recognition of ROU assets and lease liabilities for operating leases. The impact of the new lease standard on our consolidated balance sheet upon adoption follows:

	As of December 31, 2018		ASC 842 Adjustment			As of January 1, 2019
Assets
Operating lease right-of-use assets	$	—	$	56,463		$	56,463
Liabilities
Accrued expenses and other current liabilities	$	17,207	$	(2,557	)	$	14,650
Current maturities of operating lease liabilities	$	—	$	10,537		$	10,537
Deferred compensation and other liabilities	$	20,875	$	(536	)	$	20,339
Deferred lease incentives	$	13,693	$	(13,693	)	$	—
Operating lease liabilities, net of current portion	$	—	$	62,712		$	62,712

Not Yet Adopted

In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement, which modifies certain disclosure requirements related to fair value measurements. ASU 2018-13 will be effective for us beginning January 1, 2020, with early adoption permitted. We do not expect this guidance to have an impact on the amounts reported on our consolidated financial statements, and we are currently evaluating the potential impact this guidance will have on our disclosures within the notes to our consolidated financial statements.

4. Goodwill and Intangible Assets

The table below sets forth the changes in the carrying amount of goodwill by reportable segment for the three months ended March 31, 2019.

	Healthcare			Business Advisory			Education		Total
Balance as of December 31, 2018:
Goodwill	$	636,810		$	301,700		$	102,829	$	1,041,339
Accumulated impairment losses	(208,081		)	(187,995		)	—		(396,076		)
Goodwill, net as of December 31, 2018	428,729			113,705			102,829		645,263
Foreign currency translation	—			278			—		278
Goodwill, net as of March 31, 2019	$	428,729		$	113,983		$	102,829	$	645,541

6

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

Intangible Assets

Intangible assets as of March 31, 2019 and December 31, 2018 consisted of the following:

		As of March 31, 2019				As of December 31, 2018
	Useful Life  (in years)	Gross Carrying Amount		Accumulated Amortization		Gross Carrying Amount		Accumulated Amortization
Customer relationships	4 to 13	$	98,338	$	63,653	$	98,235	$	60,462
Trade names	5 to 6	28,930		23,859		28,930		23,181
Technology and software	3 to 5	5,694		3,211		5,694		2,842
Non-competition agreements	3 to 5	3,650		2,446		3,650		2,241
Favorable lease contract	3	720		702		720		646
Total		$	137,332	$	93,871	$	137,229	$	89,372

Identifiable intangible assets with finite lives are amortized over their estimated useful lives. Customer relationships, as well as certain trade names and technology and software, are amortized on an accelerated basis to correspond to the cash flows expected to be derived from the assets. All other intangible assets with finite lives are amortized on a straight-line basis.

Intangible asset amortization expense was $4.5 million and $6.3 million for the three months ended March 31, 2019 and 2018, respectively.The table below sets forth the estimated annual amortization expense for the year ending December 31, 2019 and each of the five succeeding years for the intangible assets recorded as of March 31, 2019.

Year Ending December 31,	Estimated Amortization Expense
2019	$	17,206
2020	$	12,083
2021	$	8,064
2022	$	6,090
2023	$	3,512
2024	$	741

Actual future amortization expense could differ from these estimated amounts as a result of future acquisitions, dispositions, and other factors.

5. Leases

We lease office space, data centers and certain equipment under operating leases expiring on various dates through 2028, with various renewal options that can extend the lease terms by one to ten years. Our operating leases include fixed payments plus, in some cases, scheduled base rent increases over the term of the lease. Certain leases require variable payments of real estate taxes and insurance. We exclude these variable payments from the measurements of our lease liabilities and expense them as incurred. Additionally, certain leases require payments for operating expenses applicable to the property. We account for these nonlease components separately from the lease components. No lease agreements contain any residual value guarantees or material restrictive covenants. As of March 31, 2019, we have not entered into any material finance leases. We sublease certain office spaces to third parties resulting from restructuring activities in certain locations.

During the first quarter of 2019, we exited a portion of a corporate office space and determined that the carrying amount of the asset group to which the related operating lease right-of-use ("ROU") asset is assigned may not be recoverable. Therefore, we performed a long-lived asset impairment test on the asset group, which is comprised of the operating lease ROU asset and leasehold improvements of the office space. First, we tested the asset group for recoverability by comparing the undiscounted cash flows of the asset group, which included expected future lease and nonlease payments under the lease agreement offset by expected sublease income, to the carrying amount of the asset group. This first step of the long-lived asset impairment test concluded that the carrying amount of the asset group was not recoverable. Therefore, we performed the second step of the long-lived asset impairment test by comparing the fair value of the asset group to its carrying amount and recognizing a lease impairment charge for the amount by which the carrying amount exceeded the fair value. To estimate the fair value of the asset group, we relied on a discounted cash flow approach using market participant assumptions of the expected cash flows and discount rate. Based on the estimated fair value o

7

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

f the asset group, we recorded a $0.7 million lease impairment charge, of which $0.5 million was allocated to the operating lease ROU asset and $0.2 million was allocated to the leasehold improvements based on their relative carrying amounts. The $0.7 million lease impairment charge was recognized in restructuring charges on our consolidated statement of operations. See Note 9 "Restructuring Charges" for additional information on our restructuring activities.

Additional information on our operating leases as of March 31, 2019 follows.

Balance Sheet	March 31, 2019
Operating lease right-of-use assets	$	53,805
Current maturities of operating lease liabilities	$	10,293
Operating lease liabilities, net of current portion	60,280
Total lease liabilities	$	70,573

Lease Cost	Three Months Ended March 31, 2019
Operating lease cost	$	3,000
Short-term leases (1)	47
Variable lease costs	374
Sublease income	(617		)
Net lease cost (2)	$	2,804

(1) Includes variable lease costs related to short-term leases.

(2) Rent expense, including operating expenses, real estate taxes and insurance, recorded under ASC 840 for the three months ended March 31, 2018 was $3.9 million.

The table below summarizes the remaining expected lease payments under our operating leases as of March 31, 2019 and December 31, 2018.

Future Lease Payments	March 31, 2019			December 31, 2018 (1, 2)
2019	$	10,136		$	13,701
2020	12,717			12,724
2021	11,595			11,590
2022	10,775			10,766
2023	10,711			10,707
Thereafter	27,035			27,033
Total operating lease payments	$	82,969		$	86,521
Less: imputed interest	(12,396		)	n/a
Present value of operating lease liabilities	$	70,573		n/a

(1) The expected lease payments as of December 31, 2018 represent our future minimum rental commitments as defined by ASC 840.

(2) As of December 31, 2018, the expected total future minimum sublease income to be received was $10.2 million.

8

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

Other Information	Three Months Ended March 31, 2019
Cash paid for operating lease liabilities	$	3,554
Weighted average remaining lease term - operating leases	7.0 years
Weighted average discount rate - operating leases	4.7		%

During the first quarter of 2019, we entered into two new agreements to lease office space in Denver, Colorado and Bangalore, India. Both leases are expected to commence in the second quarter of 2019.

6. Revenues

For the three months ended March 31, 2019 and 2018, we recognized revenues of $204.4 million and $193.7 million, respectively. Of the $204.4 million recognized in the first quarter of 2019, we recognized revenues of $3.9 million from obligations satisfied, or partially satisfied, in prior periods, due to the release of allowances on unbilled services due to securing contract amendments. During the first quarter of 2019, we recognized a $1.2 million decrease to revenues due to changes in the estimates of our variable consideration under performance-based billing arrangements. Of the $193.7 million recognized in the first quarter of 2018, we recognized revenues of $5.9 million from obligations satisfied, or partially satisfied, in prior periods, of which $3.1 million was primarily due to the release of allowances on unbilled services due to securing contract amendments and $2.8 million was due to changes in the estimates of our variable consideration under performance-based billing arrangements.

As of March 31, 2019, we had $75.1 million of remaining performance obligations under engagements with original expected durations greater than one year. These remaining performance obligations exclude obligations under contracts with an original expected duration of one year or less, variable consideration which has been excluded from the total transaction price due to the constraint, and performance obligations under time-and-expense engagements which are recognized in the amount invoiced. Of the $75.1 million of performance obligations, we expect to recognize approximately $56.9 million as revenue in 2019, $12.4 million in 2020, and the remaining $5.8 million thereafter. Actual revenue recognition could differ from these amounts as a result of changes in the estimated timing of work to be performed, adjustments to estimated variable consideration in performance-based arrangements, or other factors.

Contract Assets and Liabilities

The payment terms and conditions in our customer contracts vary. Differences between the timing of billings and the recognition of revenue are recognized as either unbilled services or deferred revenues in the consolidated balance sheets.

Unbilled services include revenues recognized for services performed but not yet billed to clients. Services performed that we are not yet entitled to bill because certain events, such as the completion of the measurement period or client approval in performance-based engagements, must occur are recorded as contract assets and included within unbilled services, net. The contract asset balance as of March 31, 2019 and December 31, 2018 was $3.7 million and $9.1 million, respectively. The $5.4 million decrease primarily reflects timing differences between the completion of our performance obligations and the amounts billed or billable to clients in accordance with their contractual billing terms.

Client prepayments and retainers are classified as deferred revenues and recognized over future periods in accordance with the applicable engagement agreement and our revenue recognition policy. Our deferred revenues balance as of March 31, 2019 and December 31, 2018, was $30.0 million and $28.1 million, respectively. The $1.9 million increase primarily reflects timing differences between client payments in accordance with their contract terms and the completion of our performance obligations. For the three months ended March 31, 2019, $11.7 million of revenues recognized were included in the deferred revenue balance as of December 31, 2018.

9

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

7. Earnings Per Share

Basic earnings per share excludes dilution and is computed by dividing net income by the weighted average number of common shares outstanding for the period, excluding unvested restricted common stock. Diluted earnings per share reflects the potential reduction in earnings per share that could occur if securities or other contracts to issue common stock were exercised or converted into common stock under the treasury stock method. Such securities or other contracts include unvested restricted stock awards, outstanding common stock options, convertible senior notes, and outstanding warrants, to the extent dilutive. In periods for which we report a net loss from continuing operations, diluted weighted average common shares outstanding excludes all potential common stock equivalents as their impact on diluted net loss from continuing operations per share would be anti-dilutive.

Earnings (loss) per share under the basic and diluted computations are as follows: 

	Three Months Ended March 31,
	2019			2018
Net income (loss) from continuing operations	$	3,350		$	(3,222	)
Loss from discontinued operations, net of tax	(46		)	(42		)
Net income (loss)	$	3,304		$	(3,264	)
Weighted average common shares outstanding – basic	21,868			21,592
Weighted average common stock equivalents	443			—
Weighted average common shares outstanding – diluted	22,311			21,592
Net earnings (loss) per basic share:
Net income (loss) from continuing operations	$	0.15		$	(0.15	)
Loss from discontinued operations, net of tax	—			—
Net income (loss)	$	0.15		$	(0.15	)
Net earnings (loss) per diluted share:
Net income (loss) from continuing operations	$	0.15		$	(0.15	)
Loss from discontinued operations, net of tax	—			—
Net income (loss)	$	0.15		$	(0.15	)

The number of anti-dilutive securities excluded from the computation of the weighted average common stock equivalents presented above were as follows:

	As of March 31,
	2019	2018
Unvested restricted stock awards	12	723
Outstanding common stock options	—	184
Convertible senior notes	3,129	3,129
Warrants related to the issuance of convertible senior notes	3,129	3,129
Total anti-dilutive securities	6,270	7,165

See Note 8 “Financing Arrangements” for further information on the convertible senior notes and warrants related to the issuance of convertible notes.

We currently have a share repurchase program permitting us to repurchase up to $125 million of our common stock through October 31, 2019 (the “Share Repurchase Program”). The amount and timing of the repurchases will be determined by management and will depend on a variety of factors, including the trading price of our common stock, capacity under our credit facility, general market and business conditions, and applicable legal requirements. No shares were repurchased during the first three months of 2019 and 2018. As of March 31, 2019, $35.1 million remains available for share repurchases.

10

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

8. Financing Arrangements

A summary of the carrying amounts of our debt follows:

	March 31, 2019			December 31, 2018
1.25% convertible senior notes due 2019	$	245,051		$	242,617
Senior secured credit facility	76,000			50,000
Promissory note due 2024	4,240			4,368
Total long-term debt	$	325,291		$	296,985
Current maturities of long-term debt	(245,569		)	(243,132		)
Long-term debt, net of current portion	$	79,722		$	53,853

Below is a summary of the scheduled remaining principal payments of our debt as of March 31, 2019.

	Principal Payments of Long-Term Debt
2019	$	250,387
2020	$	529
2021	$	544
2022	$	559
2023	$	76,575
Thereafter	$	1,646

Convertible Notes

In September 2014, the Company issued $250 million principal amount of 1.25% convertible senior notes due 2019 (the “Convertible Notes”) in a private offering. The Convertible Notes are governed by the terms of an indenture between the Company and U.S. Bank National Association, as Trustee (the “Indenture”). The Convertible Notes are senior unsecured obligations of the Company and will pay interest semi-annually on April 1 and October 1 of each year at an annual rate of 1.25%. The Convertible Notes will mature on October 1, 2019, unless earlier repurchased by the Company or converted in accordance with their terms. We expect to refinance the principal amount of the outstanding Convertible Notes at maturity with the borrowing capacity available under our revolving credit facility.

Upon conversion, the Convertible Notes will be settled, at our election, in cash, shares of the Company’s common stock, or a combination of cash and shares of the Company’s common stock. Our current intent and policy is to settle conversions with a combination of cash and shares of common stock with the principal amount of the Convertible Notes paid in cash, in accordance with the settlement provisions of the Indenture.

The initial conversion rate for the Convertible Notes is 12.5170 shares of our common stock per $1,000 principal amount of the Convertible Notes, which is equal to an initial conversion price of approximately $79.89 per share of our common stock. The conversion rate will be subject to adjustment upon the occurrence of certain specified events but will not be adjusted for accrued and unpaid interest, except in certain limited circumstances described in the Indenture. Upon the occurrence of a “make-whole fundamental change” (as defined in the Indenture) the Company will, in certain circumstances, increase the conversion rate by a number of additional shares for a holder that elects to convert its Convertible Notes in connection with such make-whole fundamental change. Additionally, if the Company undergoes a “fundamental change” (as defined in the Indenture), a holder will have the option to require the Company to repurchase all or a portion of its Convertible Notes for cash at a price equal to 100% of the principal amount of the Convertible Notes being repurchased plus any accrued and unpaid interest. As discussed below, the convertible note hedge transactions and warrants, which were entered into in connection with the Convertible Notes, effectively raise the price at which economic dilution would occur from the initial conversion price of approximately $79.89 to approximately $97.12 per share.

11

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

Holders of the Convertible Notes may convert their Convertible Notes at their option at any time prior to July 1, 2019, only under the following circumstances:

• during any calendar quarter (and only during such calendar quarter) commencing after December 31, 2014 if, for each of at least 20 trading days (whether or not consecutive) during the 30 consecutive trading day period ending on, and including, the last trading day of the immediately preceding calendar quarter, the last reported sale price of the Company’s common stock for such trading day is equal to or greater than 130% of the applicable conversion price on such trading day;

• during the five consecutive business day period immediately following any five consecutive trading day period (such five consecutive trading day period, the “measurement period”) in which, for each trading day of the measurement period, the “trading price” (as defined in the Indenture) per $1,000 principal amount of the Convertible Notes for such trading day was less than 98% of the product of the last reported sale price of the Company’s common stock for such trading day and the applicable conversion rate on such trading day; or

• upon the occurrence of specified corporate transactions described in the Indenture.

On or after July 1, 2019 until the close of business on the second scheduled trading day immediately preceding the maturity date, a holder may convert all or a portion of its Convertible Notes, regardless of the foregoing circumstances.

We have separated the Convertible Notes into liability and equity components. The carrying amount of the liability component was determined by measuring the fair value of a similar liability that does not have an associated convertible feature, assuming our non-convertible debt borrowing rate. The carrying value of the equity component representing the conversion option, which is recognized as a debt discount, was determined by deducting the fair value of the liability component from the proceeds of the Convertible Notes. The debt discount is amortized to interest expense using an effective interest rate of 4.751% over the term of the Convertible Notes. As of March 31, 2019, the remaining life of the Convertible Notes is six months. The equity component will not be remeasured as long as it continues to meet the conditions for equity classification.

The transaction costs related to the issuance of the Convertible Notes were separated into liability and equity components based on their relative values, as determined above. Transaction costs attributable to the liability component are recorded as a deduction to the carrying amount of the liability and amortized to interest expense over the term of the Convertible Notes; and transaction costs attributable to the equity component are netted with the equity component of the Convertible Notes in stockholders’ equity. Total debt issuance costs were approximately $7.3 million, of which $6.2 million was allocated to liability issuance costs and $1.1 million was allocated to equity issuance costs.

As of March 31, 2019 and December 31, 2018, the Convertible Notes consisted of the following:

	March 31, 2019			December 31, 2018
Liability component:
Proceeds	$	250,000		$	250,000
Less: debt discount, net of amortization	(4,316		)	(6,436		)
Less: debt issuance costs, net of amortization	(633		)	(947		)
Net carrying amount	$	245,051		$	242,617
Equity component (1)	$	39,287		$	39,287

(1)Included in additional paid-in capital on the consolidated balance sheet.

12

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

The following table presents the amount of interest expense recognized related to the Convertible Notes for the periods presented.

	Three Months Ended March 31,
	2019		2018
Contractual interest coupon	$	781	$	781
Amortization of debt discount	2,120		2,021
Amortization of debt issuance costs	315		309
Total interest expense	$	3,216	$	3,111

In connection with the issuance of the Convertible Notes, we entered into convertible note hedge transactions and warrant transactions. The convertible note hedge transactions are intended to reduce the potential future economic dilution associated with the conversion of the Convertible Notes and, combined with the warrants, effectively raise the price at which economic dilution would occur from the initial conversion price of approximately $79.89 to approximately $97.12 per share. For purposes of the computation of diluted earnings per share in accordance with GAAP, dilution will occur when the average share price of our common stock for a given period exceeds the conversion price of the Convertible Notes, which initially is equal to approximately $79.89 per share. The convertible note hedge transactions and warrant transactions are discussed separately below.

• Convertible Note Hedge Transactions. In connection with the issuance of the Convertible Notes, the Company entered into convertible note hedge transactions whereby the Company has call options to purchase a total of approximately 3.1 million shares of the Company’s common stock, which is the number of shares initially issuable upon conversion of the Convertible Notes in full, at a price of approximately $79.89, which corresponds to the initial conversion price of the Convertible Notes, subject to customary anti-dilution adjustments substantially similar to those in the Convertible Notes. The convertible note hedge transactions are exercisable upon conversion of the Convertible Notes and will expire in 2019 if not earlier exercised. We paid an aggregate amount of $42.1 million for the convertible note hedge transactions, which was recorded as additional paid-in capital on the consolidated balance sheet. The convertible note hedge transactions are separate transactions and are not part of the terms of the Convertible Notes.

• Warrants. In connection with the issuance of the Convertible Notes, the Company sold warrants whereby the holders of the warrants have the option to purchase a total of approximately 3.1 million shares of the Company’s common stock at a strike price of approximately $97.12. The warrants will expire incrementally on 100 different dates from January 6, 2020 to May 28, 2020 and are exercisable at each such expiry date. If the average market value per share of our common stock for the reporting period exceeds the strike price of the warrants, the warrants will have a dilutive effect on our earnings per share. We received aggregate proceeds of $23.6 million from the sale of the warrants, which was recorded as additional paid-in capital on the consolidated balance sheet. The warrants are separate transactions and are not part of the terms of the Convertible Notes or the convertible note hedge transactions.

The Company recorded an initial deferred tax liability of $15.4 million in connection with the debt discount associated with the Convertible Notes and recorded an initial deferred tax asset of $16.5 million in connection with the convertible note hedge transactions. The deferred tax liability and deferred tax asset are included in deferred income taxes, net on the consolidated balance sheets.

Senior Secured Credit Facility

The Company has a $500 millionfive-year senior secured revolving credit facility, subject to the terms of a Second Amended and Restated Credit Agreement dated as of March 31, 2015, as amended to date (as amended and modified the "Amended Credit Agreement"), that becomes due and payable in full upon maturity on March 23, 2023. The Amended Credit Agreement provides the option to increase the revolving credit facility or establish term loan facilities in an aggregate amount of up to $150 million, subject to customary conditions and the approval of any lender whose commitment would be increased, resulting in a maximum available principal amount under the Amended Credit Agreement of $650 million. The initial borrowings under the Amended Credit Agreement were used to refinance borrowings outstanding under a prior credit agreement, and future borrowings under the Amended Credit Agreement may be used for working capital, capital expenditures, acquisitions of businesses, share repurchases, and general corporate purposes.

Fees and interest on borrowings vary based on our Consolidated Leverage Ratio (as defined in the Amended Credit Agreement). At our option, borrowings under the Amended Credit Agreement will bear interest at one, two, three or six-month LIBOR or an alternate base rate, in each case plus the applicable margin. The applicable margin will fluctuate between 1.25% per annum and 2.00% per annum, in the case of

13

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

LIBOR borrowings, or between 0.25% per annum and 1.00% per annum, in the case of base rate loans, based upon our Consolidated Leverage Ratio at such time.

Amounts borrowed under the Amended Credit Agreement may be prepaid at any time without premium or penalty. We are required to prepay the amounts outstanding under the Amended Credit Agreement in certain circumstances, including a requirement to pay all amounts outstanding under the Amended Credit Agreement 90 days prior to the Convertible Indebtedness Maturity Date (as defined in the Amended Credit Agreement) unless (1) the Convertible Indebtedness Maturity Date is waived or extended to a later date, (2) the Company can demonstrate (a) Liquidity (as defined in the Amended Credit Agreement) in an amount at least equal to the principal amount due on the Convertible Indebtedness Maturity Date, and (b) financial covenant compliance after giving effect to such payments and any additional indebtedness incurred on a pro forma basis, or (3) this requirement is waived by the Required Lenders (as defined in the Amended Credit Agreement). In addition, we have the right to permanently reduce or terminate the unused portion of the commitments provided under the Amended Credit Agreement at any time.

The loans and obligations under the Amended Credit Agreement are secured pursuant to a Second Amended and Restated Security Agreement and a Second Amended and Restated Pledge Agreement (the “Pledge Agreement”) with Bank of America, N.A. as collateral agent, pursuant to which the Company and the subsidiary guarantors grant Bank of America, N.A., for the ratable benefit of the lenders under the Amended Credit Agreement, a first-priority lien, subject to permitted liens, on substantially all of the personal property assets of the Company and the subsidiary guarantors, and a pledge of 100% of the stock or other equity interests in all domestic subsidiaries and 65% of the stock or other equity interests in each “material first-tier foreign subsidiary” (as defined in the Pledge Agreement).

The Amended Credit Agreement contains usual and customary representations and warranties; affirmative and negative covenants, which include limitations on liens, investments, additional indebtedness, and restricted payments; and two quarterly financial covenants as follows: (i) a maximum Consolidated Leverage Ratio (defined as the ratio of debt to consolidated EBITDA) ranging from 3.50 to 1.00 to 4.00 to 1.00, depending on the measurement period, and (ii) a minimum Consolidated Interest Coverage Ratio (defined as the ratio of consolidated EBITDA to interest) of 3.50 to 1.00. Consolidated EBITDA for purposes of the financial covenants is calculated on a continuing operations basis and includes adjustments to add back non-cash goodwill impairment charges, share-based compensation costs, certain non-cash restructuring charges, pro forma historical EBITDA for businesses acquired, and other specified items in accordance with the Amended Credit Agreement. At March 31, 2019, we were in compliance with these financial covenants with a Consolidated Leverage Ratio of 2.99 to 1.00 and a Consolidated Interest Coverage Ratio of 12.08 to 1.00.

Borrowings outstanding under the Amended Credit Agreement at March 31, 2019 totaled $76.0 million. These borrowings carried a weighted average interest rate of 4.5%, including the effect of the interest rate swap described in Note 10 “Derivative Instrument and Hedging Activity." Borrowings outstanding under the Amended Credit Agreement at December 31, 2018 were $50.0 million and carried a weighted average interest rate of 3.7%, including the effect of the interest rate swap described in Note 10 “Derivative Instrument and Hedging Activity." The borrowing capacity under the revolving credit facility is reduced by any outstanding borrowings under the revolving credit facility and outstanding letters of credit. At March 31, 2019, we had outstanding letters of credit totaling $1.6 million, which are primarily used as security deposits for our office facilities. As of March 31, 2019, the unused borrowing capacity under the revolving credit facility was $422.4 million.

Promissory Note due 2024

On June 30, 2017, in conjunction with our purchase of an aircraft related to the acquisition of Innosight, we assumed, from the sellers of the aircraft, a promissory note with an outstanding principal balance of $5.1 million. The principal balance of the promissory note is subject to scheduled monthly principal payments until the maturity date of March 1, 2024, at which time a final payment of $1.5 million, plus any accrued and unpaid interest, will be due. Under the terms of the promissory note, we will pay interest on the outstanding principal amount at a rate of one-month LIBOR plus 1.97% per annum. The obligations under the promissory note are secured pursuant to a Loan and Aircraft Security Agreement with Banc of America Leasing & Capital, LLC, which grants the lender a first priority security interest in the aircraft. At March 31, 2019, the outstanding principal amount of the promissory note was $4.2 million. As of March 31, 2019, the aircraft had a carrying amount of $5.6 million. At December 31, 2018, the outstanding principal amount of the promissory note was $4.4 million, and the aircraft had a carrying amount of $5.8 million.

9. Restructuring Charges

Restructuring charges for the first three months of 2019 totaled $1.3 million, compared to $0.7 million for the first three months of 2018. During the first quarter of 2019, we exited a portion of our Lake Oswego, Oregon corporate office resulting in a $0.7 million lease impairment charge on the related operating lease right-of-use asset and leasehold improvements and $0.2 million of accelerated depreciation on related furniture and fixtures. The lease impairment charge was recognized in accordance with ASC 842, Leases, which we adopted on a modified retrospective basis on J

14

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

anuary 1, 2019. See Note 2 "Basis of Presentation and Significant Accounting Policies" and Note 3 "New Accounting Pronouncements" for additional information on our adoption of ASC 842. See Note 5 "Leases" for additional information on the long-lived asset impairment test performed in the first quarter of 2019. Additionally, we recognized a $0.2 million restructuring charge in the first quarter of 2019 related to workforce reductions in our corporate operations. The $0.7 million restructuring charge incurred in the first three months of 2018 primarily related to updated lease assumptions for our San Francisco office vacated in the second quarter of 2017, which was accounted for in accordance with ASC 840, Leases.

The table below sets forth the changes in the carrying amount of our restructuring charge liability by restructuring type for the three months ended March 31, 2019.

	Employee Costs			Office Space Reductions			Total
Balance as of December 31, 2018	$	443		$	2,468		$	2,911
Adoption of ASC 842 (1)	—			(1,119		)	(1,119		)
Balance as of January 1, 2019	443			1,349			1,792
Additions (2)	247			289			536
Payments	(435		)	(371		)	(806		)
Adjustments (3)	(2		)	65			63
Non-cash items	—			(249		)	(249		)
Balance as of March 31, 2019	$	253		$	1,083		$	1,336

(1) Upon adoption of ASC 842 on January 1, 2019, we reclassified the restructuring charge liabilities, which represented the present value of remaining lease payments, net of estimated sublease income, for vacated office spaces from restructuring charge liabilities to operating lease right-of-use assets. See Note 3 "New Accounting Pronouncements" for additional information on the impact of adoption.

(2) Additions for the three months ended March 31, 2019 excludes the $0.7 million lease impairment charge recognized as restructuring charges on our consolidated statement of operations. See Note 5 "Leases" within the notes to our consolidated financial statements for additional information on the long-lived asset impairment test performed in the first quarter of 2019.

(3) Adjustments for the three months ended March 31, 2019 includes restructuring charges of $0.1 million related to updated operating expense assumptions for vacated office spaces directly related to discontinued operations.

As of March 31, 2019, our restructuring charge liability related to office space reductions of $1.1 million represented the present value of the remaining estimated operating expense payments for vacated office spaces, primarily in Chicago, Illinois; Washington, D.C.; and Middleton, Wisconsin. This restructuring charge liability is included as a component of accrued expenses and other current liabilities and deferred compensation and other liabilities. All of the $0.3 million restructuring charge liability related to employee costs at March 31, 2019 is expected to be paid in the next 12 months. The restructuring charge liability related to employee costs is included as a component of accrued payroll and related benefits.

10. Derivative Instrument and Hedging Activity

On June 22, 2017, we entered into a forward interest rate swap agreement effective August 31, 2017 and ending August 31, 2022, with a notional amount of $50.0 million. We entered into this derivative instrument to hedge against the interest rate risks of our variable-rate borrowings. Under the terms of the interest rate swap agreement, we receive from the counterparty interest on the notional amount based on one-month LIBOR and we pay to the counterparty a fixed rate of 1.900%.

We recognize all derivative instruments as either assets or liabilities at fair value on the balance sheet. We have designated this derivative instrument as a cash flow hedge. Therefore, changes in the fair value of the derivative instrument are recorded to other comprehensive income (“OCI”) and reclassified into interest expense upon settlement. As of March 31, 2019, it was anticipated that $0.2 million of the gains, net of tax, currently recorded in accumulated other comprehensive income will be reclassified into earnings within the next 12 months.

15

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

The table below sets forth additional information relating to the interest rate swap designated as a cash flow hedging instrument as of March 31, 2019 and December 31, 2018.

	Fair Value (Derivative Asset and Liability)
Balance Sheet Location	March 31, 2019		December 31, 2018
Prepaid expenses and other current assets	$	240	$	302
Other non-current assets	$	192	$	451

All of our derivative instruments are transacted under the International Swaps and Derivatives Association (ISDA) master agreements. These agreements permit the net settlement of amounts owed in the event of default and certain other termination events. Although netting is permitted, it is our policy to record all derivative assets and liabilities on a gross basis on our consolidated balance sheet.

We do not use derivative instruments for trading or other speculative purposes. Refer to Note 12 “Other Comprehensive Income (Loss)” for additional information on our derivative instrument.

11. Fair Value of Financial Instruments

Certain of our assets and liabilities are measured at fair value. Fair value is defined as the price that would be received to sell an asset or the price that would be paid to transfer a liability in an orderly transaction between market participants at the measurement date. GAAP establishes a fair value hierarchy for inputs used in measuring fair value and requires companies to maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy consists of three levels based on the objectivity of the inputs as follows:

Level 1 Inputs	Quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.
Level 2 Inputs	Quoted prices in active markets for similar assets or liabilities; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; or inputs that are derived principally from or corroborated by observable market data by correlation or other means.
Level 3 Inputs	Unobservable inputs for the asset or liability, and include situations in which there is little, if any, market activity for the asset or liability.

16

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

The table below sets forth our fair value hierarchy for our financial assets and liabilities measured at fair value on a recurring basis as of March 31, 2019 and December 31, 2018.

	Level 1		Level 2		Level 3		Total
March 31, 2019
Assets:
Interest rate swap	$	—	$	432	$	—	$	432
Convertible debt investment	—		—		54,038		54,038
Deferred compensation assets	—		23,918		—		23,918
Total assets	$	—	$	24,350	$	54,038	$	78,388
Liabilities:
Contingent consideration for business acquisitions	$	—	$	—	$	11,129	$	11,129
Total liabilities	$	—	$	—	$	11,129	$	11,129
December 31, 2018
Assets:
Interest rate swap	$	—	$	753	$	—	$	753
Convertible debt investment	—		—		50,429		50,429
Deferred compensation assets	—		18,205		—		18,205
Total assets	$	—	$	18,958	$	50,429	$	69,387
Liabilities:
Contingent consideration for business acquisitions	$	—	$	—	$	11,441	$	11,441
Total liabilities	$	—	$	—	$	11,441	$	11,441

Interest rate swap: The fair value of our interest rate swap was derived using estimates to settle the interest rate swap agreement, which is based on the net present value of expected future cash flows on each leg of the swap utilizing market-based inputs and a discount rate reflecting the risks involved.

Convertible debt investment: In 2014 and 2015, we invested $27.9 million, in the form of zero coupon convertible debt, in Shorelight Holdings, LLC (“Shorelight”), the parent company of Shorelight Education, a U.S.-based company that partners with leading universities to increase access to and retention of international students, boost institutional growth, and enhance an institution’s global footprint. The notes will mature on July 1, 2020, unless converted earlier.

To determine the appropriate accounting treatment for our investment, we performed a variable interest entity (“VIE”) analysis and concluded that Shorelight does not meet the definition of a VIE. We also reviewed the characteristics of our investment to confirm that the convertible notes are not in-substance common stock that would warrant equity method accounting. After we reviewed all of the terms of the investment, we concluded the appropriate accounting treatment to be that of an available-for-sale debt security.

The convertible debt investment is carried at fair value with unrealized holding gains and losses excluded from earnings and reported in other comprehensive income. We estimate the fair value of our investment using a Monte Carlo simulation model, cash flow projections discounted at a risk-adjusted rate, and certain assumptions related to equity volatility and applicable holding period, all of which are Level 3 inputs. The use of alternative estimates and assumptions could increase or decrease the estimated fair value of the investment, which would result in different impacts to our consolidated balance sheet and comprehensive income. Actual results may differ from our estimates. The fair value of the convertible debt investment is recorded in long-term investment on our consolidated balance sheets.

The table below sets forth the changes in the balance of the convertible debt investment for the three months ended March 31, 2019.

	Convertible Debt Investment
Balance as of December 31, 2018	$	50,429
Change in fair value of convertible debt investment	3,609
Balance as of March 31, 2019	$	54,038

Deferred compensation assets: We have a non-qualified deferred compensation plan (the "Plan") for the members of our board of directors and a select group of our employees. The deferred compensation liability is funded by the Plan assets, which consist of life insurance policies maintained within a trust. The cash surrender value of the life insurance policies approximates fair value and is based on third-party broker

17

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

statements which provide the fair value of the life insurance policies' underlying investments, which are Level 2 inputs. The cash surrender value of the life insurance policies is invested primarily in mutual funds. The Plan assets are included in other non-current assets on our consolidated balance sheets. Realized and unrealized gains (losses) from the deferred compensation assets are recorded to other income (expense), net in our consolidated statements of operations.

Contingent consideration for business acquisitions: We estimate the fair value of acquisition-related contingent consideration using either a probability-weighted assessment of the specific financial performance targets being achieved or a Monte Carlo simulation model, as appropriate. These fair value measurements are based on significant inputs not observable in the market and thus represent Level 3 inputs. The significant unobservable inputs used in the fair value measurements of our contingent consideration are our measures of the estimated payouts based on internally generated financial projections on a probability-weighted basis and discount rates, which typically reflect a risk-free rate. The fair value of the contingent consideration is reassessed quarterly based on assumptions used in our latest projections and input provided by practice leaders and management. Any change in the fair value estimate is recorded in our consolidated statement of operations for that period. The use of alternative estimates and assumptions could increase or decrease the estimated fair value of our contingent consideration liability, which would result in different impacts to our consolidated balance sheets and consolidated statements of operations. Actual results may differ from our estimates. The table below sets forth the changes in the balance of the contingent consideration for business acquisitions for the three months ended March 31, 2019.

	Contingent Consideration for Business Acquisitions
Balance as of December 31, 2018	$	11,441
Remeasurement of contingent consideration for business acquisitions	(391		)
Unrealized loss due to foreign currency translation	79
Balance as of March 31, 2019	$	11,129

Financial assets and liabilities not recorded at fair value are as follows:

Senior Secured Credit Facility

The carrying value of our borrowings outstanding under our senior secured credit facility is stated at cost. Our carrying value approximates fair value, using Level 2 inputs, as the senior secured credit facility bears interest at variable rates based on current market rates as set forth in the Amended Credit Agreement. Refer to Note 8 “Financing Arrangements” for additional information on our senior secured credit facility.

Promissory Note due 2024

The carrying value of our promissory note due 2024 is stated at cost. Our carrying value approximates fair value, using Level 2 inputs, as the promissory note bears interest at rates based on current market rates as set forth in the terms of the promissory note. Refer to Note 8 “Financing Arrangements” for additional information on our promissory note due 2024.

Convertible Notes

The carrying amount and estimated fair value of the Convertible Notes are as follows:

	March 31, 2019				December 31, 2018
	Carrying Amount		Estimated Fair Value		Carrying Amount		Estimated Fair Value
1.25% convertible senior notes due 2019	$	245,051	$	246,190	$	242,617	$	242,940

The differences between the $250 million principal amount of the Convertible Notes and the carrying amounts shown above represent the unamortized debt discount and issuance costs. As of March 31, 2019 and December 31, 2018, the carrying value of the equity component of $39.3 million was unchanged from the date of issuance. Refer to Note 8 “Financing Arrangements” for additional information on our Convertible Notes. The estimated fair value of the Convertible Notes was determined based on the quoted bid price of the Convertible Notes in an over-the-counter market, which is a Level 2 input, on the last day of trading for the quarters ended March 31, 2019 and December 31, 2018.

18

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

Based on the closing price of our common stock of $47.22 on March 31, 2019, the if-converted value of the Convertible Notes was less than the principal amount.

Cash and cash equivalents are stated at cost, which approximates fair market value. The carrying values of all other financial instruments not described above reasonably approximate fair market value due to the nature of the financial instruments and the short-term maturity of these items.

12. Other Comprehensive Income (Loss)

The table below sets forth the components of other comprehensive income (loss), net of tax, for the three months ended March 31, 2019 and 2018.

	Three Months Ended March 31, 2019									Three Months Ended March 31, 2018
	Before Taxes			Tax (Expense) Benefit			Net of Taxes			Before Taxes		Tax (Expense) Benefit			Net of Taxes
Other comprehensive income (loss):
Foreign currency translation adjustments	$	316		$	—		$	316		$	34	$	—		$	34
Unrealized gain on investment	$	3,609		$	(952	)	$	2,657		$	2,927	$	(761	)	$	2,166
Unrealized gain (loss) on cash flow hedges:
Change in fair value	$	(247	)	$	65		$	(182	)	$	545	$	(141	)	$	404
Reclassification adjustments into earnings	(74		)	19			(55		)	38		(10		)	28
Net unrealized gain (loss)	$	(321	)	$	84		$	(237	)	$	583	$	(151	)	$	432
Other comprehensive income	$	3,604		$	(868	)	$	2,736		$	3,544	$	(912	)	$	2,632

The before tax amounts reclassified from accumulated other comprehensive income related to our cash flow hedges are recorded to interest expense, net of interest income.

Accumulated other comprehensive income, net of tax, includes the following components:

	Foreign Currency Translation			Available-for-Sale Investment		Cash Flow Hedges			Total
Balance, December 31, 2018	$	(665	)	$	16,584	$	576		$	16,495
Current period change	316			2,657		(237		)	2,736
Balance, March 31, 2019	$	(349	)	$	19,241	$	339		$	19,231

13. Income Taxes

For the three months ended March 31, 2019, our effective tax rate was 29.0% as we recognized income tax expense from continuing operations of $1.4 million on income from continuing operations of $4.7 million. The effective tax rate of 29.0% was less favorable than the statutory rate, inclusive of state income taxes, of 26.4% primarily due to $0.5 million of foreign losses with no tax benefit, which had an unfavorable impact of 2.9% on the effective tax rate; and $0.1 million of additional tax expense related to disallowed executive compensation deductions, which had an unfavorable impact of 1.8% on the effective tax rate. These unfavorable adjustments to our effective tax rate were partially offset by $0.1 million of discrete tax benefit for share-based compensation awards that vested during the first quarter of 2019 and which had a favorable impact of 1.8% on the effective tax rate.

For the three months ended March 31, 2018, our effective tax rate was (14.7)% as we recognized income tax expense from continuing operations of $0.4 million on a loss from continuing operations of $2.8 million. The effective tax rate of (14.7)% was less favorable than the statutory rate, inclusive of state income taxes, of 26.0% primarily due to discrete tax expense for share-based compensation awards that vested during the first quarter of 2018 and which had an unfavorable impact of 43.7% on the effective tax rate.

19

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

14. Commitments, Contingencies and Guarantees

Litigation

From time to time, we are involved in legal proceedings and litigation arising in the ordinary course of business. As of the date of this Quarterly Report on Form 10-Q, we are not a party to any litigation or legal proceeding that, in the current opinion of management, could have a material adverse effect on our financial position or results of operations. However, due to the risks and uncertainties inherent in legal proceedings, actual results could differ from current expected results.

Guarantees

Guarantees in the form of letters of credit totaling $1.6 million were outstanding at both March 31, 2019 and December 31, 2018, primarily to support certain office lease obligations.

In connection with certain business acquisitions, we may be required to pay post-closing consideration to the sellers if specific financial performance targets are met over a number of years as specified in the related purchase agreements. As of March 31, 2019 and December 31, 2018, the total estimated fair value of our contingent consideration liabilities was $11.1 million and $11.4 million, respectively.

To the extent permitted by law, our bylaws and articles of incorporation require that we indemnify our officers and directors against judgments, fines and amounts paid in settlement, including attorneys’ fees, incurred in connection with civil or criminal action or proceedings, as it relates to their services to us if such person acted in good faith. Although there is no limit on the amount of indemnification, we may have recourse against our insurance carrier for certain payments made.

15. Segment Information

Segments are defined as components of a company that engage in business activities from which they may earn revenues and incur expenses, and for which separate financial information is available and is evaluated regularly by the chief operating decision maker, or decision-making group, in deciding how to allocate resources and in assessing performance. Our chief operating decision maker, who is our chief executive officer, manages the business under three operating segments, which are our reportable segments: Healthcare, Business Advisory, and Education.

• Healthcare

Our Healthcare segment has a depth of expertise in care transformation, financial and operational excellence, technology and analytics, and leadership development. We serve national and regional hospitals and integrated health systems, academic medical centers, community hospitals, and medical groups. Our solutions help clients evolve and adapt to the rapidly changing healthcare environment and achieve growth, optimize performance, enhance profitability, improve quality and clinical outcomes, align leaders, improve organizational culture, and drive physician, patient, and employee engagement across the enterprise to deliver better consumer outcomes.

We help organizations transform and innovate their delivery model to focus on patient wellness by improving quality outcomes, minimizing care variation and fundamentally improving patient and population health. Our consultants partner with clients to help build and sustain today’s business to invest in the future by reducing complexity, improving operational efficiency and growing market share. We enable the healthcare of the future by identifying, integrating and optimizing technology investments to collect data that transforms care delivery and improves patient outcomes. We also develop future leaders capable of driving meaningful operational and organizational change and who transform the consumer experience.

• Business Advisory

Our Business Advisory segment provides services to large and middle market organizations, not-for-profit organizations, lending institutions, law firms, investment banks and private equity firms. We assist clients in a broad range of industries and across the spectrum from healthy, well-capitalized companies to organizations in transition, as well as creditors, equity owners, and other key constituents. Our Business Advisory professionals resolve complex business issues and enhance client enterprise value through a suite of services including capital advisory, transaction advisory, operational improvement, restructuring and turnaround, valuation, and dispute advisory. Our Enterprise Solutions and Analytics professionals deliver technology and analytic solutions that enable organizations to manage and optimize their financial performance, operational efficiency, and client or stakeholder experience. Our Strategy and Innovation professionals collaborate with clients across a range of industries to identify new growth opportunities, build new ventures and capabilities, and accelerate organizational change. Our Life Sciences professionals providestrategic

20

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

solutions to help pharmaceutical, medical device, and biotechnology companies deliver more value to patients, payers, and providers, and comply with regulations.

• Education

Our Education segment provides consulting and technology solutions to higher education institutions and academic medical centers. We partner with clients to address challenges relating to business and technology strategy, financial management, operational and organizational effectiveness, research administration, and regulatory compliance. Our institutional strategy, market research, budgeting and financial management, business operations and student life cycle management solutions align missions with business priorities, improve quality and reduce costs institution-wide. Our student solutions improve attraction, retention and graduation rates, increase student satisfaction and help generate quality outcomes. Our technology strategy, enterprise applications, and analytic solutions transform and optimize operations, deliver time and cost savings, and enhance the student experience. Our research enterprise solutions assist clients in identifying and implementing institutional research strategy, optimizing clinical research operations, improving financial management and cost reimbursement, improving service to faculty, and mitigating risk compliance.

Segment operating income consists of the revenues generated by a segment, less the direct costs of revenue and selling, general and administrative expenses that are incurred directly by the segment. Unallocated corporate costs include costs related to administrative functions that are performed in a centralized manner that are not attributable to a particular segment. These administrative function costs include costs for corporate office support, certain office facility costs, costs relating to accounting and finance, human resources, legal, marketing, information technology, and company-wide business development functions, as well as costs related to overall corporate management.

The table below sets forth information about our operating segments for the three months ended March 31, 2019 and 2018, along with the items necessary to reconcile the segment information to the totals reported in the accompanying consolidated financial statements.

	Three Months Ended March 31,
	2019			2018
Healthcare:
Revenues	$	93,682		$	89,895
Operating income	$	27,851		$	24,460
Segment operating income as a percentage of segment revenues	29.7		%	27.2		%
Business Advisory:
Revenues	$	58,806		$	55,895
Operating income	$	9,581		$	8,998
Segment operating income as a percentage of segment revenues	16.3		%	16.1		%
Education:
Revenues	$	51,957		$	47,889
Operating income	$	12,618		$	11,425
Segment operating income as a percentage of segment revenues	24.3		%	23.9		%
Total Company:
Revenues	$	204,445		$	193,679
Reimbursable expenses	18,617			17,619
Total revenues and reimbursable expenses	$	223,062		$	211,298
Segment operating income	$	50,050		$	44,883
Items not allocated at the segment level:
Other operating expenses	36,578			32,928
Other losses (gains), net	(456		)	830
Depreciation and amortization	7,172			8,803
Other expense, net	2,041			5,131
Income (loss) from continuing operations before taxes	$	4,715		$	(2,809	)

21

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

The following table illustrates the disaggregation of revenues by billing arrangements, employee types, and timing of revenue recognition, including a reconciliation of the disaggregated revenues to revenues from our three operating segments for the three months ended March 31, 2019 and 2018.

	Three Months Ended March 31, 2019
	Healthcare		Business Advisory		Education		Total
Billing Arrangements
Fixed-fee	$	63,584	$	21,672	$	12,383	$	97,639
Time and expense	12,763		35,309		35,358		83,430
Performance-based	11,810		664		—		12,474
Software support, maintenance and subscriptions	5,525		1,161		4,216		10,902
Total	$	93,682	$	58,806	$	51,957	$	204,445
Employee Type (1)
Revenue generated by full-time billable consultants	$	64,818	$	57,094	$	46,007	$	167,919
Revenue generated by full-time equivalents	28,864		1,712		5,950		36,526
Total	$	93,682	$	58,806	$	51,957	$	204,445
Timing of Revenue Recognition
Revenue recognized over time	$	91,642	$	58,806	$	51,711	$	202,159
Revenue recognized at a point in time	2,040		—		246		2,286
Total	$	93,682	$	58,806	$	51,957	$	204,445

	Three Months Ended March 31, 2018
	Healthcare		Business Advisory		Education		Total
Billing Arrangements
Fixed-fee	$	60,269	$	22,420	$	11,306	$	93,995
Time and expense	12,789		31,337		33,442		77,568
Performance-based	10,191		909		—		11,100
Software support, maintenance and subscriptions	6,646		1,229		3,141		11,016
Total	$	89,895	$	55,895	$	47,889	$	193,679
Employee Type (1)
Revenue generated by full-time billable consultants	$	59,273	$	53,416	$	41,632	$	154,321
Revenue generated by full-time equivalents	30,622		2,479		6,257		39,358
Total	$	89,895	$	55,895	$	47,889	$	193,679
Timing of Revenue Recognition
Revenue recognized over time	$	88,341	$	55,895	$	46,585	$	190,821
Revenue recognized at a point in time	1,554		—		1,304		2,858
Total	$	89,895	$	55,895	$	47,889	$	193,679

(1) Full-time billable consultants consist of our full-time professionals who provide consulting services to our clients and are billable to our clients based on the number of hours worked. Full-time equivalent professionals consist of leadership coaches and their support staff within our Studer Group solution, consultants who work variable schedules as needed by our clients, and full-time employees who provide software support and maintenance services to our clients.

At March 31, 2019 and December 31, 2018, no single client accounted for greater than 10% of our combined receivables and unbilled services balances. During the three months ended March 31, 2019 and 2018, no single client generated greater than 10% of our consolidated revenues.

22

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

In this Quarterly Report on Form 10-Q, unless the context otherwise requires, the terms “Huron,” “Company,” “we,” “us” and “our” refer to Huron Consulting Group Inc. and its subsidiaries.

Statements in this Quarterly Report on Form 10-Q that are not historical in nature, including those concerning the Company’s current expectations about its future results, are “forward-looking” statements as defined in Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and the Private Securities Litigation Reform Act of 1995. Forward-looking statements are identified by words such as “may,” “should,” “expects,” “provides,” “anticipates,” “assumes,” “can,” “will,” “meets,” “could,” “likely,” “intends,” “might,” “predicts,” “seeks,” “would,” “believes,” “estimates,” “plans,” “continues,” “guidance,” or “outlook,” or similar expressions. These forward-looking statements reflect our current expectations about our future requirements and needs, results, levels of activity, performance, or achievements. Some of the factors that could cause actual results to differ materially from the forward-looking statements contained herein include, without limitation: failure to achieve expected utilization rates, billing rates, and the number of revenue-generating professionals; inability to expand or adjust our service offerings in response to market demands; our dependence on renewal of client-based services; dependence on new business and retention of current clients and qualified personnel; failure to maintain third-party provider relationships and strategic alliances; inability to license technology to and from third parties; the impairment of goodwill; various factors related to income and other taxes; difficulties in successfully integrating the businesses we acquire and achieving expected benefits from such acquisitions; risks relating to privacy, information security, and related laws and standards; and a general downturn in market conditions. These forward-looking statements involve known and unknown risks, uncertainties, and other factors, including, among others, those described under Item 1A. “Risk Factors,” in our Annual Report on Form 10-K for the year ended December 31, 2018 that may cause actual results, levels of activity, performance or achievements to be materially different from any anticipated results, levels of activity, performance, or achievements expressed or implied by these forward-looking statements. We disclaim any obligation to update or revise any forward-looking statements as a result of new information or future events, or for any other reason.

OVERVIEW

Our Business

Huron is a global consultancy that helps clients drive growth, enhance performance and sustain leadership in the markets they serve. We partner with clients to develop strategies and implement solutions that enable the transformative change our clients need to own their future.

We provide professional services through three operating segments: Healthcare, Business Advisory, and Education.

• Healthcare

Our Healthcare segment has a depth of expertise in care transformation, financial and operational excellence, technology and analytics, and leadership development. We serve national and regional hospitals and integrated health systems, academic medical centers, community hospitals, and medical groups. Our solutions help clients evolve and adapt to the rapidly changing healthcare environment and achieve growth, optimize performance, enhance profitability, improve quality and clinical outcomes, align leaders, improve organizational culture, and drive physician, patient, and employee engagement across the enterprise to deliver better consumer outcomes.

We help organizations transform and innovate their delivery model to focus on patient wellness by improving quality outcomes, minimizing care variation and fundamentally improving patient and population health. Our consultants partner with clients to help build and sustain today’s business to invest in the future by reducing complexity, improving operational efficiency and growing market share. We enable the healthcare of the future by identifying, integrating and optimizing technology investments to collect data that transforms care delivery and improves patient outcomes. We also develop future leaders capable of driving meaningful operational and organizational change and who transform the consumer experience.

• Business Advisory

Our Business Advisory segment provides services to large and middle market organizations, not-for-profit organizations, lending institutions, law firms, investment banks and private equity firms. We assist clients in a broad range of industries and across the spectrum from healthy, well-capitalized companies to organizations in transition, as well as creditors, equity owners, and other key constituents. Our Business Advisory professionals resolve complex business issues and enhance client enterprise value through a suite of services including capital advisory, transaction advisory, operational improvement, restructuring and turnaround, valuation, and dispute advisory. Our Enterprise Solutions and Analytics professionals deliver technology and analytic solutions that enable organizations to manage and optimize their financial performance, operational efficiency, and client or stakeholder experience. Our Strategy and Innovation professionals collaborate with clients across a range of industries to identify new growth opportunities, build new ventures and capabilities, and accelerate organizational change. Our Life Sciences professionals providestrategic solutions to help pharmaceutical, medical device, and biotechnology companies deliver more value to patients, payers, and providers, and comply with regulations.

23

• Education

Our Education segment provides consulting and technology solutions to higher education institutions and academic medical centers. We partner with clients to address challenges relating to business and technology strategy, financial management, operational and organizational effectiveness, research administration, and regulatory compliance. Our institutional strategy, market research, budgeting and financial management, business operations and student life cycle management solutions align missions with business priorities, improve quality and reduce costs institution-wide. Our student solutions improve attraction, retention and graduation rates, increase student satisfaction and help generate quality outcomes. Our technology strategy, enterprise applications, and analytic solutions transform and optimize operations, deliver time and cost savings, and enhance the student experience. Our research enterprise solutions assist clients in identifying and implementing institutional research strategy, optimizing clinical research operations, improving financial management and cost reimbursement, improving service to faculty, and mitigating risk compliance.

Huron is a Platinum level member of the Oracle PartnerNetwork, an Oracle Cloud Premier Partner within North America, a Workday Services Partner, and a Gold level consulting partner with Salesforce.com.

How We Generate Revenues

A large portion of our revenues is generated by our full-time consultants who provide consulting services to our clients and are billable to our clients based on the number of hours worked. A smaller portion of our revenues is generated by our other professionals, also referred to as full-time equivalents, some of whom work variable schedules as needed by our clients. Full-time equivalent professionals consist of our leadership coaches and their support staff from our Studer Group solution, specialized finance and operational consultants, and our employees who provide software support and maintenance services to our clients. We translate the hours that these other professionals work on client engagements into a full-time equivalent measure that we use to manage our business. We refer to our full-time consultants and other professionals collectively as revenue-generating professionals.

Revenues generated by our full-time consultants are primarily driven by the number of consultants we employ and their utilization rates, as well as the billing rates we charge our clients. Revenues generated by our other professionals, or full-time equivalents, are largely dependent on the number of consultants we employ, their hours worked, and billing rates charged. Revenues generated by our coaches are largely dependent on the number of coaches we employ and the total value, scope, and terms of the consulting contracts under which they provide services, which are primarily fixed-fee contracts.

We generate our revenues from providing professional services under four types of billing arrangements: fixed-fee (including software license revenue); time-and-expense; performance-based; and software support, maintenance and subscriptions.

In fixed-fee billing arrangements, we agree to a pre-established fee in exchange for a predetermined set of professional services. We set the fees based on our estimates of the costs and timing for completing the engagements. It is the client’s expectation in these engagements that the pre-established fee will not be exceeded except in mutually agreed upon circumstances. We generally recognize revenues under fixed-fee billing arrangements using a proportionate performance approach, which is based on work completed to-date versus our estimates of the total services to be provided under the engagement. Contracts within our Studer Group solution include fixed-fee partner contracts with multiple performance obligations, which primarily consist of coaching services, as well as speaking engagements, conferences, publications and software products (“Partner Contracts”). Revenues for coaching services and software products are generally recognized on a straight-line basis over the length of the contract. All other revenues under Partner Contracts, including speaking engagements, conferences and publications, are recognized at the time the goods or services are provided.

Fixed-fee arrangements also include software licenses for our revenue cycle management software and research administration and compliance software. Licenses for our revenue cycle management software are sold only as a component of our consulting projects, and the services we provide are essential to the functionality of the software. Therefore, revenues from these software licenses are recognized over the term of the related consulting services contract. License revenue from our research administration and compliance software is generally recognized in the month in which the software is delivered.

Fixed-fee engagements represented 47.8% and 48.5% of our revenues for the three months ended March 31, 2019 and 2018, respectively.

Time-and-expense billing arrangements require the client to pay based on the number of hours worked by our revenue-generating professionals at agreed upon rates. Time-and-expense arrangements also include certain speaking engagements, conferences and publications purchased by our clients outside of Partner Contracts within our Studer Group solution. We recognize revenues under time-and-expense billing arrangements as the related services or publications are provided. Time-and-expense engagements represented 40.8% and 40.1% of our revenues for the three months ended March 31, 2019 and 2018, respectively.

In performance-based fee billing arrangements, fees are tied to the attainment of contractually defined objectives. We enter into performance-based engagements in essentially two forms. First, we generally earn fees that are directly related to the savings formally acknowledged by the client as a result of adopting our recommendations for improving operational and cost effectiveness in the areas we review. Second, we have performance-based engagements in which we earn a success fee when and if certain predefined outcomes occur. Often, performance-based fees supplement our

24

fixed-fee or time-and-expense engagements. We recognize revenues under performance-based billing arrangements by estimating the amount of variable consideration that is probable of being earned and recognizing that estimate over the length of the contract using a proportionate performance approach. Performance-based fee revenues represented 6.1% and 5.7% of our revenues for the three months ended March 31, 2019 and 2018, respectively. The level of performance-based fees earned may vary based on our clients' risk sharing preferences and the mix of services we provide.

Clients that have purchased one of our software licenses can pay an annual fee for software support and maintenance. We also generate subscription revenue from our cloud-based analytic tools and solutions. Software support, maintenance and subscription revenues are recognized ratably over the support or subscription period. These fees are billed in advance and included in deferred revenues until recognized. Software support, maintenance and subscription revenues represented 5.3% and 5.7% of our revenues for the three months ended March 31, 2019 and 2018, respectively.

Our quarterly results are impacted principally by our full-time consultants’ utilization rate, the bill rates we charge our clients, and the number of our revenue-generating professionals who are available to work. Our utilization rate can be negatively affected by increased hiring because there is generally a transition period for new professionals that results in a temporary drop in our utilization rate. Our utilization rate can also be affected by seasonal variations in the demand for our services from our clients. For example, during the third and fourth quarters of the year, vacations taken by our clients can result in the deferral of activity on existing and new engagements, which would negatively affect our utilization rate. The number of business work days is also affected by the number of vacation days taken by our consultants and holidays in each quarter. We typically have fewer business work days available in the fourth quarter of the year, which can impact revenues during that period.

Time-and-expense engagements do not provide us with a high degree of predictability as to performance in future periods. Unexpected changes in the demand for our services can result in significant variations in utilization and revenues and present a challenge to optimal hiring and staffing. Moreover, our clients typically retain us on an engagement-by-engagement basis, rather than under long-term recurring contracts. The volume of work performed for any particular client can vary widely from period to period.

Business Strategy, Opportunities and Challenges

Our primary strategy is to meet the needs of our clients by providing a balanced portfolio of service offerings and capabilities so that we can adapt quickly and effectively to emerging opportunities in the marketplace. To achieve this, we continue to hire highly qualified professionals and have entered into select acquisitions of complementary businesses.

To expand our business, we will remain focused on growing our existing relationships and developing new relationships, executing our managing director compensation plan to attract and retain senior practitioners, continuing to promote and provide an integrated approach to service delivery, broadening the scope of our existing services, and acquiring complementary businesses. We will regularly evaluate the performance of our practices to ensure our investments meet these objectives. Furthermore, we intend to enhance our visibility in the marketplace by refining our overarching messaging and value propositions for the organization as well as each practice. We will continue to focus on reaching our client base through clear, concise, and endorsed messages.

25

RESULTS OF OPERATIONS

The following table sets forth, for the periods indicated, selected segment and consolidated operating results and other operating data.

Segment and Consolidated Operating Results (in thousands, except per share amounts):	Three Months Ended March 31,
	2019			2018
Healthcare:
Revenues	$	93,682		$	89,895
Operating income	$	27,851		$	24,460
Segment operating income as a percentage of segment revenues	29.7		%	27.2		%
Business Advisory:
Revenues	$	58,806		$	55,895
Operating income	$	9,581		$	8,998
Segment operating income as a percentage of segment revenues	16.3		%	16.1		%
Education:
Revenues	$	51,957		$	47,889
Operating income	$	12,618		$	11,425
Segment operating income as a percentage of segment revenues	24.3		%	23.9		%
Total Company:
Revenues	$	204,445		$	193,679
Reimbursable expenses	18,617			17,619
Total revenues and reimbursable expenses	$	223,062		$	211,298
Statements of Operations reconciliation:
Segment operating income	$	50,050		$	44,883
Items not allocated at the segment level:
Other operating expenses	36,578			32,928
Other losses (gains), net	(456		)	830
Depreciation and amortization	7,172			8,803
Operating income	6,756			2,322
Other expense, net	(2,041		)	(5,131		)
Income (loss) from continuing operations before taxes	4,715			(2,809		)
Income tax expense	1,365			413
Net income (loss) from continuing operations	$	3,350		$	(3,222	)
Earnings (loss) per share from continuing operations:
Basic	$	0.15		$	(0.15	)
Diluted	$	0.15		$	(0.15	)

26

	Three Months Ended March 31,
Other Operating Data:	2019			2018
Number of full-time billable consultants (at period end) (1):
Healthcare	836			792
Business Advisory	864			783
Education	649			568
Total	2,349			2,143
Average number of full-time billable consultants (for the period) (1):
Healthcare	819			780
Business Advisory	839			784
Education	631			562
Total	2,289			2,126
Full-time billable consultant utilization rate (2):
Healthcare	78.6		%	81.3		%
Business Advisory	73.1		%	69.1		%
Education	76.4		%	75.0		%
Total	75.9		%	75.1		%
Full-time billable consultant average billing rate per hour (3):
Healthcare	$	224		$	202
Business Advisory (4)	$	200		$	209
Education	$	204		$	207
Total (4)	$	210		$	206
Revenue per full-time billable consultant (in thousands):
Healthcare	$	79		$	76
Business Advisory	$	68		$	68
Education	$	73		$	74
Total	$	73		$	73
Average number of full-time equivalents (for the period) (5):
Healthcare	223			208
Business Advisory	8			16
Education	36			40
Total	267			264
Revenue per full-time equivalent (in thousands):
Healthcare	$	129		$	148
Business Advisory	$	206		$	153
Education	$	166		$	155
Total	$	137		$	149

(1) Consists of our full-time professionals who provide consulting services and generate revenues based on the number of hours worked.

(2) Utilization rate for our full-time billable consultants is calculated by dividing the number of hours our full-time billable consultants worked on client assignments during a period by the total available working hours for these consultants during the same period, assuming a forty-hour work week, less paid holidays and vacation days.

(3) Average billing rate per hour for our full-time billable consultants is calculated by dividing revenues for a period by the number of hours worked on client assignments during the same period.

(4) Beginning in the third quarter of 2018, the average billing rate per hour excludes the number of hours charged on internal assignments by consultants within Huron Eurasia India to provide a more meaningful average billing rate charged to external clients. Prior year periods have been revised for consistent presentation.

(5) Consists of leadership coaches and their support staff within the Studer Group solution, consultants who work variable schedules as needed by our clients, and full-time employees who provide software support and maintenance services to our clients.

27

Non-GAAP Measures

We also assess our results of operations using certain non-GAAP financial measures. These non-GAAP financial measures differ from GAAP because the non-GAAP financial measures we calculate to measure earnings before interest, taxes, depreciation and amortization ("EBITDA"), adjusted EBITDA, adjusted EBITDA as a percentage of revenues, adjusted net income from continuing operations, and adjusted diluted earnings per share from continuing operations exclude a number of items required by GAAP, each discussed below. These non-GAAP financial measures should be considered in addition to, and not as a substitute for or superior to, any measure of performance, cash flows, or liquidity prepared in accordance with GAAP. Our non-GAAP financial measures may be defined differently from time to time and may be defined differently than similar terms used by other companies, and accordingly, care should be exercised in understanding how we define our non-GAAP financial measures.

Our management uses the non-GAAP financial measures to gain an understanding of our comparative operating performance, for example when comparing such results with previous periods or forecasts. These non-GAAP financial measures are used by management in their financial and operating decision making because management believes they reflect our ongoing business in a manner that allows for meaningful period-to-period comparisons. Management also uses these non-GAAP financial measures when publicly providing our business outlook, for internal management purposes, and as a basis for evaluating potential acquisitions and dispositions. We believe that these non-GAAP financial measures provide useful information to investors and others in understanding and evaluating Huron’s current operating performance and future prospects in the same manner as management does and in comparing in a consistent manner Huron’s current financial results with Huron’s past financial results.

The reconciliations of these financial measures from GAAP to non-GAAP are as follows (in thousands, except per share amounts):

	Three Months Ended March 31,
	2019			2018
Revenues	$	204,445		$	193,679
Net income (loss) from continuing operations	$	3,350		$	(3,222	)
Add back:
Income tax expense	1,365			413
Interest expense, net of interest income	4,258			4,986
Depreciation and amortization	8,289			10,021
Earnings before interest, taxes, depreciation and amortization (EBITDA)	17,262			12,198
Add back:
Restructuring charges	1,275			712
Other losses (gains), net	(456		)	830
Foreign currency transaction gains, net	(82		)	(53		)
Adjusted EBITDA	$	17,999		$	13,687
Adjusted EBITDA as a percentage of revenues	8.8		%	7.1		%

	Three Months Ended March 31,
	2019			2018
Net income (loss) from continuing operations	$	3,350		$	(3,222	)
Weighted average shares - diluted	22,311			21,592
Diluted earnings (loss) per share from continuing operations	$	0.15		$	(0.15	)
Add back:
Amortization of intangible assets	4,517			6,303
Restructuring charges	1,275			712
Other losses (gains), net	(456		)	830
Non-cash interest on convertible notes	2,120			2,021
Tax effect	(1,953		)	(2,565		)
Tax expense related to the enactment of Tax Cut and Jobs Act of 2017	—			132
Total adjustments, net of tax	5,503			7,433
Adjusted net income from continuing operations	$	8,853		$	4,211
Adjusted weighted average shares - diluted	22,311			21,813
Adjusted diluted earnings per share from continuing operations	$	0.40		$	0.19

28

These non-GAAP financial measures include adjustments for the following items:

Amortization of intangible assets: We have excluded the effect of amortization of intangible assets from the calculation of adjusted net income from continuing operations presented above. Amortization of intangible assets is inconsistent in its amount and frequency and is significantly affected by the timing and size of our acquisitions.

Restructuring charges: We have incurred charges due to the restructuring of various parts of our business. These restructuring charges have primarily consisted of costs associated with office space consolidations, including lease impairment charges and accelerated depreciation on lease-related property and equipment, and severance charges. We have excluded the effect of the restructuring charges from our non-GAAP measures because the amount of each restructuring charge is significantly affected by the timing and size of the restructured business or component of a business.

Other losses (gains), net: We have excluded the effects of other losses (gains), net which primarily consist of remeasurement losses (gains) related to contingent acquisition liabilities to permit comparability with periods that were not impacted by these items.

Non-cash interest on convertible notes: We incur non-cash interest expense relating to the implied value of the equity conversion component of our Convertible Notes. The value of the equity conversion component is treated as a debt discount and amortized to interest expense over the life of the Convertible Notes using the effective interest rate method. We exclude this non-cash interest expense that does not represent cash interest payments from the calculation of adjusted net income from continuing operations as management believes that this non-cash expense is not indicative of the ongoing performance of our business.

Foreign currency transaction gains, net: We have excluded the effect of foreign currency transaction losses and gains from the calculation of adjusted EBITDA because the amount of each loss or gain is significantly affected by timing and changes in foreign exchange rates.

Tax effect: The non-GAAP income tax adjustment reflects the incremental tax impact applicable to the non-GAAP adjustments.

Tax expense related to the enactment of Tax Cuts and Jobs Act of 2017 ("2017 Tax Reform"): We have excluded the impact of the 2017 Tax Reform, which was enacted in the fourth quarter of 2017. In the first quarter of 2018, we recorded an adjustment to our estimated one-time income tax expense related to the transition tax on accumulated foreign earnings. The exclusion of the 2017 Tax Reform impact permits comparability with periods that were not impacted by this item.

Income tax expense, Interest expense, net of interest income, Depreciation and amortization: We have excluded the effects of income tax expense, interest expense, net of interest income, and depreciation and amortization in the calculation of EBITDA as these are customary exclusions as defined by the calculation of EBITDA to arrive at meaningful earnings from core operations excluding the effect of such items.

Adjusted weighted average shares - diluted: As we reported a net loss for the three months ended March 31, 2018, GAAP diluted weighted average shares outstanding equals the basic weighted average shares outstanding for that period. For the three months ended March 31, 2018, the non-GAAP adjustments described above resulted in adjusted net income from continuing operations. Therefore, we included the dilutive common stock equivalents in the calculation of adjusted diluted weighted average shares outstanding for that period.

Three Months EndedMarch 31, 2019 Compared to Three Months EndedMarch 31, 2018

Revenues

Revenues increased$10.8 million, or 5.6%, to $204.4 million for the first three months of 2019 from $193.7 million for the first three months of 2018. Of the overall $10.8 millionincrease in revenues, $13.6 million was attributable to an increase in revenues from our full-time billable consultants, partially offset by a $2.8 million decrease in revenues attributable to our full-time equivalents. The increase in full-time billable consultant revenues was attributable to strengthened demand for services in all of our segments, as discussed below in Segment Results; and reflected increases in the average number of full-time billable consultants, the consultant utilization rate, and the average billing rate during the first three months of 2019 compared to the same prior year period. The decrease in full-time equivalent revenues was attributable to decreases in full-time equivalent revenues in all of our segments, as discussed below in Segment Results; and reflected an overall decrease in revenue per full-time equivalent, partially offset by an overall increase in the average number of full-time equivalents.

Total Direct Costs

Our total direct costs, including amortization of intangible assets and software development costs, increased$4.9 million, or 3.7%, to $138.9 million for the three months ended March 31, 2019, from $134.0 million for the three months ended March 31, 2018. The overall $4.9 millionincrease primarily related to a $3.1 million increase in salaries and related expenses for our revenue-generating professionals, which was largely driven by increased headcount in our Education and Business Advisory segments, and a $1.2 million increase in performance bonus expense for our revenue-generating professionals. As a percentage of revenues, our total direct costs decreased to 67.9% during the first three months of 2019 compared to 69.2% during the first three months of 2018 primarily due to revenue growth that outpaced the increase in salaries and related expenses for our revenue-generating professionals and a decrease in contractor expenses. These decreases to direct costs as a percentage of revenues were

29

partially offset by increases in signing, retention and other bonus expense for our revenue-generating professionals and project costs, as percentages of revenues, for the first three months of 2019 compared to the same prior year period.

Total direct costs for the three months ended March 31, 2019 included $1.1 million of amortization expense for internal software development costs and intangible assets, compared to $1.2 million of amortization expense for the same prior year period. The $0.1 milliondecrease in amortization expense was primarily attributable to certain intangible assets acquired in our Studer Group acquisition which were fully amortized, largely offset by an increase in amortization for internal software development costs. Intangible asset amortization included within direct costs primarily relates to technology and software, certain customer relationships, publishing content and customer contracts acquired in connection with our business acquisitions. See Note 4 "Goodwill and Intangible Assets" within the notes to our consolidated financial statements for additional information about our intangible assets.

Operating Expenses and Other Losses (Gains), Net

Selling, general and administrative expenses increased$3.7 million, or 7.8%, to $50.7 million in the three months ended March 31, 2019, from $47.1 million in the three months ended March 31, 2018. The overall $3.7 millionincrease was primarily related to a $3.3 million increase in salaries and related expenses for our support personnel, a $0.5 million increase in computer and related equipment expenses, and a $0.4 million increase in share-based compensation expense for our support personnel. These increases were partially offset by a $0.3 million decrease in accounting, tax and audit fees. As a percentage of revenues, selling, general and administrative expenses increased to 24.8% during the first three months of 2019 compared to 24.3% during the first three months of 2018, primarily due to the increase in salaries and related expenses for our support personnel, as a percentage of revenues.

Restructuring charges for the first three months of 2019 totaled $1.3 million, compared to $0.7 million for the first three months of 2018. During the first quarter of 2019, we exited a portion of our Lake Oswego, Oregon corporate office resulting in a $0.7 million lease impairment charge on the related operating lease right-of-use ("ROU") asset and leasehold improvements and $0.2 million of accelerated depreciation on related furniture and fixtures. The lease impairment charge was recognized in accordance with ASC 842, Leases, which we adopted on a modified retrospective basis on January 1, 2019. See Note 2 "Basis of Presentation and Significant Accounting Policies" and Note 3 "New Accounting Pronouncements" within the notes to our consolidated financial statements for additional information on our adoption of ASC 842. See Note 5 "Leases" within the notes to our consolidated financial statements for additional information on the long-lived asset impairment test performed in the first quarter of 2019. Additionally, we recognized a $0.2 million restructuring charge in the first quarter of 2019 related to workforce reductions in our corporate operations. The $0.7 million restructuring charge incurred in the first three months of 2018 primarily related to updated lease assumptions for our San Francisco office vacated in the second quarter of 2017, which was accounted for in accordance with ASC 840, Leases. See Note 9 "Restructuring Charges" within the notes to our consolidated financial statements for additional information on our restructuring charges.

Other losses (gains), net totaled a gain of $0.5 million for the three months ended March 31, 2019, which primarily consisted of a $0.4 million remeasurement gain to decrease the estimated fair value of our liabilities for contingent consideration payments related to business acquisitions. Other losses (gains), net totaled a loss of $0.8 million for the three months ended March 31, 2018, which represented increases in the estimated fair value of our liabilities for contingent consideration payments related to business acquisitions. In connection with certain business acquisitions, we may be required to pay post-closing consideration to the sellers if specific financial performance targets are met over a number of years as specified in the related purchase agreements. See Note 11 "Fair Value of Financial Instruments" within the notes to our consolidated financial statements for additional information on the fair value of contingent consideration liabilities.

Depreciation and amortization expense decreased by $1.6 million to $7.2 million in the three months ended March 31, 2019, from $8.8 million in the three months ended March 31, 2018. The decrease was primarily attributable to decreasing amortization expense of the trade name and customer relationships acquired in our Studer Group acquisition as well as certain customer relationships acquired in other business acquisitions, due to the accelerated basis of amortization in prior periods. Intangible asset amortization included within operating expenses primarily relates to certain customer relationships, trade names and non-competition agreements acquired in connection with our business acquisitions. See Note 4 "Goodwill and Intangible Assets" within the notes to our consolidated financial statements for additional information about our intangible assets.

Operating Income

Operating income increased$4.4 million to $6.8 million in the first three months of 2019 from $2.3 million in the first three months of 2018. Operating margin, which is defined as operating income expressed as a percentage of revenues, increased to 3.3% for the three months ended March 31, 2019, compared to 1.2% for the three months ended March 31, 2018. The increase in operating margin was primarily attributable to the revenue growth that outpaced the increase in salaries and related expenses for our revenue-generating professionals, the decrease in intangible asset amortization expense, and the remeasurement gain recognized in the first quarter of 2019 related to our liabilities for contingent consideration compared to the remeasurement loss recognized in the first quarter of 2018. These increases to the operating margin were partially offset by the increase in salaries and related expenses for our support personnel, as a percentage of revenues, during the first three months of 2019 compared to the same prior year period.

30

Other Expense, Net

Total other expense, net decreased by $3.1 million to $2.0 million in the first three months of 2019 from $5.1 million in the first three months of 2018.The decrease in total other expense, net was primarily attributable to a $2.1 million gain in the market value of our investments that are used to fund our deferred compensation liability compared to a $0.2 million loss in the same prior year period, and a $0.7 million decrease in interest expense, net of interest income in the first quarter of 2019 compared to the first quarter of 2018. The decrease in interest expense was due to lower levels of borrowing under our credit facility during the first three months of 2019 compared to the same prior year period, partially offset by higher interest rates during the first three months of 2019 compared to the same prior year period.

Income Tax Expense

For the three months ended March 31, 2019, our effective tax rate was 29.0% as we recognized income tax expense from continuing operations of $1.4 million on income from continuing operations of $4.7 million. The effective tax rate of 29.0% was less favorable than the statutory rate, inclusive of state income taxes, of 26.4% primarily due to $0.5 million of foreign losses with no tax benefit, which had an unfavorable impact of 2.9% on the effective tax rate; and $0.1 million of additional tax expense related to disallowed executive compensation deductions, which had an unfavorable impact of 1.8% on the effective tax rate. These unfavorable adjustments to our effective tax rate were partially offset by $0.1 million of discrete tax benefit for share-based compensation awards that vested during the first quarter of 2019 and which had a favorable impact of 1.8% on the effective tax rate.

For the three months ended March 31, 2018, our effective tax rate was (14.7)% as we recognized income tax expense from continuing operations of $0.4 million on a loss from continuing operations of $2.8 million. The effective tax rate of (14.7)% was less favorable than the statutory rate inclusive of state income taxes, of 26.0% primarily due to discrete tax expense for share-based compensation awards that vested during the quarter and which had an unfavorable impact of 43.7% on the effective tax rate.

Net Income (Loss) from Continuing Operations

Net income from continuing operations increased by $6.6 million to $3.4 million for the three months ended March 31, 2019, from a net loss from continuing operations of $3.2 million for the same prior year period. As a result of the increase in net income from continuing operations, diluted earnings per share from continuing operations for the first three months of 2019 was $0.15 compared to diluted loss per share from continuing operations of $0.15 for the first three months of 2018.

EBITDA and Adjusted EBITDA

EBITDA increased $5.1 million to $17.3 million for the three months ended March 31, 2019, from $12.2 million for the three months ended March 31, 2018. Adjusted EBITDA increased $4.3 million to $18.0 million in the first three months of 2019 from $13.7 million in the first three months of 2018. The increases in EBITDA and adjusted EBITDA were primarily attributable to the increase in revenues, partially offset by the increases in salaries and related expenses for both our support personnel and our revenue-generating professionals and performance bonus expense for our revenue-generating professionals.

Adjusted Net Income from Continuing Operations

Adjusted net income from continuing operations increased$4.6 million to $8.9 million in the first three months of 2019 compared to $4.2 million in the first three months of 2018. As a result of the increase in adjusted net income from continuing operations, adjusted diluted earnings per share from continuing operations for the first three months of 2019 was $0.40 compared to $0.19 for the first three months of 2018.

Segment Results

Healthcare

Revenues

Healthcare segment revenues increased$3.8 million, or 4.2%, to $93.7 million for the first three months of 2019 from $89.9 million for the first three months of 2018.

During the three months ended March 31, 2019, revenues from fixed-fee engagements; time-and-expense engagements; performance-based arrangements; and software support, maintenance and subscription arrangements represented 67.9%, 13.6%, 12.6%, and 5.9% of this segment’s revenues, respectively, compared to 67.0%, 14.2%, 11.4%, and 7.4% of this segment’s revenues, respectively, for the same prior year period. Performance-based fee revenue was $11.8 million during the first three months of 2019, compared to $10.2 million during the first three months of 2018. The level of performance-based fees earned may vary based on our clients’ risk sharing preferences and the mix of services we provide.

Of the overall $3.8 millionincrease in revenues, $5.5 million was attributable to an increase in revenues from our full-time billable consultants, partially offset by a $1.8 million decrease in revenues attributable to our full-time equivalents. The increase in revenues attributable to our full-time billable consultants reflected increases in the average billing rate and the average number of full-time billable consultants, partially offset by a

31

decrease in the consultant utilization rate. The decrease in revenues attributable to our full-time equivalents reflected a decrease in revenue per full-time equivalent, partially offset by an increase in the average number of full-time equivalents.

Operating Income

Healthcare segment operating income increased$3.4 million, or 13.9%, to $27.9 million for the three months ended March 31, 2019, from $24.5 million for the three months ended March 31, 2018. The Healthcare segment operating margin increased to 29.7% for the first three months of 2019 from 27.2% in the same period last year. The increase in this segment’s operating margin was primarily attributable to decreases in salaries and related expenses for our revenue-generating professionals, which included an increase in capitalization of salaries and related expenses related to internal software development projects, and contractor expense; partially offset by increases in salaries and related expenses for our support personnel, practice administration and meetings expense and project costs, all as percentages of revenues.

Business Advisory

Revenues

Business Advisory segment revenues increased$2.9 million, or 5.2%, to $58.8 million for the first three months of 2019 from $55.9 million for the first three months of 2018.

During the first three months of 2019, revenues from fixed-fee engagements; time-and-expense engagements; performance-based arrangements; and software support, maintenance and subscription arrangements represented 36.9%, 60.0%, 1.1%, and 2.0% of this segment’s revenues, respectively, compared to 40.1%, 56.1%, 1.6%, and 2.2% of this segment’s revenues, respectively, during the same prior year period. Performance-based fee revenue was $0.7 million for the first three months of 2019, compared to $0.9 million for the first three months of 2018. The level of performance-based fees earned may vary based on our clients’ preferences and the mix of services we provide.

Of the overall $2.9 millionincrease in revenues, $3.7 million was attributable to an increase in revenues from our full-time billable consultants, partially offset by a $0.8 million decrease in revenues attributable to our full-time equivalents. The increase in revenues from our full-time billable consultants was primarily driven by increases in the consultant utilization rate and the average number of full-time billable consultants, partially offset by a decrease in the average billing rate. The decrease in revenues from our full-time equivalents was driven by a decreased use of contractors and our part-time project consultants; and reflected a decrease in the average number of full-time equivalents, partially offset by an increase in revenue per full-time equivalent in the first three months of 2019 compared to the same prior year period.

Operating Income

Business Advisory segment operating income increased by $0.6 million, or 6.5%, to $9.6 million for the three months ended March 31, 2019, from $9.0 million for the three months ended March 31, 2018. The Business Advisory segment operating margin increased to 16.3% for the first three months of 2019 from 16.1% in the same period last year. The increase in this segment’s operating margin was primarily attributable to revenue growth that outpaced increases in salaries and related expenses and performance bonus expense for our revenue-generating professionals. These increases to the segment's operating margin were largely offset by increases in signing, retention and other bonus expense and share-based compensation expense for our revenue generating professionals, both as percentages of revenues.

Education

Revenues

Education segment revenues increased$4.1 million, or 8.5%, to $52.0 million for the first three months of 2019 from $47.9 million for the first three months of 2018.

For the three months ended March 31, 2019, revenues from fixed-fee engagements; time-and-expense engagements; and software support, maintenance and subscription arrangements represented 23.8%, 68.1%, and 8.1% of this segment’s revenues, respectively, compared to 23.6%, 69.8%, and 6.6% of this segment's revenues, respectively, during the same prior year period.

Of the overall $4.1 millionincrease in revenues, $4.4 million was attributable to an increase in revenues from to our full-time billable consultants, partially offset by a $0.3 million decrease in revenues attributable to our full-time equivalents. The increase in revenues from our full-time billable consultants reflected increases in the average number of full-time billable consultants and the consultant utilization rate, partially offset by a decrease in the average billing rate. The decrease in revenues from our full-time equivalents was driven by a decreased use of our part-time project consultants; and reflected decreases in the average number of full-time equivalents, partially offset by an increase in revenue per full-time equivalent in the first three months of 2019 compared to the same prior year period.

32

Operating Income

Education segment operating income increased$1.2 million, or 10.4%, to $12.6 million for the three months ended March 31, 2019, from $11.4 million for the three months ended March 31, 2018. The Education segment operating margin increased to 24.3% for the first three months of 2019 from 23.9% in the same period last year. The increase in this segment’s operating margin was primarily attributable to a decrease in practice administration and meetings expense, revenue growth that outpaced the increase in salaries and related expenses for our revenue-generating professionals, and decreases in technology expense and salaries and related expenses for our support personnel, as percentages of revenues. These increases to the segment's operating margin were partially offset by increases in performance bonus expense for our revenue-generating professionals, contractor expenses, and promotion and marketing expenses, all as percentages of revenue.

LIQUIDITY AND CAPITAL RESOURCES

Cash and cash equivalents decreased$24.6 million to $8.5 million at March 31, 2019 from $33.1 million at December 31, 2018. As of March 31, 2019, our primary sources of liquidity are cash on hand, cash flows from our U.S. operations, and borrowing capacity available under our credit facility.

	Three Months Ended March 31,
Cash Flows (in thousands):	2019			2018
Net cash used in operating activities	$	(38,289	)	$	(36,263	)
Net cash used in investing activities	(8,087		)	(3,767		)
Net cash provided by financing activities	21,722			29,541
Effect of exchange rate changes on cash	73			16
Net decrease in cash and cash equivalents	$	(24,581	)	$	(10,473	)

Operating Activities

Net cash used in operating activities totaled $38.3 million and $36.3 million for the three months ended March 31, 2019 and 2018, respectively. Our operating assets and liabilities consist primarily of receivables from billed and unbilled services, accounts payable and accrued expenses, accrued payroll and related benefits, and deferred revenues. The volume of services rendered and the related billings and timing of collections on those billings, as well as payments of our accounts payable and salaries, bonuses, and related benefits to employees affect these account balances.

The increase in cash used in operating activities for the first three months of 2019 compared to the same prior year period was primarily attributable to an increase in the amount paid for annual performance bonuses during the first quarter of 2019 compared to the first quarter of 2018, largely offset by an increase in cash collections from clients.

Investing Activities

Net cash used in investing activities was $8.1 million and $3.8 million for the three months ended March 31, 2019 and 2018, respectively.

The use of cash in the first three months of 2019 primarily consisted of $3.6 million for contributions to our life insurance policies which fund our deferred compensation plan; $2.3 million for purchases of property and equipment, primarily related to purchases of computers and related equipment; and $2.1 million for payments related to internally developed software.

The use of cash in the first three months of 2018 primarily consisted of $1.5 million for contributions to our life insurance policies which fund our deferred compensation plan; $1.4 million for purchases of property and equipment, primarily related to purchases of computers and related equipment; and $0.7 million for payments related to internally developed software.

We estimate that cash utilized for purchases of property and equipment and software development in 2019 will be approximately $15 million to $20 million, primarily consisting of information technology related equipment to support our corporate infrastructure, leasehold improvements for certain office locations, and software development costs.

Financing Activities

Net cash provided by financing activities was $21.7 million for the three months ended March 31, 2019. During the first three months of 2019, we borrowed $40.5 million under our credit facility, primarily to fund our annual performance bonus payment, and made repayments on our credit facility of $14.5 million.

Net cash provided by financing activities was $29.5 million for the three months ended March 31, 2018. During the first three months of 2018, we borrowed $91.5 million under our credit facility, primarily to fund our annual performance bonus payment, and made repayments on our credit facility of $58.0 million.

33

Share Repurchase Program

We currently have a share repurchase program permitting us to repurchase up to $125 million of our common stock through October 31, 2019 (the "Share Repurchase Program"). The amount and timing of the repurchases will be determined by management and will depend on a variety of factors, including the trading price of our common stock, capacity under our credit facility, general market and business conditions, and applicable legal requirements. No shares were repurchased in the first three months of 2019 or 2018. As of March 31, 2019, $35.1 million remains available for share repurchases.

Financing Arrangements

At March 31, 2019, we had $250.0 million principal amount of our 1.25% convertible senior notes outstanding, $76.0 million outstanding under our senior secured credit facility, and $4.2 million outstanding under a promissory note, as discussed below.

1.25% Convertible Senior Notes

In September 2014, we issued $250.0 million principal amount of the Convertible Notes in a private offering. The Convertible Notes are senior unsecured obligations of the Company and will pay interest semi-annually on April 1 and October 1 of each year at an annual rate of 1.25%. The Convertible Notes will mature on October 1, 2019, unless earlier repurchased by the Company or converted in accordance with their terms. We expect to refinance the principal amount of the outstanding notes at maturity with the borrowing capacity available under our revolving credit facility.

Upon conversion, the Convertible Notes will be settled, at our election, in cash, shares of the Company’s common stock, or a combination of cash and shares of the Company’s common stock. Our current intent and policy is to settle conversions with a combination of cash and shares of common stock with the principal amount of the Convertible Notes paid in cash, in accordance with the settlement provisions of the Indenture.

The initial conversion rate for the Convertible Notes is 12.5170 shares of our common stock per $1,000 principal amount of the Convertible Notes, which is equal to an initial conversion price of approximately $79.89 per share of our common stock.

In connection with the issuance of the Convertible Notes, we entered into convertible note hedge transactions and warrant transactions. The convertible note hedge transactions are intended to reduce the potential future economic dilution associated with the conversion of the Convertible Notes and, combined with the warrants, effectively raise the price at which economic dilution would occur from the initial conversion price of approximately $79.89 to approximately $97.12 per share.

The carrying amount of our Convertible Notes as of March 31, 2019 and December 31, 2018, was $245.1 million and $242.6 million, respectively, which represented the $250.0 million principal amount net of unamortized debt discount and issuance costs. The carrying amount of our Convertible Notes is included in current maturities of long-term debt on the consolidated balance sheet.

For further information, see Note 8 “Financing Arrangements” within the notes to our consolidated financial statements.

Senior Secured Credit Facility

The Company has a $500 million senior secured revolving credit facility, subject to the terms of a Second Amended and Restated Credit Agreement dated as of March 31, 2015, as amended to date (as amended and modified the "Amended Credit Agreement"), that becomes due and payable in full upon maturity on March 23, 2023. The Amended Credit Agreement provides the option to increase the revolving credit facility or establish term loan facilities in an aggregate amount of up to $150 million, subject to customary conditions and the approval of any lender whose commitment would be increased, resulting in a maximum available principal amount under the Amended Credit Agreement of $650 million. The initial borrowings under the Amended Credit Agreement were used to refinance borrowings outstanding under a prior credit agreement, and future borrowings under the Amended Credit Agreement may be used for working capital, capital expenditures, acquisitions of businesses, share repurchases, and general corporate purposes.

Fees and interest on borrowings vary based on our Consolidated Leverage Ratio (as defined in the Amended Credit Agreement). At our option, borrowings under the Amended Credit Agreement will bear interest at one, two, three or six-month LIBOR or an alternate base rate, in each case plus the applicable margin. The applicable margin will fluctuate between 1.25% per annum and 2.00% per annum, in the case of LIBOR borrowings, or between 0.25% per annum and 1.00% per annum, in the case of base rate loans, based upon our Consolidated Leverage Ratio at such time.

Amounts borrowed under the Amended Credit Agreement may be prepaid at any time without premium or penalty. We are required to prepay the amounts outstanding under the Amended Credit Agreement in certain circumstances, including a requirement to pay all amounts outstanding under the Amended Credit Agreement 90 days prior to the Convertible Indebtedness Maturity Date (as defined in the Amended Credit Agreement) unless (1) the Convertible Indebtedness Maturity Date is waived or extended to a later date, (2) the Company can demonstrate (a) Liquidity (as defined in the Amended Credit Agreement) in an amount at least equal to the principal amount due on the Convertible Indebtedness Maturity Date, and (b) financial covenant compliance after giving effect to such payments and any additional indebtedness incurred on a pro forma basis, or (3) this requirement is waived by the Required Lenders (as defined in the Amended Credit Agreement). In addition, we have the right to permanently reduce or terminate the unused portion of the commitments provided under the Amended Credit Agreement at any time.

34

The Amended Credit Agreement contains usual and customary representations and warranties; affirmative and negative covenants, which include limitations on liens, investments, additional indebtedness, and restricted payments; and two quarterly financial covenants as follows: (i) a maximum Consolidated Leverage Ratio (defined as the ratio of debt to consolidated EBITDA) ranging from 3.50 to 1.00 to 4.00 to 1.00, depending on the measurement period, and (ii) a minimum Consolidated Interest Coverage Ratio (defined as the ratio of consolidated EBITDA to interest) of 3.50 to 1.00. Consolidated EBITDA for purposes of the financial covenants is calculated on a continuing operations basis and includes adjustments to add back non-cash goodwill impairment charges, share-based compensation costs, certain non-cash restructuring charges, pro forma historical EBITDA for businesses acquired, and other specified items in accordance with the Amended Credit Agreement. At March 31, 2019, we were in compliance with these financial covenants with a Consolidated Leverage Ratio of 2.99 to 1.00 and a Consolidated Interest Coverage Ratio of 12.08 to 1.00.

The Amended Credit Agreement contains restricted payment provisions, including a potential limit on the amount of dividends we may pay. Pursuant to the terms of the Amended Credit Agreement, if our Consolidated Leverage Ratio is greater than 3.00, the amount of dividends and other Restricted Payments (as defined in the Amended Credit Agreement) we may pay is limited to an amount up to $75 million plus 50% of cumulative consolidated net income (as defined in the Amended Credit Agreement) from the closing date of the Amended Credit Agreement plus 50% of the net cash proceeds from equity issuances after the closing date of the Amended Credit Agreement.

Borrowings outstanding under the Amended Credit Agreement at March 31, 2019 totaled $76.0 million. These borrowings carried a weighted average interest rate of 4.5%, including the impact of the interest rate swap in effect as of March 31, 2019 and described in Note 10 “Derivative Instrument and Hedging Activity” within the notes to the consolidated financial statements. Borrowings outstanding under the Amended Credit Agreement at December 31, 2018 were $50.0 million and carried a weighted average interest rate of 3.7%, including the impact of the interest rate swap described in Note 10 “Derivative Instrument and Hedging Activity” within the notes to the consolidated financial statements. The borrowing capacity under the revolving credit facility is reduced by any outstanding borrowings under the revolving credit facility and outstanding letters of credit. At March 31, 2019, we had outstanding letters of credit totaling $1.6 million, which are primarily used as security deposits for our office facilities. As of March 31, 2019, the unused borrowing capacity under the revolving credit facility was $422.4 million.

Promissory Note due 2024

On June 30, 2017, in conjunction with our purchase of an aircraft related to the acquisition of Innosight, we assumed, from the sellers of the aircraft, a promissory note with an outstanding principal balance of $5.1 million. The principal balance of the promissory note is subject to scheduled monthly principal payments until the maturity date of March 1, 2024, at which time a final payment of $1.5 million, plus any accrued and unpaid interest, will be due. Under the terms of the promissory note, we will pay interest on the outstanding principal amount at a rate of one-month LIBOR plus 1.97% per annum. The obligations under the promissory note are secured pursuant to a Loan and Aircraft Security Agreement with Banc of America Leasing & Capital, LLC, which grants the lender a first priority security interest in the aircraft. At March 31, 2019, the outstanding principal amount of the promissory note was $4.2 million, and the aircraft had a carrying amount of $5.6 million. At December 31, 2018, the outstanding principal amount of the promissory note was $4.4 million, and the aircraft had a carrying amount of $5.8 million.

For further information, see Note 8 “Financing Arrangements” within the notes to the consolidated financial statements.

Future Needs

Our primary financing need has been to fund our growth. Our growth strategy is to expand our service offerings, which may require investments in new hires, acquisitions of complementary businesses, possible expansion into other geographic areas, and related capital expenditures. We believe our internally generated liquidity, together with our available cash, the borrowing capacity available under our revolving credit facility, and access to external capital resources will be adequate to fund our long-term growth and capital needs arising from cash commitments and debt service obligations. Our ability to secure short-term and long-term financing in the future will depend on several factors, including our future profitability, the quality of our accounts receivable and unbilled services, our relative levels of debt and equity, and the overall condition of the credit markets.

CONTRACTUAL OBLIGATIONS

For a summary of our commitments to make future payments under contractual obligations, see “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Contractual Obligations” in our Annual Report on Form 10-K for the year ended December 31, 2018. There have been no material changes to our contractual obligations since December 31, 2018. See Note 2 "Basis of Presentation and Significant Accounting Policies" and Note 3 "New Accounting Pronouncements" within the notes to our consolidated financial statements for information on our adoption of ASC 842, Leases. See Note 5 "Leases" within the notes to our consolidated financial statements for information on our future lease payments and a reconciliation of those lease payments to our operating lease liabilities recorded on our consolidated balance sheet.

OFF-BALANCE SHEET ARRANGEMENTS

We are not a party to any material off-balance sheet arrangements.

35

CRITICAL ACCOUNTING POLICIES

Management’s discussion and analysis of financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with GAAP. We regularly review our financial reporting and disclosure practices and accounting policies to ensure that our financial reporting and disclosures provide accurate information relative to the current economic and business environment. The preparation of financial statements in conformity with GAAP requires management to make assessments, estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period. Critical accounting policies are those policies that we believe present the most complex or subjective measurements and have the most potential to impact our financial position and operating results. While all decisions regarding accounting policies are important, we believe there are five accounting policies that could be considered critical: revenue recognition, allowances for doubtful accounts and unbilled services, business combinations, carrying values of goodwill and other intangible assets, and accounting for income taxes. For a detailed discussion of these critical accounting policies, see “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Critical Accounting Policies” in our Annual Report on Form 10-K for the year ended December 31, 2018. There have been no material changes to our critical accounting policies during the first three months of 2019.

NEW ACCOUNTING PRONOUNCEMENTS

Refer to Note 3 “New Accounting Pronouncements” within the notes to the consolidated financial statements for information on new accounting pronouncements.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

We are exposed to market risks primarily from changes in interest rates and changes in the market value of our investments.

Market Risk and Interest Rate Risk

The value of our Convertible Notes is exposed to interest rate risk. Generally, the fair value of our fixed interest rate Convertible Notes will increase as interest rates fall and decrease as interest rates rise. In addition, the fair value of our Convertible Notes is affected by our stock price. The carrying value of our Convertible Notes was $245.1 million as of March 31, 2019, which represents the liability component of the $250.0 million principal balance. The estimated fair value of our Convertible Notes at March 31, 2019 was $246.2 million, and was determined based on the quoted bid price of the Convertible Notes in an over-the-counter market as of the last day of trading for the quarter ended March 31, 2019, which was $98.476 per $100 principal amount. At December 31, 2018, the carrying value of our Convertible Notes was $242.6 million, and the estimated fair value of our Convertible Notes was $242.9 million, which was determined based on the quoted bid price of the Convertible Notes in an over-the-counter market as of the last day of trading for the year ended December 31, 2018, which was $97.176 per $100 principal amount.

Concurrent with the issuance of the Convertible Notes, we entered into separate convertible note hedge and warrant transactions. The convertible note hedge transactions are intended to reduce the potential future economic dilution associated with the conversion of the Convertible Notes and, combined with the warrants, effectively raise the price at which economic dilution would occur from the initial conversion price of approximately $79.89 to approximately $97.12 per share. Under the convertible note hedge transactions, we have the option to purchase a total of approximately 3.1 million shares of our common stock, which is the number of shares initially issuable upon conversion of the Convertible Notes in full, at a price of approximately $79.89, which corresponds to the initial conversion price of the Convertible Notes, subject to customary anti-dilution adjustments substantially similar to those in the Convertible Notes. Under the warrant transactions, the holders of the warrants have the option to purchase a total of approximately 3.1 million shares of our common stock at a price of approximately $97.12. If the average market value per share of our common stock for the reporting period exceeds the strike price of the warrants, the warrants will have a dilutive effect on our earnings per share.

We have exposure to changes in interest rates associated with borrowings under our bank credit facility, which has variable interest rates tied to LIBOR or an alternate base rate, at our option. At March 31, 2019, we had borrowings outstanding under the credit facility totaling $76.0 million that carried a weighted average interest rate of 4.5%, including the impact of the interest rate swap described below. A hypothetical 100 basis point change in this interest rate would have a $0.3 million effect on our pretax income, on an annualized basis, including the effect of the interest rate swap. At December 31, 2018, we had borrowings outstanding under the credit facility totaling $50.0 million that carried a weighted average interest rate of 3.7% including the impact of the interest rate swap described below. As of December 31, 2018, these variable rate borrowings were fully hedged against changes in interest rates by the interest rate swap, which had a notional amount of $50.0 million. As our variable rate borrowings were fully hedged as of December 31, 2018, a change in the interest rate would have had no impact on our consolidated financial statements.

On June 22, 2017, we entered into a forward interest rate swap agreement effective August 31, 2017 and ending August 31, 2022, with a notional amount of $50.0 million. We entered into this derivative instrument to hedge against the interest rate risks of our variable-rate borrowings. Under the terms of the interest rate swap agreement, we receive from the counterparty interest on the notional amount based on one-month LIBOR and we pay to the counterparty a fixed rate of 1.900%.

We also have exposure to changes in interest rates associated with the promissory note assumed on June 30, 2017 in connection with our purchase of an aircraft, which has variable interest rates tied to LIBOR. At March 31, 2019, the outstanding principal amount of the promissory note was $4.2

36

million and carried an interest rate of 4.5%. A hypothetical 100 basis point change in this interest rate would not have a material effect on our pretax income. At December 31, 2018, the outstanding principal amount of the promissory note was $4.4 million and carried an interest rate of 4.3%. A hypothetical 100 basis point change in the interest rate as of December 31, 2018 would not have had a material effect on our pretax income.

We do not use derivative instruments for trading or other speculative purposes. From time to time, we invest excess cash in short-term marketable securities. These investments principally consist of overnight sweep accounts. Due to the short maturity of these investments, we have concluded that we do not have material market risk exposure.

We have a non-interest bearing convertible debt investment in a privately-held company, which we account for as an available-for-sale debt security. As such, the investment is carried at fair value with unrealized holding gains and losses excluded from earnings and reported in other comprehensive income. As of March 31, 2019, the fair value of the investment was $54.0 million, with a total cost basis of $27.9 million. At December 31, 2018, the fair value of the investment was $50.4 million, with a total cost basis of $27.9 million.

ITEM 4. CONTROLS AND PROCEDURES.

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of March 31, 2019. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that, as of March 31, 2019, our disclosure controls and procedures were effective in recording, processing, summarizing and reporting, on a timely basis, information required to be disclosed by us in the reports we file or submit under the Exchange Act, and such information is accumulated and communicated to management as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting

There has been no change in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the three months ended March 31, 2019 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II—OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS.

The information required by this Item is incorporated by reference from Note 14 "Commitments, Contingencies and Guarantees" included in Part I, Item 1 of this Quarterly Report on Form 10-Q. 

From time to time, we are involved in legal proceedings and litigation arising in the ordinary course of business. As of the date of this Quarterly Report on Form 10-Q, we are not a party to any litigation or legal proceeding that, in the current opinion of management, could have a material adverse effect on our financial position or results of operations. However, due to the risks and uncertainties inherent in legal proceedings, actual results could differ from current expected results.

ITEM 1A. RISK FACTORS.

See Part 1, Item 1A, “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2018, which was filed with the Securities and Exchange Commission on February 27, 2019, for a complete description of the material risks we face.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

Our Stock Ownership Participation Program, 2012 Omnibus Incentive Plan, and 2004 Omnibus Stock Plan, which was replaced by the 2012 Omnibus Incentive Plan, permit the netting of common stock upon vesting of restricted stock awards to satisfy individual tax withholding requirements. During the quarter ended March 31, 2019, we reacquired 94,500 shares of common stock with a weighted average fair market value of $46.40 as a result of such tax withholdings.

In October 2014, our board of directors authorized a share repurchase program pursuant to which we may, from time to time, repurchase up to $125 million of our common stock, which expires on October 31, 2019 (the "Share Repurchase Program"). The amount and timing of the repurchases will be determined by management and will depend on a variety of factors, including the trading price of our common stock, capacity under our line of credit, general market and business conditions, and applicable legal requirements. The following table provides information with respect to purchases we made of our common stock during the quarter ended March 31, 2019.

37

Period	Total Number of Shares Purchased (1)	Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	Dollar Value of Shares that may yet be Purchased under the Plans or Programs (2)
January 1, 2019 - January 31, 2019	7,745	$	51.31	—	$	35,143,546
February 1, 2019 - February 28, 2019	—	$	—	—	$	35,143,546
March 1, 2019 - March 31, 2019	86,755	$	45.96	—	$	35,143,546
Total	94,500	$	46.40	—

(1) The number of shares repurchased for each period represents shares to satisfy employee tax withholding requirements. These shares do not reduce the repurchase authority under the Share Repurchase Program.

(2) As of the end of the period.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES.

None.

ITEM 4. MINE SAFETY DISCLOSURES.

Not applicable.

ITEM 5. OTHER INFORMATION.

None.

38

ITEM 6. EXHIBITS.

(a) The following exhibits are filed as part of this Quarterly Report on Form 10-Q.

				Incorporated by Reference
Exhibit Number	Exhibit Description	Filed herewith	Furnished herewith	Form	Period Ending	Exhibit	Filing Date
31.1	Certification of the Chief Executive Officer, pursuant to Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.	X
31.2	Certification of the Chief Financial Officer, pursuant to Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.	X
32.1	Certification of the Chief Executive Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.		X
32.2	Certification of the Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.		X
101.INS	XBRL Instance Document	X
101.SCH	XBRL Taxonomy Extension Schema Document	X
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document	X
101.LAB	XBRL Taxonomy Extension Label Linkbase Document	X
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document	X
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document	X

39

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

		Huron Consulting Group Inc.
		(Registrant)
Date:	April 30, 2019	/S/    JOHN D. KELLY
		John D. Kelly
		Executive Vice President, Chief Financial Officer and Treasurer

40

EX-31.1

EXHIBIT 31.1

CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER,

PURSUANT TO RULE 13a-14(a)/15d-14(a), AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, James H. Roth, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Huron Consulting Group Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s Board of Directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:	April 30, 2019	By:	/S/    JAMES H. ROTH
			James H. Roth
			Chief Executive Officer

EX-31.2

EXHIBIT 31.2

CERTIFICATION OF THE CHIEF FINANCIAL OFFICER,

PURSUANT TO RULE 13a-14(a)/15d-14(a), AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, John D. Kelly, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Huron Consulting Group Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s Board of Directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:	April 30, 2019	By:	/S/    JOHN D. KELLY
			John D. Kelly
			Executive Vice President, Chief Financial Officer and Treasurer

EX-32.1

EXHIBIT 32.1

CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER,

PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Huron Consulting Group Inc. (the “Company”) on Form 10-Q for the quarter ended March 31, 2019 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, James H. Roth, Chief Executive Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for the periods presented therein.

Date:	April 30, 2019	By:	/S/    JAMES H. ROTH
			James H. Roth
			Chief Executive Officer

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

The foregoing certification is being furnished to the Securities and Exchange Commission as an exhibit to the Form 10-Q and shall not be considered filed as part of the Form 10-Q.

EX-32.2

EXHIBIT 32.2

CERTIFICATION OF THE CHIEF FINANCIAL OFFICER,

PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Huron Consulting Group Inc. (the “Company”) on Form 10-Q for the quarter ended March 31, 2019 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, John D. Kelly, Executive Vice President, Chief Financial Officer and Treasurer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for the periods presented therein.

Date:	April 30, 2019	By:	/S/    JOHN D. KELLY
			John D. Kelly
			Executive Vice President, Chief Financial Officer and Treasurer

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

The foregoing certification is being furnished to the Securities and Exchange Commission as an exhibit to the Form 10-Q and shall not be considered filed as part of the Form 10-Q.

XML

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2019	Apr. 23, 2019
Document And Entity Information [Abstract]
Entity Registrant Name	Huron Consulting Group Inc.
Trading Symbol	HURN
Entity Central Index Key	0001289848
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Document Type	10-Q
Document Period End Date	Mar. 31, 2019
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	Q1
Amendment Flag	false
Entity Common Stock, Shares Outstanding		22,883,027

XML

Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Mar. 31, 2019	Jan. 01, 2019	Dec. 31, 2018
Current assets:
Cash and cash equivalents	$ 8,526		$ 33,107
Receivables from clients, net	104,674		109,677
Costs in Excess of Billings, Current	86,504		69,613
Income tax receivable	3,209		6,612
Prepaid Expense and Other Assets, Current	13,596		13,922
Total current assets	216,509		232,931
Property and equipment, net	38,359		40,374
Deferred Tax Assets, Net, Noncurrent	1,302		2,153
Long-term investment	54,038		50,429
Operating Lease, Right-of-Use Asset	53,805	$ 56,463	0
Other non-current assets	38,345		30,525
Intangible assets, net	43,461		47,857
Goodwill	645,541		645,263
Total assets	1,091,360		1,049,532
Current liabilities:
Accounts payable	7,469		10,020
Accrued expenses and other current liabilities	16,611	14,650	17,207
Accrued payroll and related benefits	53,966		109,825
Business Combination, Contingent Consideration, Liability, Current	10,014		9,991
Long-term Debt, Current Maturities	245,569		243,132
Operating Lease, Liability, Current	10,293	10,537	0
Deferred revenues	30,023		28,130
Total current liabilities	373,945		418,305
Non-current liabilities:
Deferred compensation and other liabilities	25,886	20,339	20,875
Business Combination, Contingent Consideration, Liability, Noncurrent	1,115		1,450
Long-term debt, net of current portion	79,722		53,853
Operating Lease, Liability, Noncurrent	60,280	62,712	0
Operating lease liabilities, net of current portion	0	$ 0	13,693
Deferred income taxes, net	759		732
Total non-current liabilities	167,762		90,603
Commitments and contingencies
Stockholders’ equity
Common stock	247		244
Treasury stock	(126,983)		(124,794)
Additional paid-in capital	457,748		452,573
Retained earnings	199,410		196,106
Accumulated other comprehensive income	19,231		16,495
Total stockholders’ equity	549,653		540,624
Total liabilities and stockholders’ equity	$ 1,091,360		$ 1,049,532

XML

Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares	Mar. 31, 2019	Dec. 31, 2018
Statement of Financial Position [Abstract]
Common stock, par value (USD per share)	$ 0.01	$ 0.01
Common stock, shares authorized (shares)	500,000,000	500,000,000
Common stock, shares issued (shares)	25,275,901	25,114,739
Treasury stock, shares (shares)	2,392,531	2,568,288

XML

Consolidated Statements of Earnings and Other Comprehensive Income (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Revenues and reimbursable expenses:
Revenues	$ 204,445	$ 193,679
Reimbursable expenses	18,617	17,619
Total revenues and reimbursable expenses	223,062	211,298
Direct costs and reimbursable expenses (exclusive of depreciation and amortization shown in operating expenses):
Direct costs	137,780	132,786
Amortization of intangible assets and software development costs	1,117	1,218
Reimbursable expenses	18,669	17,549
Total direct costs and reimbursable expenses	157,566	151,553
Operating expenses and other losses (gains), net
Selling, general and administrative expenses	50,749	47,078
Restructuring charges	1,275	712
Gain (Loss) Related To Litigation Settlement And Other Operating Gains	456	(830)
Depreciation and amortization	7,172	8,803
Total operating expenses and other losses (gains), net	58,740	57,423
Operating income	6,756	2,322
Other income (expense), net:
Interest expense, net of interest income	(4,258)	(4,986)
Other income (expense), net	2,217	(145)
Total other expense, net	(2,041)	(5,131)
Income (loss) from continuing operations before taxes	4,715	(2,809)
Income tax expense	1,365	413
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent	3,350	(3,222)
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent	(46)	(42)
Net income (loss)	$ 3,304	$ (3,264)
Net earnings (loss) per basic share:
Income (Loss) from Continuing Operations, Per Basic Share	$ 0.15	$ (0.15)
Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share	0.00	0.00
Basic (USD per share)	0.15	(0.15)
Net earnings per diluted share:
Income (Loss) from Continuing Operations, Per Diluted Share	0.15	(0.15)
Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share	0.00	0.00
Earnings Per Share, Diluted	$ 0.15	$ (0.15)
Weighted average shares used in calculating earnings per share:
Weighted average common shares outstanding – basic	21,868	21,592
Weighted average common shares outstanding – diluted	22,311	21,592
Comprehensive income (loss):
Net income (loss)	$ 3,304	$ (3,264)
Foreign currency translation adjustments, net of tax	316	34
Unrealized gain on investment, net of tax	2,657	2,166
Unrealized gain (loss) on cash flow hedging instruments, net of tax	(237)	432
Other comprehensive income	2,736	2,632
Comprehensive income (loss)	$ 6,040	$ (632)

XML

Consolidated Statement of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Treasury Stock	Additional Paid-In Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)
Beginning Balance, shares at Dec. 31, 2017		(24,098,822)	(2,591,135)
Beginning Balance at Dec. 31, 2017	$ 503,316	$ 241	$ (121,994)	$ 434,256	$ 180,443	$ 10,370
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Comprehensive income (loss)	(632)				(3,264)	2,632
Issuance of common stock in connection with:
Restricted stock awards, net of cancellations, shares		198,546	34,177
Restricted stock awards, net of cancellations	0	$ 2	$ 1,443	(1,445)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period		10,000
Stock Issued During Period, Value, Stock Options Exercised	234	$ 0		234
Share-based compensation	5,280			5,280
Shares redeemed for employee tax withholdings, shares			(75,832)
Shares redeemed for employee tax withholdings	(2,684)		$ 2,684
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification | Accounting Standards Update 2014-09 [Member]	1,956				1,956
Ending Balance, shares at Mar. 31, 2018		(24,307,368)	(2,632,790)
Ending Balance at Mar. 31, 2018	507,470	$ 243	$ (123,235)	438,325	179,135	13,002
Beginning Balance, shares at Dec. 31, 2018		(24,418,252.000)	(2,671,962.000)
Beginning Balance at Dec. 31, 2018	540,624	$ 244	$ (124,794)	452,573	196,106	16,495
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Comprehensive income (loss)	6,040				3,304	2,736
Issuance of common stock in connection with:
Restricted stock awards, net of cancellations, shares		254,550	27,612
Restricted stock awards, net of cancellations	0	$ 3	$ 2,196	(2,199)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period		10,000
Stock Issued During Period, Value, Stock Options Exercised	234	$ 0		234
Share-based compensation	7,140			7,140
Shares redeemed for employee tax withholdings, shares			(94,500)
Shares redeemed for employee tax withholdings	(4,385)		$ 4,385
Ending Balance, shares at Mar. 31, 2019		(24,682,802)	(2,738,850)
Ending Balance at Mar. 31, 2019	$ 549,653	$ 247	$ (126,983)	$ 457,748	$ 199,410	$ 19,231

XML

Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Cash flows from operating activities:
Net income	$ 3,304	$ (3,264)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization	10,710	10,021
Operating Lease, Impairment Loss	740	0
Share-based compensation	5,366	4,483
Amortization of debt discount and issuance costs	2,618	2,615
Allowances For Doubtful Accounts And Unbilled Services	59	201
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability	(391)	830
Changes in operating assets and liabilities, net of acquisitions:
(Increase) decrease in receivables from clients, net	5,129	(4,452)
(Increase) decrease in unbilled services, net	(16,850)	(15,991)
(Increase) decrease in current income tax receivable / payable, net	3,490	(805)
(Increase) decrease in other assets	(2,554)	(3,753)
Increase (decrease) in accounts payable and other liabilities	2,396	901
Increase (decrease) in accrued payroll and related benefits	(54,151)	(23,633)
Increase (decrease) in deferred revenues	1,845	(3,416)
Net cash used in operating activities	(38,289)	(36,263)
Cash flows from investing activities:
Purchases of property and equipment, net	(2,349)	(1,369)
Investment in life insurance policies	(3,645)	(1,455)
Purchases of businesses, net of cash acquired	0	(215)
Capitalization of internally developed software costs	(2,093)	(728)
Net cash used in investing activities	(8,087)	(3,767)
Cash flows from financing activities:
Proceeds from exercise of stock options	234	234
Shares redeemed for employee tax withholdings	(4,385)	(2,684)
Proceeds from borrowings under credit facility	40,500	91,500
Repayments of debt	(14,627)	(58,124)
Payments of Debt Issuance Costs	0	1,385
Net cash provided by financing activities	21,722	29,541
Effect of exchange rate changes on cash	73	16
Net decrease in cash and cash equivalents	(24,581)	(10,473)
Cash and cash equivalents at beginning of the period	33,107	16,909
Cash and cash equivalents at end of the period	8,526	6,436
Non-cash investing and financing activities:
Property and equipment expenditures and capitalized software included in accounts payable and accrued expenses	1,913	1,937
Contingent consideration related to business acquisitions	$ 0	$ 212

XML

Description of Business

3 Months Ended

Mar. 31, 2019

Accounting Policies [Abstract]

Description of Business

Description of Business

Huron is a global consultancy that helps clients drive growth, enhance performance and sustain leadership in the markets they serve. We partner with clients to develop strategies and implement solutions that enable the transformative change our clients need to own their future.

XML

Basis of Presentation

3 Months Ended

Mar. 31, 2019

Accounting Policies [Abstract]

Basis of Presentation

Basis of Presentation and Significant Accounting Policies

The accompanying unaudited consolidated financial statements reflect the financial position, results of operations, and cash flows as of and for the three months ended March 31, 2019 and 2018. These financial statements have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission ("SEC") for Quarterly Reports on Form 10-Q. Accordingly, these financial statements do not include all of the information and note disclosures required by accounting principles generally accepted in the United States of America (“GAAP”) for annual financial statements. In the opinion of management, these financial statements reflect all adjustments of a normal, recurring nature necessary for the fair statement of our financial position, results of operations, and cash flows for the interim periods presented in conformity with GAAP. These financial statements should be read in conjunction with our consolidated financial statements and notes thereto for the year ended December 31, 2018 included in our Annual Report on Form 10-K. Our results for any interim period are not necessarily indicative of results for a full year or any other interim period.

On January 1, 2019, we adopted Accounting Standard Update ("ASU") 2016-02, Leases. Below is an update to our lease accounting policy as a result of the adoption. Refer to Note 3 "New Accounting Pronouncements" for additional information on the adoption of ASU 2016-02.

Leases

We determine if an arrangement contains a lease and the classification of such lease at inception. As of March 31, 2019, all of our material leases are classified as operating leases; we have not entered into any material finance leases. For all operating leases with an initial term greater than 12 months, we recognize an operating lease right-of-use ("ROU") asset and operating lease liability. Leases with an initial term of 12 months or less are not recorded on the balance sheet; we recognize lease expense for these leases on a straight-line basis over the lease term.

Operating lease ROU assets represent our right to use an underlying asset for the lease term, and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at lease commencement date based on the present value of lease payments over the lease term. As our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at lease commencement date and provided by Bank of America, N.A., the administrative agent for our senior secured credit facility, in determining the present value of lease payments. The operating lease ROU asset excludes lease incentives.

Certain lease agreements contain variable lease payments that do not depend on an index or rate. These variable lease payments are not included in the calculation of the operating lease ROU asset and operating lease liability; instead, they are expensed as incurred. Certain lease agreements contain lease and nonlease components, which are accounted for separately. We separate the contract consideration between lease and nonlease components based on the relative standalone price of each component. Our leases may contain options to extend or terminate the lease, and we include these terms in our calculation of the operating lease ROU asset and operating lease liability when it is reasonably certain that we will exercise the option.

Operating lease expense is recognized on a straight-line basis over the lease term and recorded within selling, general and administrative expenses on our consolidated statement of operations. In accordance with our accounting policy for impairment of long-lived assets, operating lease ROU assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset group to which the operating lease ROU asset is assigned may not be recoverable. We evaluate the recoverability of the asset group based on forecasted undiscounted cash flows. See Note 5 "Leases" for additional information on our leases, including the lease impairment charge recorded in the first quarter of 2019.

XML

New Accounting Pronouncements

3 Months Ended

Mar. 31, 2019

New Accounting Pronouncements and Changes in Accounting Principles [Abstract]

New Accounting Pronouncements

New Accounting Pronouncements

Recently Adopted

In March 2016, the Financial Accounting Standards Board ("FASB") issued ASU 2016-02, Leases, as a new Topic, ASC 842, which superseded ASC Topic 840, Leases, and sets forth the principles for the recognition, measurement, presentation, and disclosure of leases for both lessees and lessors. ASU 2016-02 requires lessees to classify leases as either finance or operating leases and to record on the balance sheet a right-of-use asset and a lease liability, equal to the present value of the remaining lease payments, for all leases with a term greater than 12 months regardless of the lease classification. The lease classification will determine whether the lease expense is recognized using an effective interest rate method or on a straight-line basis over the term of the lease. In July 2018, the FASB issued ASU 2018-11, Leases (Topic 842): Targeted Improvements, which provides an optional transition method that allows entities to initially apply ASC 842 at the adoption date and recognize a cumulative-effect adjustment to the opening balance of retained earnings on the adoption date. We adopted ASC 842 effective January 1, 2019 on a modified retrospective basis for existing leases using the transition method allowed by ASU 2018-11, which had no impact on our consolidated financial statements in the prior periods presented. The new lease standard has a material impact on our consolidated balance sheet upon adoption, but does not impact our consolidated statement of operations. The most significant impact to our consolidated balance sheet is the recognition of ROU assets and lease liabilities for operating leases. The impact of the new lease standard on our consolidated balance sheet upon adoption follows:

	As of December 31, 2018		ASC 842 Adjustment			As of January 1, 2019
Assets
Operating lease right-of-use assets	$	—	$	56,463		$	56,463
Liabilities
Accrued expenses and other current liabilities	$	17,207	$	(2,557	)	$	14,650
Current maturities of operating lease liabilities	$	—	$	10,537		$	10,537
Deferred compensation and other liabilities	$	20,875	$	(536	)	$	20,339
Deferred lease incentives	$	13,693	$	(13,693	)	$	—
Operating lease liabilities, net of current portion	$	—	$	62,712		$	62,712

Not Yet Adopted

In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement, which modifies certain disclosure requirements related to fair value measurements. ASU 2018-13 will be effective for us beginning January 1, 2020, with early adoption permitted. We do not expect this guidance to have an impact on the amounts reported on our consolidated financial statements, and we are currently evaluating the potential impact this guidance will have on our disclosures within the notes to our consolidated financial statements.

XML

Goodwill and Intangible Assets

3 Months Ended

Mar. 31, 2019

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and Intangible Assets

Goodwill and Intangible Assets

The table below sets forth the changes in the carrying amount of goodwill by reportable segment for the three months ended March 31, 2019.

	Healthcare			Business Advisory			Education		Total
Balance as of December 31, 2018:
Goodwill	$	636,810		$	301,700		$	102,829	$	1,041,339
Accumulated impairment losses	(208,081		)	(187,995		)	—		(396,076		)
Goodwill, net as of December 31, 2018	428,729			113,705			102,829		645,263
Foreign currency translation	—			278			—		278
Goodwill, net as of March 31, 2019	$	428,729		$	113,983		$	102,829	$	645,541

Intangible Assets

Intangible assets as of March 31, 2019 and December 31, 2018 consisted of the following:

		As of March 31, 2019				As of December 31, 2018
	Useful Life  (in years)	Gross Carrying Amount		Accumulated Amortization		Gross Carrying Amount		Accumulated Amortization
Customer relationships	4 to 13	$	98,338	$	63,653	$	98,235	$	60,462
Trade names	5 to 6	28,930		23,859		28,930		23,181
Technology and software	3 to 5	5,694		3,211		5,694		2,842
Non-competition agreements	3 to 5	3,650		2,446		3,650		2,241
Favorable lease contract	3	720		702		720		646
Total		$	137,332	$	93,871	$	137,229	$	89,372

Identifiable intangible assets with finite lives are amortized over their estimated useful lives. Customer relationships, as well as certain trade names and technology and software, are amortized on an accelerated basis to correspond to the cash flows expected to be derived from the assets. All other intangible assets with finite lives are amortized on a straight-line basis.

Intangible asset amortization expense was $4.5 million and $6.3 million for the three months ended March 31, 2019 and 2018, respectively.The table below sets forth the estimated annual amortization expense for the year ending December 31, 2019 and each of the five succeeding years for the intangible assets recorded as of March 31, 2019.

Year Ending December 31,	Estimated Amortization Expense
2019	$	17,206
2020	$	12,083
2021	$	8,064
2022	$	6,090
2023	$	3,512
2024	$	741

Actual future amortization expense could differ from these estimated amounts as a result of future acquisitions, dispositions, and other factors.

XML

Leases Leases

3 Months Ended

Mar. 31, 2019

Leases [Abstract]

Leases of Lessee Disclosure [Text Block]

Leases

We lease office space, data centers and certain equipment under operating leases expiring on various dates through 2028, with various renewal options that can extend the lease terms by one to ten years. Our operating leases include fixed payments plus, in some cases, scheduled base rent increases over the term of the lease. Certain leases require variable payments of real estate taxes and insurance. We exclude these variable payments from the measurements of our lease liabilities and expense them as incurred. Additionally, certain leases require payments for operating expenses applicable to the property. We account for these nonlease components separately from the lease components. No lease agreements contain any residual value guarantees or material restrictive covenants. As of March 31, 2019, we have not entered into any material finance leases. We sublease certain office spaces to third parties resulting from restructuring activities in certain locations.

During the first quarter of 2019, we exited a portion of a corporate office space and determined that the carrying amount of the asset group to which the related operating lease right-of-use ("ROU") asset is assigned may not be recoverable. Therefore, we performed a long-lived asset impairment test on the asset group, which is comprised of the operating lease ROU asset and leasehold improvements of the office space. First, we tested the asset group for recoverability by comparing the undiscounted cash flows of the asset group, which included expected future lease and nonlease payments under the lease agreement offset by expected sublease income, to the carrying amount of the asset group. This first step of the long-lived asset impairment test concluded that the carrying amount of the asset group was not recoverable. Therefore, we performed the second step of the long-lived asset impairment test by comparing the fair value of the asset group to its carrying amount and recognizing a lease impairment charge for the amount by which the carrying amount exceeded the fair value. To estimate the fair value of the asset group, we relied on a discounted cash flow approach using market participant assumptions of the expected cash flows and discount rate. Based on the estimated fair value of the asset group, we recorded a $0.7 million lease impairment charge, of which $0.5 million was allocated to the operating lease ROU asset and $0.2 million was allocated to the leasehold improvements based on their relative carrying amounts. The $0.7 million lease impairment charge was recognized in restructuring charges on our consolidated statement of operations. See Note 9 "Restructuring Charges" for additional information on our restructuring activities.

Additional information on our operating leases as of March 31, 2019 follows.

Balance Sheet	March 31, 2019
Operating lease right-of-use assets	$	53,805
Current maturities of operating lease liabilities	$	10,293
Operating lease liabilities, net of current portion	60,280
Total lease liabilities	$	70,573

Lease Cost	Three Months Ended March 31, 2019
Operating lease cost	$	3,000
Short-term leases (1)	47
Variable lease costs	374
Sublease income	(617		)
Net lease cost (2)	$	2,804

(1) Includes variable lease costs related to short-term leases.

(2) Rent expense, including operating expenses, real estate taxes and insurance, recorded under ASC 840 for the three months ended March 31, 2018 was $3.9 million.

The table below summarizes the remaining expected lease payments under our operating leases as of March 31, 2019 and December 31, 2018.

Future Lease Payments	March 31, 2019			December 31, 2018 (1, 2)
2019	$	10,136		$	13,701
2020	12,717			12,724
2021	11,595			11,590
2022	10,775			10,766
2023	10,711			10,707
Thereafter	27,035			27,033
Total operating lease payments	$	82,969		$	86,521
Less: imputed interest	(12,396		)	n/a
Present value of operating lease liabilities	$	70,573		n/a

(1) The expected lease payments as of December 31, 2018 represent our future minimum rental commitments as defined by ASC 840.

(2) As of December 31, 2018, the expected total future minimum sublease income to be received was $10.2 million.

Other Information	Three Months Ended March 31, 2019
Cash paid for operating lease liabilities	$	3,554
Weighted average remaining lease term - operating leases	7.0 years
Weighted average discount rate - operating leases	4.7		%

During the first quarter of 2019, we entered into two new agreements to lease office space in Denver, Colorado and Bangalore, India. Both leases are expected to commence in the second quarter of 2019.

XML

Revenues Revenue

3 Months Ended

Mar. 31, 2019

Revenue from Contract with Customer [Abstract]

Revenue from Contract with Customer [Text Block]

Revenues

For the three months ended March 31, 2019 and 2018, we recognized revenues of $204.4 million and $193.7 million, respectively. Of the $204.4 million recognized in the first quarter of 2019, we recognized revenues of $3.9 million from obligations satisfied, or partially satisfied, in prior periods, due to the release of allowances on unbilled services due to securing contract amendments. During the first quarter of 2019, we recognized a $1.2 million decrease to revenues due to changes in the estimates of our variable consideration under performance-based billing arrangements. Of the $193.7 million recognized in the first quarter of 2018, we recognized revenues of $5.9 million from obligations satisfied, or partially satisfied, in prior periods, of which $3.1 million was primarily due to the release of allowances on unbilled services due to securing contract amendments and $2.8 million was due to changes in the estimates of our variable consideration under performance-based billing arrangements.

As of March 31, 2019, we had $75.1 million of remaining performance obligations under engagements with original expected durations greater than one year. These remaining performance obligations exclude obligations under contracts with an original expected duration of one year or less, variable consideration which has been excluded from the total transaction price due to the constraint, and performance obligations under time-and-expense engagements which are recognized in the amount invoiced. Of the $75.1 million of performance obligations, we expect to recognize approximately $56.9 million as revenue in 2019, $12.4 million in 2020, and the remaining $5.8 million thereafter. Actual revenue recognition could differ from these amounts as a result of changes in the estimated timing of work to be performed, adjustments to estimated variable consideration in performance-based arrangements, or other factors.

Contract Assets and Liabilities

The payment terms and conditions in our customer contracts vary. Differences between the timing of billings and the recognition of revenue are recognized as either unbilled services or deferred revenues in the consolidated balance sheets.

Unbilled services include revenues recognized for services performed but not yet billed to clients. Services performed that we are not yet entitled to bill because certain events, such as the completion of the measurement period or client approval in performance-based engagements, must occur are recorded as contract assets and included within unbilled services, net. The contract asset balance as of March 31, 2019 and December 31, 2018 was $3.7 million and $9.1 million, respectively. The $5.4 million decrease primarily reflects timing differences between the completion of our performance obligations and the amounts billed or billable to clients in accordance with their contractual billing terms.

Client prepayments and retainers are classified as deferred revenues and recognized over future periods in accordance with the applicable engagement agreement and our revenue recognition policy. Our deferred revenues balance as of March 31, 2019 and December 31, 2018, was $30.0 million and $28.1 million, respectively. The $1.9 million increase primarily reflects timing differences between client payments in accordance with their contract terms and the completion of our performance obligations. For the three months ended March 31, 2019, $11.7 million of revenues recognized were included in the deferred revenue balance as of December 31, 2018.

XML

Earnings Per Share

3 Months Ended

Mar. 31, 2019

Earnings Per Share [Abstract]

Earnings Per Share

Earnings Per Share

Basic earnings per share excludes dilution and is computed by dividing net income by the weighted average number of common shares outstanding for the period, excluding unvested restricted common stock. Diluted earnings per share reflects the potential reduction in earnings per share that could occur if securities or other contracts to issue common stock were exercised or converted into common stock under the treasury stock method. Such securities or other contracts include unvested restricted stock awards, outstanding common stock options, convertible senior notes, and outstanding warrants, to the extent dilutive. In periods for which we report a net loss from continuing operations, diluted weighted average common shares outstanding excludes all potential common stock equivalents as their impact on diluted net loss from continuing operations per share would be anti-dilutive.

Earnings (loss) per share under the basic and diluted computations are as follows: 

	Three Months Ended March 31,
	2019			2018
Net income (loss) from continuing operations	$	3,350		$	(3,222	)
Loss from discontinued operations, net of tax	(46		)	(42		)
Net income (loss)	$	3,304		$	(3,264	)
Weighted average common shares outstanding – basic	21,868			21,592
Weighted average common stock equivalents	443			—
Weighted average common shares outstanding – diluted	22,311			21,592
Net earnings (loss) per basic share:
Net income (loss) from continuing operations	$	0.15		$	(0.15	)
Loss from discontinued operations, net of tax	—			—
Net income (loss)	$	0.15		$	(0.15	)
Net earnings (loss) per diluted share:
Net income (loss) from continuing operations	$	0.15		$	(0.15	)
Loss from discontinued operations, net of tax	—			—
Net income (loss)	$	0.15		$	(0.15	)

The number of anti-dilutive securities excluded from the computation of the weighted average common stock equivalents presented above were as follows:

	As of March 31,
	2019	2018
Unvested restricted stock awards	12	723
Outstanding common stock options	—	184
Convertible senior notes	3,129	3,129
Warrants related to the issuance of convertible senior notes	3,129	3,129
Total anti-dilutive securities	6,270	7,165

See Note 8 “Financing Arrangements” for further information on the convertible senior notes and warrants related to the issuance of convertible notes.

We currently have a share repurchase program permitting us to repurchase up to $125 million of our common stock through October 31, 2019 (the “Share Repurchase Program”). The amount and timing of the repurchases will be determined by management and will depend on a variety of factors, including the trading price of our common stock, capacity under our credit facility, general market and business conditions, and applicable legal requirements. No shares were repurchased during the first three months of 2019 and 2018. As of March 31, 2019, $35.1 million remains available for share repurchases.

XML

Financing Arrangements

3 Months Ended

Mar. 31, 2019

Debt Disclosure [Abstract]

Financing Arrangements

Financing Arrangements

A summary of the carrying amounts of our debt follows:

	March 31, 2019			December 31, 2018
1.25% convertible senior notes due 2019	$	245,051		$	242,617
Senior secured credit facility	76,000			50,000
Promissory note due 2024	4,240			4,368
Total long-term debt	$	325,291		$	296,985
Current maturities of long-term debt	(245,569		)	(243,132		)
Long-term debt, net of current portion	$	79,722		$	53,853

Below is a summary of the scheduled remaining principal payments of our debt as of March 31, 2019.

	Principal Payments of Long-Term Debt
2019	$	250,387
2020	$	529
2021	$	544
2022	$	559
2023	$	76,575
Thereafter	$	1,646

Convertible Notes

In September 2014, the Company issued $250 million principal amount of 1.25% convertible senior notes due 2019 (the “Convertible Notes”) in a private offering. The Convertible Notes are governed by the terms of an indenture between the Company and U.S. Bank National Association, as Trustee (the “Indenture”). The Convertible Notes are senior unsecured obligations of the Company and will pay interest semi-annually on April 1 and October 1 of each year at an annual rate of 1.25%. The Convertible Notes will mature on October 1, 2019, unless earlier repurchased by the Company or converted in accordance with their terms. We expect to refinance the principal amount of the outstanding Convertible Notes at maturity with the borrowing capacity available under our revolving credit facility.

Upon conversion, the Convertible Notes will be settled, at our election, in cash, shares of the Company’s common stock, or a combination of cash and shares of the Company’s common stock. Our current intent and policy is to settle conversions with a combination of cash and shares of common stock with the principal amount of the Convertible Notes paid in cash, in accordance with the settlement provisions of the Indenture.

The initial conversion rate for the Convertible Notes is 12.5170 shares of our common stock per $1,000 principal amount of the Convertible Notes, which is equal to an initial conversion price of approximately $79.89 per share of our common stock. The conversion rate will be subject to adjustment upon the occurrence of certain specified events but will not be adjusted for accrued and unpaid interest, except in certain limited circumstances described in the Indenture. Upon the occurrence of a “make-whole fundamental change” (as defined in the Indenture) the Company will, in certain circumstances, increase the conversion rate by a number of additional shares for a holder that elects to convert its Convertible Notes in connection with such make-whole fundamental change. Additionally, if the Company undergoes a “fundamental change” (as defined in the Indenture), a holder will have the option to require the Company to repurchase all or a portion of its Convertible Notes for cash at a price equal to 100% of the principal amount of the Convertible Notes being repurchased plus any accrued and unpaid interest. As discussed below, the convertible note hedge transactions and warrants, which were entered into in connection with the Convertible Notes, effectively raise the price at which economic dilution would occur from the initial conversion price of approximately $79.89 to approximately $97.12 per share.

Holders of the Convertible Notes may convert their Convertible Notes at their option at any time prior to July 1, 2019, only under the following circumstances:

• during any calendar quarter (and only during such calendar quarter) commencing after December 31, 2014 if, for each of at least 20 trading days (whether or not consecutive) during the 30 consecutive trading day period ending on, and including, the last trading day of the immediately preceding calendar quarter, the last reported sale price of the Company’s common stock for such trading day is equal to or greater than 130% of the applicable conversion price on such trading day;

• during the five consecutive business day period immediately following any five consecutive trading day period (such five consecutive trading day period, the “measurement period”) in which, for each trading day of the measurement period, the “trading price” (as defined in the Indenture) per $1,000 principal amount of the Convertible Notes for such trading day was less than 98% of the product of the last reported sale price of the Company’s common stock for such trading day and the applicable conversion rate on such trading day; or

• upon the occurrence of specified corporate transactions described in the Indenture.

On or after July 1, 2019 until the close of business on the second scheduled trading day immediately preceding the maturity date, a holder may convert all or a portion of its Convertible Notes, regardless of the foregoing circumstances.

We have separated the Convertible Notes into liability and equity components. The carrying amount of the liability component was determined by measuring the fair value of a similar liability that does not have an associated convertible feature, assuming our non-convertible debt borrowing rate. The carrying value of the equity component representing the conversion option, which is recognized as a debt discount, was determined by deducting the fair value of the liability component from the proceeds of the Convertible Notes. The debt discount is amortized to interest expense using an effective interest rate of 4.751% over the term of the Convertible Notes. As of March 31, 2019, the remaining life of the Convertible Notes is six months. The equity component will not be remeasured as long as it continues to meet the conditions for equity classification.

The transaction costs related to the issuance of the Convertible Notes were separated into liability and equity components based on their relative values, as determined above. Transaction costs attributable to the liability component are recorded as a deduction to the carrying amount of the liability and amortized to interest expense over the term of the Convertible Notes; and transaction costs attributable to the equity component are netted with the equity component of the Convertible Notes in stockholders’ equity. Total debt issuance costs were approximately $7.3 million, of which $6.2 million was allocated to liability issuance costs and $1.1 million was allocated to equity issuance costs.

As of March 31, 2019 and December 31, 2018, the Convertible Notes consisted of the following:

	March 31, 2019			December 31, 2018
Liability component:
Proceeds	$	250,000		$	250,000
Less: debt discount, net of amortization	(4,316		)	(6,436		)
Less: debt issuance costs, net of amortization	(633		)	(947		)
Net carrying amount	$	245,051		$	242,617
Equity component (1)	$	39,287		$	39,287

(1)Included in additional paid-in capital on the consolidated balance sheet.

The following table presents the amount of interest expense recognized related to the Convertible Notes for the periods presented.

	Three Months Ended March 31,
	2019		2018
Contractual interest coupon	$	781	$	781
Amortization of debt discount	2,120		2,021
Amortization of debt issuance costs	315		309
Total interest expense	$	3,216	$	3,111

In connection with the issuance of the Convertible Notes, we entered into convertible note hedge transactions and warrant transactions. The convertible note hedge transactions are intended to reduce the potential future economic dilution associated with the conversion of the Convertible Notes and, combined with the warrants, effectively raise the price at which economic dilution would occur from the initial conversion price of approximately $79.89 to approximately $97.12 per share. For purposes of the computation of diluted earnings per share in accordance with GAAP, dilution will occur when the average share price of our common stock for a given period exceeds the conversion price of the Convertible Notes, which initially is equal to approximately $79.89 per share. The convertible note hedge transactions and warrant transactions are discussed separately below.

• Convertible Note Hedge Transactions. In connection with the issuance of the Convertible Notes, the Company entered into convertible note hedge transactions whereby the Company has call options to purchase a total of approximately 3.1 million shares of the Company’s common stock, which is the number of shares initially issuable upon conversion of the Convertible Notes in full, at a price of approximately $79.89, which corresponds to the initial conversion price of the Convertible Notes, subject to customary anti-dilution adjustments substantially similar to those in the Convertible Notes. The convertible note hedge transactions are exercisable upon conversion of the Convertible Notes and will expire in 2019 if not earlier exercised. We paid an aggregate amount of $42.1 million for the convertible note hedge transactions, which was recorded as additional paid-in capital on the consolidated balance sheet. The convertible note hedge transactions are separate transactions and are not part of the terms of the Convertible Notes.

• Warrants. In connection with the issuance of the Convertible Notes, the Company sold warrants whereby the holders of the warrants have the option to purchase a total of approximately 3.1 million shares of the Company’s common stock at a strike price of approximately $97.12. The warrants will expire incrementally on 100 different dates from January 6, 2020 to May 28, 2020 and are exercisable at each such expiry date. If the average market value per share of our common stock for the reporting period exceeds the strike price of the warrants, the warrants will have a dilutive effect on our earnings per share. We received aggregate proceeds of $23.6 million from the sale of the warrants, which was recorded as additional paid-in capital on the consolidated balance sheet. The warrants are separate transactions and are not part of the terms of the Convertible Notes or the convertible note hedge transactions.

The Company recorded an initial deferred tax liability of $15.4 million in connection with the debt discount associated with the Convertible Notes and recorded an initial deferred tax asset of $16.5 million in connection with the convertible note hedge transactions. The deferred tax liability and deferred tax asset are included in deferred income taxes, net on the consolidated balance sheets.

Senior Secured Credit Facility

The Company has a $500 millionfive-year senior secured revolving credit facility, subject to the terms of a Second Amended and Restated Credit Agreement dated as of March 31, 2015, as amended to date (as amended and modified the "Amended Credit Agreement"), that becomes due and payable in full upon maturity on March 23, 2023. The Amended Credit Agreement provides the option to increase the revolving credit facility or establish term loan facilities in an aggregate amount of up to $150 million, subject to customary conditions and the approval of any lender whose commitment would be increased, resulting in a maximum available principal amount under the Amended Credit Agreement of $650 million. The initial borrowings under the Amended Credit Agreement were used to refinance borrowings outstanding under a prior credit agreement, and future borrowings under the Amended Credit Agreement may be used for working capital, capital expenditures, acquisitions of businesses, share repurchases, and general corporate purposes.

Fees and interest on borrowings vary based on our Consolidated Leverage Ratio (as defined in the Amended Credit Agreement). At our option, borrowings under the Amended Credit Agreement will bear interest at one, two, three or six-month LIBOR or an alternate base rate, in each case plus the applicable margin. The applicable margin will fluctuate between 1.25% per annum and 2.00% per annum, in the case of LIBOR borrowings, or between 0.25% per annum and 1.00% per annum, in the case of base rate loans, based upon our Consolidated Leverage Ratio at such time.

Amounts borrowed under the Amended Credit Agreement may be prepaid at any time without premium or penalty. We are required to prepay the amounts outstanding under the Amended Credit Agreement in certain circumstances, including a requirement to pay all amounts outstanding under the Amended Credit Agreement 90 days prior to the Convertible Indebtedness Maturity Date (as defined in the Amended Credit Agreement) unless (1) the Convertible Indebtedness Maturity Date is waived or extended to a later date, (2) the Company can demonstrate (a) Liquidity (as defined in the Amended Credit Agreement) in an amount at least equal to the principal amount due on the Convertible Indebtedness Maturity Date, and (b) financial covenant compliance after giving effect to such payments and any additional indebtedness incurred on a pro forma basis, or (3) this requirement is waived by the Required Lenders (as defined in the Amended Credit Agreement). In addition, we have the right to permanently reduce or terminate the unused portion of the commitments provided under the Amended Credit Agreement at any time.

The loans and obligations under the Amended Credit Agreement are secured pursuant to a Second Amended and Restated Security Agreement and a Second Amended and Restated Pledge Agreement (the “Pledge Agreement”) with Bank of America, N.A. as collateral agent, pursuant to which the Company and the subsidiary guarantors grant Bank of America, N.A., for the ratable benefit of the lenders under the Amended Credit Agreement, a first-priority lien, subject to permitted liens, on substantially all of the personal property assets of the Company and the subsidiary guarantors, and a pledge of 100% of the stock or other equity interests in all domestic subsidiaries and 65% of the stock or other equity interests in each “material first-tier foreign subsidiary” (as defined in the Pledge Agreement).

The Amended Credit Agreement contains usual and customary representations and warranties; affirmative and negative covenants, which include limitations on liens, investments, additional indebtedness, and restricted payments; and two quarterly financial covenants as follows: (i) a maximum Consolidated Leverage Ratio (defined as the ratio of debt to consolidated EBITDA) ranging from 3.50 to 1.00 to 4.00 to 1.00, depending on the measurement period, and (ii) a minimum Consolidated Interest Coverage Ratio (defined as the ratio of consolidated EBITDA to interest) of 3.50 to 1.00. Consolidated EBITDA for purposes of the financial covenants is calculated on a continuing operations basis and includes adjustments to add back non-cash goodwill impairment charges, share-based compensation costs, certain non-cash restructuring charges, pro forma historical EBITDA for businesses acquired, and other specified items in accordance with the Amended Credit Agreement. At March 31, 2019, we were in compliance with these financial covenants with a Consolidated Leverage Ratio of 2.99 to 1.00 and a Consolidated Interest Coverage Ratio of 12.08 to 1.00.

Borrowings outstanding under the Amended Credit Agreement at March 31, 2019 totaled $76.0 million. These borrowings carried a weighted average interest rate of 4.5%, including the effect of the interest rate swap described in Note 10 “Derivative Instrument and Hedging Activity." Borrowings outstanding under the Amended Credit Agreement at December 31, 2018 were $50.0 million and carried a weighted average interest rate of 3.7%, including the effect of the interest rate swap described in Note 10 “Derivative Instrument and Hedging Activity." The borrowing capacity under the revolving credit facility is reduced by any outstanding borrowings under the revolving credit facility and outstanding letters of credit. At March 31, 2019, we had outstanding letters of credit totaling $1.6 million, which are primarily used as security deposits for our office facilities. As of March 31, 2019, the unused borrowing capacity under the revolving credit facility was $422.4 million.

Promissory Note due 2024

On June 30, 2017, in conjunction with our purchase of an aircraft related to the acquisition of Innosight, we assumed, from the sellers of the aircraft, a promissory note with an outstanding principal balance of $5.1 million. The principal balance of the promissory note is subject to scheduled monthly principal payments until the maturity date of March 1, 2024, at which time a final payment of $1.5 million, plus any accrued and unpaid interest, will be due. Under the terms of the promissory note, we will pay interest on the outstanding principal amount at a rate of one-month LIBOR plus 1.97% per annum. The obligations under the promissory note are secured pursuant to a Loan and Aircraft Security Agreement with Banc of America Leasing & Capital, LLC, which grants the lender a first priority security interest in the aircraft. At March 31, 2019, the outstanding principal amount of the promissory note was $4.2 million. As of March 31, 2019, the aircraft had a carrying amount of $5.6 million. At December 31, 2018, the outstanding principal amount of the promissory note was $4.4 million, and the aircraft had a carrying amount of $5.8 million.

XML

Restructuring Charges

3 Months Ended

Mar. 31, 2019

Restructuring and Related Activities [Abstract]

Restructuring Charges

Restructuring Charges

Restructuring charges for the first three months of 2019 totaled $1.3 million, compared to $0.7 million for the first three months of 2018. During the first quarter of 2019, we exited a portion of our Lake Oswego, Oregon corporate office resulting in a $0.7 million lease impairment charge on the related operating lease right-of-use asset and leasehold improvements and $0.2 million of accelerated depreciation on related furniture and fixtures. The lease impairment charge was recognized in accordance with ASC 842, Leases, which we adopted on a modified retrospective basis on January 1, 2019. See Note 2 "Basis of Presentation and Significant Accounting Policies" and Note 3 "New Accounting Pronouncements" for additional information on our adoption of ASC 842. See Note 5 "Leases" for additional information on the long-lived asset impairment test performed in the first quarter of 2019. Additionally, we recognized a $0.2 million restructuring charge in the first quarter of 2019 related to workforce reductions in our corporate operations. The $0.7 million restructuring charge incurred in the first three months of 2018 primarily related to updated lease assumptions for our San Francisco office vacated in the second quarter of 2017, which was accounted for in accordance with ASC 840, Leases.

The table below sets forth the changes in the carrying amount of our restructuring charge liability by restructuring type for the three months ended March 31, 2019.

	Employee Costs			Office Space Reductions			Total
Balance as of December 31, 2018	$	443		$	2,468		$	2,911
Adoption of ASC 842 (1)	—			(1,119		)	(1,119		)
Balance as of January 1, 2019	443			1,349			1,792
Additions (2)	247			289			536
Payments	(435		)	(371		)	(806		)
Adjustments (3)	(2		)	65			63
Non-cash items	—			(249		)	(249		)
Balance as of March 31, 2019	$	253		$	1,083		$	1,336

(1) Upon adoption of ASC 842 on January 1, 2019, we reclassified the restructuring charge liabilities, which represented the present value of remaining lease payments, net of estimated sublease income, for vacated office spaces from restructuring charge liabilities to operating lease right-of-use assets. See Note 3 "New Accounting Pronouncements" for additional information on the impact of adoption.

(2) Additions for the three months ended March 31, 2019 excludes the $0.7 million lease impairment charge recognized as restructuring charges on our consolidated statement of operations. See Note 5 "Leases" within the notes to our consolidated financial statements for additional information on the long-lived asset impairment test performed in the first quarter of 2019.

(3) Adjustments for the three months ended March 31, 2019 includes restructuring charges of $0.1 million related to updated operating expense assumptions for vacated office spaces directly related to discontinued operations.

As of March 31, 2019, our restructuring charge liability related to office space reductions of $1.1 million represented the present value of the remaining estimated operating expense payments for vacated office spaces, primarily in Chicago, Illinois; Washington, D.C.; and Middleton, Wisconsin. This restructuring charge liability is included as a component of accrued expenses and other current liabilities and deferred compensation and other liabilities. All of the $0.3 million restructuring charge liability related to employee costs at March 31, 2019 is expected to be paid in the next 12 months. The restructuring charge liability related to employee costs is included as a component of accrued payroll and related benefits.

XML

Derivative Instruments and Hedging Activity

3 Months Ended

Mar. 31, 2019

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivative Instruments and Hedging Activity

Derivative Instrument and Hedging Activity

On June 22, 2017, we entered into a forward interest rate swap agreement effective August 31, 2017 and ending August 31, 2022, with a notional amount of $50.0 million. We entered into this derivative instrument to hedge against the interest rate risks of our variable-rate borrowings. Under the terms of the interest rate swap agreement, we receive from the counterparty interest on the notional amount based on one-month LIBOR and we pay to the counterparty a fixed rate of 1.900%.

We recognize all derivative instruments as either assets or liabilities at fair value on the balance sheet. We have designated this derivative instrument as a cash flow hedge. Therefore, changes in the fair value of the derivative instrument are recorded to other comprehensive income (“OCI”) and reclassified into interest expense upon settlement. As of March 31, 2019, it was anticipated that $0.2 million of the gains, net of tax, currently recorded in accumulated other comprehensive income will be reclassified into earnings within the next 12 months.

The table below sets forth additional information relating to the interest rate swap designated as a cash flow hedging instrument as of March 31, 2019 and December 31, 2018.

	Fair Value (Derivative Asset and Liability)
Balance Sheet Location	March 31, 2019		December 31, 2018
Prepaid expenses and other current assets	$	240	$	302
Other non-current assets	$	192	$	451

All of our derivative instruments are transacted under the International Swaps and Derivatives Association (ISDA) master agreements. These agreements permit the net settlement of amounts owed in the event of default and certain other termination events. Although netting is permitted, it is our policy to record all derivative assets and liabilities on a gross basis on our consolidated balance sheet.

We do not use derivative instruments for trading or other speculative purposes. Refer to Note 12 “Other Comprehensive Income (Loss)” for additional information on our derivative instrument.

XML

Fair Value of Financial Instruments

3 Months Ended

Mar. 31, 2019

Fair Value Disclosures [Abstract]

Fair Value of Financial Instruments

Fair Value of Financial Instruments

Certain of our assets and liabilities are measured at fair value. Fair value is defined as the price that would be received to sell an asset or the price that would be paid to transfer a liability in an orderly transaction between market participants at the measurement date. GAAP establishes a fair value hierarchy for inputs used in measuring fair value and requires companies to maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy consists of three levels based on the objectivity of the inputs as follows:

Level 1 Inputs	Quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.
Level 2 Inputs	Quoted prices in active markets for similar assets or liabilities; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; or inputs that are derived principally from or corroborated by observable market data by correlation or other means.
Level 3 Inputs	Unobservable inputs for the asset or liability, and include situations in which there is little, if any, market activity for the asset or liability.

The table below sets forth our fair value hierarchy for our financial assets and liabilities measured at fair value on a recurring basis as of March 31, 2019 and December 31, 2018.

	Level 1		Level 2		Level 3		Total
March 31, 2019
Assets:
Interest rate swap	$	—	$	432	$	—	$	432
Convertible debt investment	—		—		54,038		54,038
Deferred compensation assets	—		23,918		—		23,918
Total assets	$	—	$	24,350	$	54,038	$	78,388
Liabilities:
Contingent consideration for business acquisitions	$	—	$	—	$	11,129	$	11,129
Total liabilities	$	—	$	—	$	11,129	$	11,129
December 31, 2018
Assets:
Interest rate swap	$	—	$	753	$	—	$	753
Convertible debt investment	—		—		50,429		50,429
Deferred compensation assets	—		18,205		—		18,205
Total assets	$	—	$	18,958	$	50,429	$	69,387
Liabilities:
Contingent consideration for business acquisitions	$	—	$	—	$	11,441	$	11,441
Total liabilities	$	—	$	—	$	11,441	$	11,441

Interest rate swap: The fair value of our interest rate swap was derived using estimates to settle the interest rate swap agreement, which is based on the net present value of expected future cash flows on each leg of the swap utilizing market-based inputs and a discount rate reflecting the risks involved.

Convertible debt investment: In 2014 and 2015, we invested $27.9 million, in the form of zero coupon convertible debt, in Shorelight Holdings, LLC (“Shorelight”), the parent company of Shorelight Education, a U.S.-based company that partners with leading universities to increase access to and retention of international students, boost institutional growth, and enhance an institution’s global footprint. The notes will mature on July 1, 2020, unless converted earlier.

To determine the appropriate accounting treatment for our investment, we performed a variable interest entity (“VIE”) analysis and concluded that Shorelight does not meet the definition of a VIE. We also reviewed the characteristics of our investment to confirm that the convertible notes are not in-substance common stock that would warrant equity method accounting. After we reviewed all of the terms of the investment, we concluded the appropriate accounting treatment to be that of an available-for-sale debt security.

The convertible debt investment is carried at fair value with unrealized holding gains and losses excluded from earnings and reported in other comprehensive income. We estimate the fair value of our investment using a Monte Carlo simulation model, cash flow projections discounted at a risk-adjusted rate, and certain assumptions related to equity volatility and applicable holding period, all of which are Level 3 inputs. The use of alternative estimates and assumptions could increase or decrease the estimated fair value of the investment, which would result in different impacts to our consolidated balance sheet and comprehensive income. Actual results may differ from our estimates. The fair value of the convertible debt investment is recorded in long-term investment on our consolidated balance sheets.

The table below sets forth the changes in the balance of the convertible debt investment for the three months ended March 31, 2019.

	Convertible Debt Investment
Balance as of December 31, 2018	$	50,429
Change in fair value of convertible debt investment	3,609
Balance as of March 31, 2019	$	54,038

Deferred compensation assets: We have a non-qualified deferred compensation plan (the "Plan") for the members of our board of directors and a select group of our employees. The deferred compensation liability is funded by the Plan assets, which consist of life insurance policies maintained within a trust. The cash surrender value of the life insurance policies approximates fair value and is based on third-party broker statements which provide the fair value of the life insurance policies' underlying investments, which are Level 2 inputs. The cash surrender value of the life insurance policies is invested primarily in mutual funds. The Plan assets are included in other non-current assets on our consolidated balance sheets. Realized and unrealized gains (losses) from the deferred compensation assets are recorded to other income (expense), net in our consolidated statements of operations.

Contingent consideration for business acquisitions: We estimate the fair value of acquisition-related contingent consideration using either a probability-weighted assessment of the specific financial performance targets being achieved or a Monte Carlo simulation model, as appropriate. These fair value measurements are based on significant inputs not observable in the market and thus represent Level 3 inputs. The significant unobservable inputs used in the fair value measurements of our contingent consideration are our measures of the estimated payouts based on internally generated financial projections on a probability-weighted basis and discount rates, which typically reflect a risk-free rate. The fair value of the contingent consideration is reassessed quarterly based on assumptions used in our latest projections and input provided by practice leaders and management. Any change in the fair value estimate is recorded in our consolidated statement of operations for that period. The use of alternative estimates and assumptions could increase or decrease the estimated fair value of our contingent consideration liability, which would result in different impacts to our consolidated balance sheets and consolidated statements of operations. Actual results may differ from our estimates. The table below sets forth the changes in the balance of the contingent consideration for business acquisitions for the three months ended March 31, 2019.

	Contingent Consideration for Business Acquisitions
Balance as of December 31, 2018	$	11,441
Remeasurement of contingent consideration for business acquisitions	(391		)
Unrealized loss due to foreign currency translation	79
Balance as of March 31, 2019	$	11,129

Financial assets and liabilities not recorded at fair value are as follows:

Senior Secured Credit Facility

The carrying value of our borrowings outstanding under our senior secured credit facility is stated at cost. Our carrying value approximates fair value, using Level 2 inputs, as the senior secured credit facility bears interest at variable rates based on current market rates as set forth in the Amended Credit Agreement. Refer to Note 8 “Financing Arrangements” for additional information on our senior secured credit facility.

Promissory Note due 2024

The carrying value of our promissory note due 2024 is stated at cost. Our carrying value approximates fair value, using Level 2 inputs, as the promissory note bears interest at rates based on current market rates as set forth in the terms of the promissory note. Refer to Note 8 “Financing Arrangements” for additional information on our promissory note due 2024.

Convertible Notes

The carrying amount and estimated fair value of the Convertible Notes are as follows:

	March 31, 2019				December 31, 2018
	Carrying Amount		Estimated Fair Value		Carrying Amount		Estimated Fair Value
1.25% convertible senior notes due 2019	$	245,051	$	246,190	$	242,617	$	242,940

The differences between the $250 million principal amount of the Convertible Notes and the carrying amounts shown above represent the unamortized debt discount and issuance costs. As of March 31, 2019 and December 31, 2018, the carrying value of the equity component of $39.3 million was unchanged from the date of issuance. Refer to Note 8 “Financing Arrangements” for additional information on our Convertible Notes. The estimated fair value of the Convertible Notes was determined based on the quoted bid price of the Convertible Notes in an over-the-counter market, which is a Level 2 input, on the last day of trading for the quarters ended March 31, 2019 and December 31, 2018.

Based on the closing price of our common stock of $47.22 on March 31, 2019, the if-converted value of the Convertible Notes was less than the principal amount.

Cash and cash equivalents are stated at cost, which approximates fair market value. The carrying values of all other financial instruments not described above reasonably approximate fair market value due to the nature of the financial instruments and the short-term maturity of these items.

XML

Other Comprehensive Income (Loss)

3 Months Ended

Mar. 31, 2019

Equity [Abstract]

Other Comprehensive Income (Loss)

Other Comprehensive Income (Loss)

The table below sets forth the components of other comprehensive income (loss), net of tax, for the three months ended March 31, 2019 and 2018.

	Three Months Ended March 31, 2019									Three Months Ended March 31, 2018
	Before Taxes			Tax (Expense) Benefit			Net of Taxes			Before Taxes		Tax (Expense) Benefit			Net of Taxes
Other comprehensive income (loss):
Foreign currency translation adjustments	$	316		$	—		$	316		$	34	$	—		$	34
Unrealized gain on investment	$	3,609		$	(952	)	$	2,657		$	2,927	$	(761	)	$	2,166
Unrealized gain (loss) on cash flow hedges:
Change in fair value	$	(247	)	$	65		$	(182	)	$	545	$	(141	)	$	404
Reclassification adjustments into earnings	(74		)	19			(55		)	38		(10		)	28
Net unrealized gain (loss)	$	(321	)	$	84		$	(237	)	$	583	$	(151	)	$	432
Other comprehensive income	$	3,604		$	(868	)	$	2,736		$	3,544	$	(912	)	$	2,632

The before tax amounts reclassified from accumulated other comprehensive income related to our cash flow hedges are recorded to interest expense, net of interest income.

Accumulated other comprehensive income, net of tax, includes the following components:

	Foreign Currency Translation			Available-for-Sale Investment		Cash Flow Hedges			Total
Balance, December 31, 2018	$	(665	)	$	16,584	$	576		$	16,495
Current period change	316			2,657		(237		)	2,736
Balance, March 31, 2019	$	(349	)	$	19,241	$	339		$	19,231

XML

Income Taxes

3 Months Ended

Mar. 31, 2019

Income Tax Disclosure [Abstract]

Income Taxes

Income Taxes

For the three months ended March 31, 2019, our effective tax rate was 29.0% as we recognized income tax expense from continuing operations of $1.4 million on income from continuing operations of $4.7 million. The effective tax rate of 29.0% was less favorable than the statutory rate, inclusive of state income taxes, of 26.4% primarily due to $0.5 million of foreign losses with no tax benefit, which had an unfavorable impact of 2.9% on the effective tax rate; and $0.1 million of additional tax expense related to disallowed executive compensation deductions, which had an unfavorable impact of 1.8% on the effective tax rate. These unfavorable adjustments to our effective tax rate were partially offset by $0.1 million of discrete tax benefit for share-based compensation awards that vested during the first quarter of 2019 and which had a favorable impact of 1.8% on the effective tax rate.

For the three months ended March 31, 2018, our effective tax rate was (14.7)% as we recognized income tax expense from continuing operations of $0.4 million on a loss from continuing operations of $2.8 million. The effective tax rate of (14.7)% was less favorable than the statutory rate, inclusive of state income taxes, of 26.0% primarily due to discrete tax expense for share-based compensation awards that vested during the first quarter of 2018 and which had an unfavorable impact of 43.7% on the effective tax rate.

XML

Commitments, Contingencies and Guarantees

3 Months Ended

Mar. 31, 2019

Commitments and Contingencies Disclosure [Abstract]

Commitments, Contingencies and Guarantees

Commitments, Contingencies and Guarantees

Litigation

From time to time, we are involved in legal proceedings and litigation arising in the ordinary course of business. As of the date of this Quarterly Report on Form 10-Q, we are not a party to any litigation or legal proceeding that, in the current opinion of management, could have a material adverse effect on our financial position or results of operations. However, due to the risks and uncertainties inherent in legal proceedings, actual results could differ from current expected results.

Guarantees

Guarantees in the form of letters of credit totaling $1.6 million were outstanding at both March 31, 2019 and December 31, 2018, primarily to support certain office lease obligations.

In connection with certain business acquisitions, we may be required to pay post-closing consideration to the sellers if specific financial performance targets are met over a number of years as specified in the related purchase agreements. As of March 31, 2019 and December 31, 2018, the total estimated fair value of our contingent consideration liabilities was $11.1 million and $11.4 million, respectively.

To the extent permitted by law, our bylaws and articles of incorporation require that we indemnify our officers and directors against judgments, fines and amounts paid in settlement, including attorneys’ fees, incurred in connection with civil or criminal action or proceedings, as it relates to their services to us if such person acted in good faith. Although there is no limit on the amount of indemnification, we may have recourse against our insurance carrier for certain payments made.

XML

Segment Information

3 Months Ended

Mar. 31, 2019

Segment Reporting [Abstract]

Segment Information

Segment Information

Segments are defined as components of a company that engage in business activities from which they may earn revenues and incur expenses, and for which separate financial information is available and is evaluated regularly by the chief operating decision maker, or decision-making group, in deciding how to allocate resources and in assessing performance. Our chief operating decision maker, who is our chief executive officer, manages the business under three operating segments, which are our reportable segments: Healthcare, Business Advisory, and Education.

• Healthcare

Our Healthcare segment has a depth of expertise in care transformation, financial and operational excellence, technology and analytics, and leadership development. We serve national and regional hospitals and integrated health systems, academic medical centers, community hospitals, and medical groups. Our solutions help clients evolve and adapt to the rapidly changing healthcare environment and achieve growth, optimize performance, enhance profitability, improve quality and clinical outcomes, align leaders, improve organizational culture, and drive physician, patient, and employee engagement across the enterprise to deliver better consumer outcomes.

We help organizations transform and innovate their delivery model to focus on patient wellness by improving quality outcomes, minimizing care variation and fundamentally improving patient and population health. Our consultants partner with clients to help build and sustain today’s business to invest in the future by reducing complexity, improving operational efficiency and growing market share. We enable the healthcare of the future by identifying, integrating and optimizing technology investments to collect data that transforms care delivery and improves patient outcomes. We also develop future leaders capable of driving meaningful operational and organizational change and who transform the consumer experience.

• Business Advisory

Our Business Advisory segment provides services to large and middle market organizations, not-for-profit organizations, lending institutions, law firms, investment banks and private equity firms. We assist clients in a broad range of industries and across the spectrum from healthy, well-capitalized companies to organizations in transition, as well as creditors, equity owners, and other key constituents. Our Business Advisory professionals resolve complex business issues and enhance client enterprise value through a suite of services including capital advisory, transaction advisory, operational improvement, restructuring and turnaround, valuation, and dispute advisory. Our Enterprise Solutions and Analytics professionals deliver technology and analytic solutions that enable organizations to manage and optimize their financial performance, operational efficiency, and client or stakeholder experience. Our Strategy and Innovation professionals collaborate with clients across a range of industries to identify new growth opportunities, build new ventures and capabilities, and accelerate organizational change. Our Life Sciences professionals providestrategic solutions to help pharmaceutical, medical device, and biotechnology companies deliver more value to patients, payers, and providers, and comply with regulations.

• Education

Our Education segment provides consulting and technology solutions to higher education institutions and academic medical centers. We partner with clients to address challenges relating to business and technology strategy, financial management, operational and organizational effectiveness, research administration, and regulatory compliance. Our institutional strategy, market research, budgeting and financial management, business operations and student life cycle management solutions align missions with business priorities, improve quality and reduce costs institution-wide. Our student solutions improve attraction, retention and graduation rates, increase student satisfaction and help generate quality outcomes. Our technology strategy, enterprise applications, and analytic solutions transform and optimize operations, deliver time and cost savings, and enhance the student experience. Our research enterprise solutions assist clients in identifying and implementing institutional research strategy, optimizing clinical research operations, improving financial management and cost reimbursement, improving service to faculty, and mitigating risk compliance.

Segment operating income consists of the revenues generated by a segment, less the direct costs of revenue and selling, general and administrative expenses that are incurred directly by the segment. Unallocated corporate costs include costs related to administrative functions that are performed in a centralized manner that are not attributable to a particular segment. These administrative function costs include costs for corporate office support, certain office facility costs, costs relating to accounting and finance, human resources, legal, marketing, information technology, and company-wide business development functions, as well as costs related to overall corporate management.

The table below sets forth information about our operating segments for the three months ended March 31, 2019 and 2018, along with the items necessary to reconcile the segment information to the totals reported in the accompanying consolidated financial statements.

	Three Months Ended March 31,
	2019			2018
Healthcare:
Revenues	$	93,682		$	89,895
Operating income	$	27,851		$	24,460
Segment operating income as a percentage of segment revenues	29.7		%	27.2		%
Business Advisory:
Revenues	$	58,806		$	55,895
Operating income	$	9,581		$	8,998
Segment operating income as a percentage of segment revenues	16.3		%	16.1		%
Education:
Revenues	$	51,957		$	47,889
Operating income	$	12,618		$	11,425
Segment operating income as a percentage of segment revenues	24.3		%	23.9		%
Total Company:
Revenues	$	204,445		$	193,679
Reimbursable expenses	18,617			17,619
Total revenues and reimbursable expenses	$	223,062		$	211,298
Segment operating income	$	50,050		$	44,883
Items not allocated at the segment level:
Other operating expenses	36,578			32,928
Other losses (gains), net	(456		)	830
Depreciation and amortization	7,172			8,803
Other expense, net	2,041			5,131
Income (loss) from continuing operations before taxes	$	4,715		$	(2,809	)

The following table illustrates the disaggregation of revenues by billing arrangements, employee types, and timing of revenue recognition, including a reconciliation of the disaggregated revenues to revenues from our three operating segments for the three months ended March 31, 2019 and 2018.

	Three Months Ended March 31, 2019
	Healthcare		Business Advisory		Education		Total
Billing Arrangements
Fixed-fee	$	63,584	$	21,672	$	12,383	$	97,639
Time and expense	12,763		35,309		35,358		83,430
Performance-based	11,810		664		—		12,474
Software support, maintenance and subscriptions	5,525		1,161		4,216		10,902
Total	$	93,682	$	58,806	$	51,957	$	204,445
Employee Type (1)
Revenue generated by full-time billable consultants	$	64,818	$	57,094	$	46,007	$	167,919
Revenue generated by full-time equivalents	28,864		1,712		5,950		36,526
Total	$	93,682	$	58,806	$	51,957	$	204,445
Timing of Revenue Recognition
Revenue recognized over time	$	91,642	$	58,806	$	51,711	$	202,159
Revenue recognized at a point in time	2,040		—		246		2,286
Total	$	93,682	$	58,806	$	51,957	$	204,445

	Three Months Ended March 31, 2018
	Healthcare		Business Advisory		Education		Total
Billing Arrangements
Fixed-fee	$	60,269	$	22,420	$	11,306	$	93,995
Time and expense	12,789		31,337		33,442		77,568
Performance-based	10,191		909		—		11,100
Software support, maintenance and subscriptions	6,646		1,229		3,141		11,016
Total	$	89,895	$	55,895	$	47,889	$	193,679
Employee Type (1)
Revenue generated by full-time billable consultants	$	59,273	$	53,416	$	41,632	$	154,321
Revenue generated by full-time equivalents	30,622		2,479		6,257		39,358
Total	$	89,895	$	55,895	$	47,889	$	193,679
Timing of Revenue Recognition
Revenue recognized over time	$	88,341	$	55,895	$	46,585	$	190,821
Revenue recognized at a point in time	1,554		—		1,304		2,858
Total	$	89,895	$	55,895	$	47,889	$	193,679

(1) Full-time billable consultants consist of our full-time professionals who provide consulting services to our clients and are billable to our clients based on the number of hours worked. Full-time equivalent professionals consist of leadership coaches and their support staff within our Studer Group solution, consultants who work variable schedules as needed by our clients, and full-time employees who provide software support and maintenance services to our clients.

At March 31, 2019 and December 31, 2018, no single client accounted for greater than 10% of our combined receivables and unbilled services balances. During the three months ended March 31, 2019 and 2018, no single client generated greater than 10% of our consolidated revenues.

XML

Basis of Presentation (Policies)

3 Months Ended

Mar. 31, 2019

Accounting Policies [Abstract]

Basis of Presentation

The accompanying unaudited consolidated financial statements reflect the financial position, results of operations, and cash flows as of and for the three months ended March 31, 2019 and 2018. These financial statements have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission ("SEC") for Quarterly Reports on Form 10-Q. Accordingly, these financial statements do not include all of the information and note disclosures required by accounting principles generally accepted in the United States of America (“GAAP”) for annual financial statements. In the opinion of management, these financial statements reflect all adjustments of a normal, recurring nature necessary for the fair statement of our financial position, results of operations, and cash flows for the interim periods presented in conformity with GAAP. These financial statements should be read in conjunction with our consolidated financial statements and notes thereto for the year ended December 31, 2018 included in our Annual Report on Form 10-K. Our results for any interim period are not necessarily indicative of results for a full year or any other interim period.

Earnings Per Share, Policy

Basic earnings per share excludes dilution and is computed by dividing net income by the weighted average number of common shares outstanding for the period, excluding unvested restricted common stock. Diluted earnings per share reflects the potential reduction in earnings per share that could occur if securities or other contracts to issue common stock were exercised or converted into common stock under the treasury stock method. Such securities or other contracts include unvested restricted stock awards, outstanding common stock options, convertible senior notes, and outstanding warrants, to the extent dilutive. In periods for which we report a net loss from continuing operations, diluted weighted average common shares outstanding excludes all potential common stock equivalents as their impact on diluted net loss from continuing operations per share would be anti-dilutive.

Convertible Senior Notes, Policy

We have separated the Convertible Notes into liability and equity components. The carrying amount of the liability component was determined by measuring the fair value of a similar liability that does not have an associated convertible feature, assuming our non-convertible debt borrowing rate.

Derivatives and Hedging, Policy

We recognize all derivative instruments as either assets or liabilities at fair value on the balance sheet. We have designated this derivative instrument as a cash flow hedge. Therefore, changes in the fair value of the derivative instrument are recorded to other comprehensive income (“OCI”) and reclassified into interest expense upon settlement.

Fair Value of Financial Instruments, Policy

Fair value is defined as the price that would be received to sell an asset or the price that would be paid to transfer a liability in an orderly transaction between market participants at the measurement date. GAAP establishes a fair value hierarchy for inputs used in measuring fair value and requires companies to maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy consists of three levels based on the objectivity of the inputs as follows:

Level 1 Inputs	Quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.
Level 2 Inputs	Quoted prices in active markets for similar assets or liabilities; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; or inputs that are derived principally from or corroborated by observable market data by correlation or other means.
Level 3 Inputs	Unobservable inputs for the asset or liability, and include situations in which there is little, if any, market activity for the asset or liability.

Segment Reporting, Policy

Segments are defined as components of a company that engage in business activities from which they may earn revenues and incur expenses, and for which separate financial information is available and is evaluated regularly by the chief operating decision maker, or decision-making group, in deciding how to allocate resources and in assessing performance. Our chief operating decision maker, who is our chief executive officer, manages the business under three operating segments, which are our reportable segments: Healthcare, Business Advisory, and Education.

Lessee, Leases, Policy

We determine if an arrangement contains a lease and the classification of such lease at inception. As of March 31, 2019, all of our material leases are classified as operating leases; we have not entered into any material finance leases. For all operating leases with an initial term greater than 12 months, we recognize an operating lease right-of-use ("ROU") asset and operating lease liability. Leases with an initial term of 12 months or less are not recorded on the balance sheet; we recognize lease expense for these leases on a straight-line basis over the lease term.

Operating lease ROU assets represent our right to use an underlying asset for the lease term, and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at lease commencement date based on the present value of lease payments over the lease term. As our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at lease commencement date and provided by Bank of America, N.A., the administrative agent for our senior secured credit facility, in determining the present value of lease payments. The operating lease ROU asset excludes lease incentives.

Certain lease agreements contain variable lease payments that do not depend on an index or rate. These variable lease payments are not included in the calculation of the operating lease ROU asset and operating lease liability; instead, they are expensed as incurred. Certain lease agreements contain lease and nonlease components, which are accounted for separately. We separate the contract consideration between lease and nonlease components based on the relative standalone price of each component. Our leases may contain options to extend or terminate the lease, and we include these terms in our calculation of the operating lease ROU asset and operating lease liability when it is reasonably certain that we will exercise the option.

Operating lease expense is recognized on a straight-line basis over the lease term and recorded within selling, general and administrative expenses on our consolidated statement of operations. In accordance with our accounting policy for impairment of long-lived assets, operating lease ROU assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset group to which the operating lease ROU asset is assigned may not be recoverable. We evaluate the recoverability of the asset group based on forecasted undiscounted cash flows.

XML

New Accounting Pronouncements New Accounting Pronouncements (Tables)

3 Months Ended

Mar. 31, 2019

New Accounting Pronouncements [Abstract]

Schedule of New Accounting Pronouncements and Changes in Accounting Principles

The impact of the new lease standard on our consolidated balance sheet upon adoption follows:

	As of December 31, 2018		ASC 842 Adjustment			As of January 1, 2019
Assets
Operating lease right-of-use assets	$	—	$	56,463		$	56,463
Liabilities
Accrued expenses and other current liabilities	$	17,207	$	(2,557	)	$	14,650
Current maturities of operating lease liabilities	$	—	$	10,537		$	10,537
Deferred compensation and other liabilities	$	20,875	$	(536	)	$	20,339
Deferred lease incentives	$	13,693	$	(13,693	)	$	—
Operating lease liabilities, net of current portion	$	—	$	62,712		$	62,712

XML

Goodwill and Intangible Assets (Tables)

3 Months Ended

Mar. 31, 2019

Goodwill and Intangible Assets Disclosure [Abstract]

Changes in Carrying Amount of Goodwill

The table below sets forth the changes in the carrying amount of goodwill by reportable segment for the three months ended March 31, 2019.

	Healthcare			Business Advisory			Education		Total
Balance as of December 31, 2018:
Goodwill	$	636,810		$	301,700		$	102,829	$	1,041,339
Accumulated impairment losses	(208,081		)	(187,995		)	—		(396,076		)
Goodwill, net as of December 31, 2018	428,729			113,705			102,829		645,263
Foreign currency translation	—			278			—		278
Goodwill, net as of March 31, 2019	$	428,729		$	113,983		$	102,829	$	645,541

Intangible Assets

Intangible assets as of March 31, 2019 and December 31, 2018 consisted of the following:

		As of March 31, 2019				As of December 31, 2018
	Useful Life  (in years)	Gross Carrying Amount		Accumulated Amortization		Gross Carrying Amount		Accumulated Amortization
Customer relationships	4 to 13	$	98,338	$	63,653	$	98,235	$	60,462
Trade names	5 to 6	28,930		23,859		28,930		23,181
Technology and software	3 to 5	5,694		3,211		5,694		2,842
Non-competition agreements	3 to 5	3,650		2,446		3,650		2,241
Favorable lease contract	3	720		702		720		646
Total		$	137,332	$	93,871	$	137,229	$	89,372

Schedule of Future Amortization Expense

The table below sets forth the estimated annual amortization expense for the year ending December 31, 2019 and each of the five succeeding years for the intangible assets recorded as of March 31, 2019.

Year Ending December 31,	Estimated Amortization Expense
2019	$	17,206
2020	$	12,083
2021	$	8,064
2022	$	6,090
2023	$	3,512
2024	$	741

XML

Leases Leases (Tables)

3 Months Ended

Mar. 31, 2019

Leases [Abstract]

Schedule of Supplemental Balance Sheet Information for Operating Leases

Balance Sheet	March 31, 2019
Operating lease right-of-use assets	$	53,805
Current maturities of operating lease liabilities	$	10,293
Operating lease liabilities, net of current portion	60,280
Total lease liabilities	$	70,573

Lease, Cost

Lease Cost	Three Months Ended March 31, 2019
Operating lease cost	$	3,000
Short-term leases (1)	47
Variable lease costs	374
Sublease income	(617		)
Net lease cost (2)	$	2,804

(1) Includes variable lease costs related to short-term leases.

(2) Rent expense, including operating expenses, real estate taxes and insurance, recorded under ASC 840 for the three months ended March 31, 2018 was $3.9 million.

Lessee, Operating Lease, Liability, Maturity

The table below summarizes the remaining expected lease payments under our operating leases as of March 31, 2019 and December 31, 2018.

Future Lease Payments	March 31, 2019			December 31, 2018 (1, 2)
2019	$	10,136		$	13,701
2020	12,717			12,724
2021	11,595			11,590
2022	10,775			10,766
2023	10,711			10,707
Thereafter	27,035			27,033
Total operating lease payments	$	82,969		$	86,521
Less: imputed interest	(12,396		)	n/a
Present value of operating lease liabilities	$	70,573		n/a

(1) The expected lease payments as of December 31, 2018 represent our future minimum rental commitments as defined by ASC 840.

(2) As of December 31, 2018, the expected total future minimum sublease income to be received was $10.2 million.

Schedule of Supplemental Operating Lease Information

Other Information	Three Months Ended March 31, 2019
Cash paid for operating lease liabilities	$	3,554
Weighted average remaining lease term - operating leases	7.0 years
Weighted average discount rate - operating leases	4.7		%

XML

Earnings Per Share (Tables)

3 Months Ended

Mar. 31, 2019

Earnings Per Share [Abstract]

Reconciliation of Basic and Diluted Earnings Per Share

Earnings (loss) per share under the basic and diluted computations are as follows: 

	Three Months Ended March 31,
	2019			2018
Net income (loss) from continuing operations	$	3,350		$	(3,222	)
Loss from discontinued operations, net of tax	(46		)	(42		)
Net income (loss)	$	3,304		$	(3,264	)
Weighted average common shares outstanding – basic	21,868			21,592
Weighted average common stock equivalents	443			—
Weighted average common shares outstanding – diluted	22,311			21,592
Net earnings (loss) per basic share:
Net income (loss) from continuing operations	$	0.15		$	(0.15	)
Loss from discontinued operations, net of tax	—			—
Net income (loss)	$	0.15		$	(0.15	)
Net earnings (loss) per diluted share:
Net income (loss) from continuing operations	$	0.15		$	(0.15	)
Loss from discontinued operations, net of tax	—			—
Net income (loss)	$	0.15		$	(0.15	)

Summary of Anti-dilutive Securities Excluded from Computation of Weighted Average Common Stock Equivalents

The number of anti-dilutive securities excluded from the computation of the weighted average common stock equivalents presented above were as follows:

	As of March 31,
	2019	2018
Unvested restricted stock awards	12	723
Outstanding common stock options	—	184
Convertible senior notes	3,129	3,129
Warrants related to the issuance of convertible senior notes	3,129	3,129
Total anti-dilutive securities	6,270	7,165

XML

Financing Arrangements (Tables)

3 Months Ended

Mar. 31, 2019

Debt Disclosure [Abstract]

Summary of Carrying Amounts of Debt

A summary of the carrying amounts of our debt follows:

	March 31, 2019			December 31, 2018
1.25% convertible senior notes due 2019	$	245,051		$	242,617
Senior secured credit facility	76,000			50,000
Promissory note due 2024	4,240			4,368
Total long-term debt	$	325,291		$	296,985
Current maturities of long-term debt	(245,569		)	(243,132		)
Long-term debt, net of current portion	$	79,722		$	53,853

Schedule of Maturities of Long-term Debt

Below is a summary of the scheduled remaining principal payments of our debt as of March 31, 2019.

	Principal Payments of Long-Term Debt
2019	$	250,387
2020	$	529
2021	$	544
2022	$	559
2023	$	76,575
Thereafter	$	1,646

Schedule of Convertible Notes

As of March 31, 2019 and December 31, 2018, the Convertible Notes consisted of the following:

	March 31, 2019			December 31, 2018
Liability component:
Proceeds	$	250,000		$	250,000
Less: debt discount, net of amortization	(4,316		)	(6,436		)
Less: debt issuance costs, net of amortization	(633		)	(947		)
Net carrying amount	$	245,051		$	242,617
Equity component (1)	$	39,287		$	39,287

(1)Included in additional paid-in capital on the consolidated balance sheet.

Summary of Interest Expense Recognized

The following table presents the amount of interest expense recognized related to the Convertible Notes for the periods presented.

	Three Months Ended March 31,
	2019		2018
Contractual interest coupon	$	781	$	781
Amortization of debt discount	2,120		2,021
Amortization of debt issuance costs	315		309
Total interest expense	$	3,216	$	3,111

XML

Restructuring Charges Restructuring Liability Rollforward (Tables)

3 Months Ended

Mar. 31, 2019

Restructuring and Related Activities [Abstract]

Schedule of Restructuring Reserve by Type of Cost

The table below sets forth the changes in the carrying amount of our restructuring charge liability by restructuring type for the three months ended March 31, 2019.

	Employee Costs			Office Space Reductions			Total
Balance as of December 31, 2018	$	443		$	2,468		$	2,911
Adoption of ASC 842 (1)	—			(1,119		)	(1,119		)
Balance as of January 1, 2019	443			1,349			1,792
Additions (2)	247			289			536
Payments	(435		)	(371		)	(806		)
Adjustments (3)	(2		)	65			63
Non-cash items	—			(249		)	(249		)
Balance as of March 31, 2019	$	253		$	1,083		$	1,336

(1) Upon adoption of ASC 842 on January 1, 2019, we reclassified the restructuring charge liabilities, which represented the present value of remaining lease payments, net of estimated sublease income, for vacated office spaces from restructuring charge liabilities to operating lease right-of-use assets. See Note 3 "New Accounting Pronouncements" for additional information on the impact of adoption.

(2) Additions for the three months ended March 31, 2019 excludes the $0.7 million lease impairment charge recognized as restructuring charges on our consolidated statement of operations. See Note 5 "Leases" within the notes to our consolidated financial statements for additional information on the long-lived asset impairment test performed in the first quarter of 2019.

(3) Adjustments for the three months ended March 31, 2019 includes restructuring charges of $0.1 million related to updated operating expense assumptions for vacated office spaces directly related to discontinued operations.

XML

Derivative Instruments and Hedging Activity (Tables)

3 Months Ended

Mar. 31, 2019

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Fair Value Interest Rate Swaps Designated as Cash Flow Hedging Instruments

The table below sets forth additional information relating to the interest rate swap designated as a cash flow hedging instrument as of March 31, 2019 and December 31, 2018.

	Fair Value (Derivative Asset and Liability)
Balance Sheet Location	March 31, 2019		December 31, 2018
Prepaid expenses and other current assets	$	240	$	302
Other non-current assets	$	192	$	451

XML

Fair Value of Financial Instruments (Tables)

3 Months Ended

Mar. 31, 2019

Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]

Financial Assets and Liabilities Measured at Fair Value on Recurring Basis

The table below sets forth our fair value hierarchy for our financial assets and liabilities measured at fair value on a recurring basis as of March 31, 2019 and December 31, 2018.

	Level 1		Level 2		Level 3		Total
March 31, 2019
Assets:
Interest rate swap	$	—	$	432	$	—	$	432
Convertible debt investment	—		—		54,038		54,038
Deferred compensation assets	—		23,918		—		23,918
Total assets	$	—	$	24,350	$	54,038	$	78,388
Liabilities:
Contingent consideration for business acquisitions	$	—	$	—	$	11,129	$	11,129
Total liabilities	$	—	$	—	$	11,129	$	11,129
December 31, 2018
Assets:
Interest rate swap	$	—	$	753	$	—	$	753
Convertible debt investment	—		—		50,429		50,429
Deferred compensation assets	—		18,205		—		18,205
Total assets	$	—	$	18,958	$	50,429	$	69,387
Liabilities:
Contingent consideration for business acquisitions	$	—	$	—	$	11,441	$	11,441
Total liabilities	$	—	$	—	$	11,441	$	11,441

Summary of Carrying Amount and Estimated Fair Value of Convertible Senior Notes

The carrying amount and estimated fair value of the Convertible Notes are as follows:

	March 31, 2019				December 31, 2018
	Carrying Amount		Estimated Fair Value		Carrying Amount		Estimated Fair Value
1.25% convertible senior notes due 2019	$	245,051	$	246,190	$	242,617	$	242,940

Contingent consideration for business acquisitions

Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]

Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]

The table below sets forth the changes in the balance of the contingent consideration for business acquisitions for the three months ended March 31, 2019.

	Contingent Consideration for Business Acquisitions
Balance as of December 31, 2018	$	11,441
Remeasurement of contingent consideration for business acquisitions	(391		)
Unrealized loss due to foreign currency translation	79
Balance as of March 31, 2019	$	11,129

Convertible senior notes

Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]

Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]

The table below sets forth the changes in the balance of the convertible debt investment for the three months ended March 31, 2019.

	Convertible Debt Investment
Balance as of December 31, 2018	$	50,429
Change in fair value of convertible debt investment	3,609
Balance as of March 31, 2019	$	54,038

XML

Other Comprehensive Income (Loss) (Tables)

3 Months Ended

Mar. 31, 2019

Equity [Abstract]

Components of Other Comprehensive Income (Loss), Net of Tax

The table below sets forth the components of other comprehensive income (loss), net of tax, for the three months ended March 31, 2019 and 2018.

	Three Months Ended March 31, 2019									Three Months Ended March 31, 2018
	Before Taxes			Tax (Expense) Benefit			Net of Taxes			Before Taxes		Tax (Expense) Benefit			Net of Taxes
Other comprehensive income (loss):
Foreign currency translation adjustments	$	316		$	—		$	316		$	34	$	—		$	34
Unrealized gain on investment	$	3,609		$	(952	)	$	2,657		$	2,927	$	(761	)	$	2,166
Unrealized gain (loss) on cash flow hedges:
Change in fair value	$	(247	)	$	65		$	(182	)	$	545	$	(141	)	$	404
Reclassification adjustments into earnings	(74		)	19			(55		)	38		(10		)	28
Net unrealized gain (loss)	$	(321	)	$	84		$	(237	)	$	583	$	(151	)	$	432
Other comprehensive income	$	3,604		$	(868	)	$	2,736		$	3,544	$	(912	)	$	2,632

Components of Accumulated Other Comprehensive Income (Loss), Net of Tax

Accumulated other comprehensive income, net of tax, includes the following components:

	Foreign Currency Translation			Available-for-Sale Investment		Cash Flow Hedges			Total
Balance, December 31, 2018	$	(665	)	$	16,584	$	576		$	16,495
Current period change	316			2,657		(237		)	2,736
Balance, March 31, 2019	$	(349	)	$	19,241	$	339		$	19,231

XML

Segment Information (Tables)

3 Months Ended

Mar. 31, 2019

Segment Reporting [Abstract]

Components of Segment Information

The table below sets forth information about our operating segments for the three months ended March 31, 2019 and 2018, along with the items necessary to reconcile the segment information to the totals reported in the accompanying consolidated financial statements.

	Three Months Ended March 31,
	2019			2018
Healthcare:
Revenues	$	93,682		$	89,895
Operating income	$	27,851		$	24,460
Segment operating income as a percentage of segment revenues	29.7		%	27.2		%
Business Advisory:
Revenues	$	58,806		$	55,895
Operating income	$	9,581		$	8,998
Segment operating income as a percentage of segment revenues	16.3		%	16.1		%
Education:
Revenues	$	51,957		$	47,889
Operating income	$	12,618		$	11,425
Segment operating income as a percentage of segment revenues	24.3		%	23.9		%
Total Company:
Revenues	$	204,445		$	193,679
Reimbursable expenses	18,617			17,619
Total revenues and reimbursable expenses	$	223,062		$	211,298
Segment operating income	$	50,050		$	44,883
Items not allocated at the segment level:
Other operating expenses	36,578			32,928
Other losses (gains), net	(456		)	830
Depreciation and amortization	7,172			8,803
Other expense, net	2,041			5,131
Income (loss) from continuing operations before taxes	$	4,715		$	(2,809	)

Disaggregation of Revenue

The following table illustrates the disaggregation of revenues by billing arrangements, employee types, and timing of revenue recognition, including a reconciliation of the disaggregated revenues to revenues from our three operating segments for the three months ended March 31, 2019 and 2018.

	Three Months Ended March 31, 2019
	Healthcare		Business Advisory		Education		Total
Billing Arrangements
Fixed-fee	$	63,584	$	21,672	$	12,383	$	97,639
Time and expense	12,763		35,309		35,358		83,430
Performance-based	11,810		664		—		12,474
Software support, maintenance and subscriptions	5,525		1,161		4,216		10,902
Total	$	93,682	$	58,806	$	51,957	$	204,445
Employee Type (1)
Revenue generated by full-time billable consultants	$	64,818	$	57,094	$	46,007	$	167,919
Revenue generated by full-time equivalents	28,864		1,712		5,950		36,526
Total	$	93,682	$	58,806	$	51,957	$	204,445
Timing of Revenue Recognition
Revenue recognized over time	$	91,642	$	58,806	$	51,711	$	202,159
Revenue recognized at a point in time	2,040		—		246		2,286
Total	$	93,682	$	58,806	$	51,957	$	204,445

	Three Months Ended March 31, 2018
	Healthcare		Business Advisory		Education		Total
Billing Arrangements
Fixed-fee	$	60,269	$	22,420	$	11,306	$	93,995
Time and expense	12,789		31,337		33,442		77,568
Performance-based	10,191		909		—		11,100
Software support, maintenance and subscriptions	6,646		1,229		3,141		11,016
Total	$	89,895	$	55,895	$	47,889	$	193,679
Employee Type (1)
Revenue generated by full-time billable consultants	$	59,273	$	53,416	$	41,632	$	154,321
Revenue generated by full-time equivalents	30,622		2,479		6,257		39,358
Total	$	89,895	$	55,895	$	47,889	$	193,679
Timing of Revenue Recognition
Revenue recognized over time	$	88,341	$	55,895	$	46,585	$	190,821
Revenue recognized at a point in time	1,554		—		1,304		2,858
Total	$	89,895	$	55,895	$	47,889	$	193,679

(1) Full-time billable consultants consist of our full-time professionals who provide consulting services to our clients and are billable to our clients based on the number of hours worked. Full-time equivalent professionals consist of leadership coaches and their support staff within our Studer Group solution, consultants who work variable schedules as needed by our clients, and full-time employees who provide software support and maintenance services to our clients.

XML

New Accounting Pronouncements Impact of Adoption - Balance Sheet (Details) - USD ($) $ in Thousands		3 Months Ended
	Jan. 01, 2019	Mar. 31, 2018	Mar. 31, 2019	Dec. 31, 2018
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Receivables from clients, net			$ 104,674	$ 109,677
Costs in Excess of Billings, Current			86,504	69,613
Operating Lease, Right-of-Use Asset	$ 56,463		53,805	0
Income tax receivable			3,209	6,612
Deferred Tax Assets, Net, Noncurrent			1,302	2,153
Other non-current assets			38,345	30,525
Accrued payroll and related benefits			53,966	109,825
Deferred revenues			30,023	28,130
Retained earnings			199,410	196,106
Operating Lease, Liability, Current	10,537		10,293	0
Deferred compensation and other liabilities	20,339		25,886	20,875
Operating lease liabilities, net of current portion	0		0	13,693
Operating Lease, Liability, Noncurrent	62,712		$ 60,280	$ 0
Accounting Standards Update 2014-09 [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification		$ 1,956
Operating lease right-of-use asset [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification	56,463
Accrued Liabilities [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification	(2,557)
Current maturities of operating lease liabilities [Domain]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification	10,537
Other Liabilities [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification	(536)
Deferred lease incentives [Domain]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification	(13,693)
Operating lease liabilities, net of current [Domain]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification	$ 62,712

XML

Goodwill and Intangible Assets - Changes in Carrying Amount of Goodwill (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Dec. 31, 2018
Goodwill [Line Items]
Goodwill		$ 1,041,339
Accumulated impairment losses		(396,076)
Goodwill [Roll Forward]
Goodwill, net beginning balance	$ 645,263
Goodwill, Foreign Currency Translation Gain (Loss)	278
Goodwill, net ending balance	645,541
Healthcare
Goodwill [Line Items]
Goodwill		636,810
Accumulated impairment losses		(208,081)
Goodwill [Roll Forward]
Goodwill, net beginning balance	428,729
Goodwill, Foreign Currency Translation Gain (Loss)	0
Goodwill, net ending balance	428,729
Education [Member]
Goodwill [Line Items]
Goodwill		102,829
Accumulated impairment losses		0
Goodwill [Roll Forward]
Goodwill, net beginning balance	102,829
Goodwill, Foreign Currency Translation Gain (Loss)	0
Goodwill, net ending balance	102,829
Business Advisory
Goodwill [Line Items]
Goodwill		301,700
Accumulated impairment losses		$ (187,995)
Goodwill [Roll Forward]
Goodwill, net beginning balance	113,705
Goodwill, Foreign Currency Translation Gain (Loss)	278
Goodwill, net ending balance	$ 113,983

XML

Goodwill and Intangible Assets - Intangible Assets (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Dec. 31, 2018
Intangible assets
Gross Carrying Amount	$ 137,332	$ 137,229
Accumulated Amortization	93,871	89,372
Customer Relationships [Member]
Intangible assets
Gross Carrying Amount	98,338	98,235
Accumulated Amortization	$ 63,653	60,462
Customer Relationships [Member] | Minimum
Intangible assets
Useful Life (in years)	4 years
Customer Relationships [Member] | Maximum
Intangible assets
Useful Life (in years)	13 years
Trade Names [Member]
Intangible assets
Gross Carrying Amount	$ 28,930	28,930
Accumulated Amortization	$ 23,859	23,181
Trade Names [Member] | Minimum
Intangible assets
Useful Life (in years)	5 years
Trade Names [Member] | Maximum
Intangible assets
Useful Life (in years)	6 years
Technology And Software [Member]
Intangible assets
Gross Carrying Amount	$ 5,694	5,694
Accumulated Amortization	$ 3,211	2,842
Technology And Software [Member] | Minimum
Intangible assets
Useful Life (in years)	3 years
Technology And Software [Member] | Maximum
Intangible assets
Useful Life (in years)	5 years
Noncompete Agreements [Member]
Intangible assets
Gross Carrying Amount	$ 3,650	3,650
Accumulated Amortization	$ 2,446	2,241
Noncompete Agreements [Member] | Minimum
Intangible assets
Useful Life (in years)	3 years
Noncompete Agreements [Member] | Maximum
Intangible assets
Useful Life (in years)	5 years
Off-Market Favorable Lease [Member]
Intangible assets
Useful Life (in years)	3 years
Gross Carrying Amount	$ 720	720
Accumulated Amortization	$ 702	$ 646

XML

Goodwill and Intangible Assets - Amortization Expense (Detail) $ in Thousands	Mar. 31, 2019 USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months	$ 17,206
Estimated annual intangible assets amortization expense, Year Two	12,083
Estimated annual intangible assets amortization expense, Year Three	8,064
Estimated annual intangible assets amortization expense, Year Four	6,090
Estimated annual intangible assets amortization expense, Year Five	3,512
Finite-Lived Intangible Assets, Amortization Expense, after Year Five	$ 741

XML

Goodwill and Intangible Assets Goodwill and Intangible Assets - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization of Intangible Assets	$ 4.5	$ 6.3

XML

Leases Schedule of Operating Lease Balances (Details) - USD ($) $ in Thousands	Mar. 31, 2019	Jan. 01, 2019	Dec. 31, 2018
Leases [Abstract]
Operating Lease, Right-of-Use Asset	$ 53,805	$ 56,463	$ 0
Operating Lease, Liability, Current	10,293	10,537	0
Operating Lease, Liability, Noncurrent	60,280	$ 62,712	$ 0
Operating Lease, Liability	$ 70,573

XML

Leases Schedule of Lease Costs (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2019 USD ($)
Leases [Abstract]
Operating Lease, Cost	$ 3,000
Short-term Lease, Cost	47
Variable Lease, Cost	374
Sublease Income	(617)
Lease, Cost	$ 2,804

XML

Leases Schedule of Maturity of Lease Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2019	Dec. 31, 2018
Leases [Abstract]
Lessee, Operating Lease, Liability, Payments, Due Next Twelve Months	$ 10,136
Lessee, Operating Lease, Liability, Payments, Due Year Two	12,717
Lessee, Operating Lease, Liability, Payments, Due Year Three	11,595
Lessee, Operating Lease, Liability, Payments, Due Year Four	10,775
Lessee, Operating Lease, Liability, Payments, Due Year Five	10,711
Lessee, Operating Lease, Liability, Payments, Due after Year Five	27,035
Lessee, Operating Lease, Liability, Payments, Due	82,969
Imputed interest of lease liabilities	(12,396)
Operating Lease, Liability	$ 70,573
Operating Leases, Future Minimum Payments Due, Next Twelve Months		$ 13,701
Operating Leases, Future Minimum Payments, Due in Two Years		12,724
Operating Leases, Future Minimum Payments, Due in Three Years		11,590
Operating Leases, Future Minimum Payments, Due in Four Years		10,766
Operating Leases, Future Minimum Payments, Due in Five Years		10,707
Operating Leases, Future Minimum Payments, Due Thereafter		27,033
Operating Leases, Future Minimum Payments Due		$ 86,521

XML

Leases Schedule of Operating Lease Additional Information (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2019 USD ($)
Leases [Abstract]
Operating Lease, Payments	$ 3,554
Operating Lease, Weighted Average Remaining Lease Term	7 years
Operating Lease, Weighted Average Discount Rate, Percent	4.70%

XML

Leases Leases Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Dec. 31, 2018
Lessee, Lease, Description [Line Items]
Lessee, Operating Lease, Lease Not yet Commenced, Description	During the first quarter of 2019, we entered into two new agreements to lease office space in Denver, Colorado and Bangalore, India. Both leases are expected to commence in the second quarter of 2019.
Operating Leases, Future Minimum Payments Receivable			$ 10,200
Operating Leases, Rent Expense, Net		$ 3,900
Operating Lease, Impairment Loss	$ 740	$ 0
Operating lease right-of-use asset [Member]
Lessee, Lease, Description [Line Items]
Operating Lease, Impairment Loss	500
Leasehold Improvements [Member]
Lessee, Lease, Description [Line Items]
Operating Lease, Impairment Loss	$ 200
Minimum
Lessee, Lease, Description [Line Items]
Lessee, Operating Lease, Renewal Term	1 year
Maximum
Lessee, Lease, Description [Line Items]
Lessee, Operating Lease, Renewal Term	10 years

XML

Leases Schedule of Oeprating Lease Balances Table (Details) - USD ($) $ in Thousands	Mar. 31, 2019	Jan. 01, 2019	Dec. 31, 2018
Leases [Abstract]
Operating Lease, Right-of-Use Asset	$ 53,805	$ 56,463	$ 0
Operating Lease, Liability, Current	10,293	10,537	0
Operating Lease, Liability, Noncurrent	60,280	$ 62,712	$ 0
Operating Lease, Liability	$ 70,573

XML

Revenues Revenue - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Dec. 31, 2018
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Sales Revenue, Services, Net	$ 204,445	$ 193,679
Contract with Customer, Performance Obligation Satisfied in Previous Period		5,900
Revenue, Remaining Performance Obligation	75,100
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Contract with Customer, Asset, Net	3,700		$ 9,100
Contract Asset, Period Increase (Decrease)	(5,400)
Deferred revenues	30,023		$ 28,130
Increase (decrease) in deferred revenues	1,900
Deferred Revenue, Revenue Recognized	11,700
Change in Estimated Variable Consideration [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Contract with Customer, Performance Obligation Satisfied in Previous Period	(1,200)	2,800
Release of Allowance [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Contract with Customer, Performance Obligation Satisfied in Previous Period	$ 3,900	$ 3,100

XML

Revenues Performance Obligations Information (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Contract with Customer, Performance Obligation Satisfied in Previous Period		$ 5.9
Revenue, Remaining Performance Obligation	$ 75.1
Release of Allowance [Member]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Contract with Customer, Performance Obligation Satisfied in Previous Period	3.9	3.1
Change in Estimated Variable Consideration [Member]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Contract with Customer, Performance Obligation Satisfied in Previous Period	(1.2)	$ 2.8
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2019-04-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation	$ 56.9
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2019-09-30
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period	9 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2020-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation	$ 12.4
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation	$ 5.8
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period	5 years

XML

Earnings Per Share - Reconciliation of Basic and Diluted Earnings Per Share (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Earnings Per Share [Abstract]
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent	$ 3,350	$ (3,222)
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent	(46)	(42)
Net income	$ 3,304	$ (3,264)
Weighted average common shares outstanding – basic	21,868	21,592
Weighted average common stock equivalents	443	0
Weighted average common shares outstanding – diluted	22,311	21,592
Net earnings (loss) per basic share:
Income (Loss) from Continuing Operations, Per Basic Share	$ 0.15	$ (0.15)
Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share	0.00	0.00
Basic (USD per share)	0.15	(0.15)
Net earnings per diluted share:
Income (Loss) from Continuing Operations, Per Diluted Share	0.15	(0.15)
Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share	0.00	0.00
Diluted (USD per share)	$ 0.15	$ (0.15)

XML

Earnings Per Share - Summary of Anti-dilutive Securities Excluded from Computation of Weighted Average Common Stock Equivalents (Detail) - shares shares in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total anti-dilutive securities	6,270	7,165
Unvested restricted stock awards
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total anti-dilutive securities	12	723
Employee Stock Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total anti-dilutive securities	0	184
Convertible senior notes
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total anti-dilutive securities	3,129	3,129
Warrants related to the issuance of convertible senior notes
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total anti-dilutive securities	3,129	3,129

XML

Earnings Per Share - Additional Information (Detail) - Share Repurchase Program [Member]	Mar. 31, 2019 USD ($)
Accelerated Share Repurchases [Line Items]
Share repurchase authorized amount	$ 125,000,000
Stock Repurchase Program, Remaining Authorized Repurchase Amount	$ 35,100,000

XML

Financing Arrangements - Summary of Carrying Amounts of Debt (Detail) - USD ($) $ in Thousands	Mar. 31, 2019	Dec. 31, 2018	Jun. 30, 2017
Debt Instrument [Line Items]
Net carrying amount	$ 325,291	$ 296,985
Long-term Debt, Current Maturities	(245,569)	(243,132)
Long-term debt, net of current portion	79,722	53,853
1.25% convertible senior notes due 2019
Debt Instrument [Line Items]
Net carrying amount	245,051	242,617
Senior secured credit facility
Debt Instrument [Line Items]
Net carrying amount	76,000	50,000
Promissory Note due 2024 [Member]
Debt Instrument [Line Items]
Net carrying amount	$ 4,240	$ 4,368	$ 5,100

XML

Financing Arrangements Schedule of Maturities of Long-Term Debt (Details) $ in Thousands	Mar. 31, 2019 USD ($)
Debt Disclosure [Abstract]
Long-term Debt, Maturities, Repayments of Principal in Next Twelve Months	$ 250,387
Long-term Debt, Maturities, Repayments of Principal in Year Two	529
Long-term Debt, Maturities, Repayments of Principal in Year Three	544
Long-term Debt, Maturities, Repayments of Principal in Year Four	559
Long-term Debt, Maturities, Repayments of Principal in Year Five	76,575
Long-term Debt, Maturities, Repayments of Principal after Year Five	$ 1,646

XML

Financing Arrangements - Schedule of Convertible Notes (Detail) - USD ($)	Mar. 31, 2019	Dec. 31, 2018	Sep. 30, 2014
Convertible Senior Notes [Line Items]
Net carrying amount	$ 325,291,000	$ 296,985,000
1.25% convertible senior notes due 2019
Convertible Senior Notes [Line Items]
Proceeds	250,000,000	250,000,000	$ 250,000,000
Less: debt discount, net of amortization	(4,316,000)	(6,436,000)
Debt Issuance Costs, Net	(633,000)	(947,000)
Net carrying amount	245,051,000	242,617,000
Equity component	$ 39,287,000	$ 39,287,000

XML

Financing Arrangements - Summary of Interest Expense Recognized (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Interest Expense Recognized [Line Items]
Interest Expense, Debt, Excluding Amortization	$ 781	$ 781
Amortization of Debt Discount (Premium)	2,120	2,021
Amortization of Debt Issuance Costs	315	309
1.25% convertible senior notes due 2019
Interest Expense Recognized [Line Items]
Interest Expense, Debt	$ 3,216	$ 3,111

XML

Financing Arrangements - Additional Information (Detail) $ / shares in Units, shares in Millions					3 Months Ended
	Jun. 30, 2017 USD ($)	Jun. 22, 2017	Mar. 31, 2015 USD ($)	Sep. 30, 2014 USD ($) $ / shares shares	Mar. 31, 2019 USD ($)	Mar. 31, 2018 USD ($)	Mar. 31, 2015 USD ($)	Dec. 31, 2018 USD ($)
Debt Instrument [Line Items]
Payments of Debt Issuance Costs					$ 0	$ 1,385,000
Deferred tax liability					759,000			$ 732,000
Net carrying amount					325,291,000			296,985,000
Duration of LIBOR		1 month
Property and equipment, net					38,359,000			40,374,000
Note Hedge
Debt Instrument [Line Items]
Common stock purchased | shares				3.1
Aggregate amount for convertible hedge				$ 42,100,000
Deferred tax asset				$ 16,500,000
Warrants related to the issuance of convertible senior notes
Debt Instrument [Line Items]
Common stock purchased | shares				3.1
Common stock price per share | $ / shares				$ 97.12
Aggregate proceeds from the sale of warrants				$ 23,600,000
1.25% convertible senior notes due 2019
Debt Instrument [Line Items]
Aggregate principal amount				$ 250,000,000	$ 250,000,000			250,000,000
Debt Instrument, Interest Rate, Stated Percentage				1.25%
Debt instrument maturity date				Oct. 01, 2019
Number of common shares converted upon debt conversion for each $1000 principal amount				12.5170
Principal amount of notes per conversion				$ 1,000
Optional right of debt instrument holders to convert debt instrument into cash, portion of principal amount				100.00%
Earliest conversion date				Jul. 01, 2019
Number of consecutive business days following consecutive trading days				5 days
Concentration risk percentage				98.00%
Effective interest rate of debt					4.751%
Debt Instrument, Convertible, Remaining Discount Amortization Period					6 months
Payments of Debt Issuance Costs				$ 7,300,000
Liability issuance costs				6,200,000
Equity issuance costs				1,100,000
Deferred tax liability				$ 15,400,000
Net carrying amount					$ 245,051,000			242,617,000
1.25% convertible senior notes due 2019 | Minimum
Debt Instrument [Line Items]
Conversion price of convertible notes | $ / shares				$ 79.89
Number of least trading days required within consecutive trading days				5
Number of consecutive trading days				20 days
Percentage of applicable conversion price				130.00%
1.25% convertible senior notes due 2019 | Maximum
Debt Instrument [Line Items]
Conversion price of convertible notes | $ / shares				$ 97.12
Number of least trading days required within consecutive trading days				30
Senior secured credit facility
Debt Instrument [Line Items]
Revolving Credit facility			$ 500,000,000				$ 500,000,000
Period of revolving credit facility			5 years
Credit agreement expiration date			Mar. 23, 2023
Option to increase revolving credit facility			$ 150,000,000
Maximum principle amount			$ 650,000,000				$ 650,000,000
Convertible debt maturity term			90 days
Percentage of other equity interests in domestic subsidiaries			100.00%
Percentage of other equity interests in foreign subsidiaries			65.00%
Debt Instrument, Covenant, Consolidated Leverage Ratio, Minimum							3.50
Maximum consolidated leverage ratio							4.00
Minimum consolidated interest coverage ratio			3.50				3.50
Actual consolidated leverage ratio					2.99
Actual interest coverage ratio					12.08
Net carrying amount					$ 76,000,000			$ 50,000,000
Percentage of weighted average interest rate of borrowings					4.50%			3.70%
Outstanding letters of credit					$ 1,600,000			$ 1,600,000
Unused borrowing capacity under Credit Agreement					422,400,000
Senior secured credit facility | Minimum | LIBOR
Debt Instrument [Line Items]
Interest rate on borrowings			1.25%
Senior secured credit facility | Minimum | Base Rate [Member]
Debt Instrument [Line Items]
Interest rate on borrowings			0.25%
Senior secured credit facility | Maximum | LIBOR
Debt Instrument [Line Items]
Interest rate on borrowings			2.00%
Senior secured credit facility | Maximum | Base Rate [Member]
Debt Instrument [Line Items]
Interest rate on borrowings			1.00%
Promissory Note due 2024 [Member]
Debt Instrument [Line Items]
Interest rate on borrowings	1.97%
Net carrying amount	$ 5,100,000				4,240,000			4,368,000
Debt Instrument, Maturity Date	Mar. 01, 2024
Repayment of Principal at Maturity Date	$ 1,500,000
Duration of LIBOR	1 month
Aircraft [Domain]
Debt Instrument [Line Items]
Property and equipment, net					$ 5,600,000			$ 5,800,000

XML

Restructuring Charges - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Jan. 01, 2019	Dec. 31, 2018
Restructuring Charges [Abstract]
Restructuring charges	$ 1,275	$ 712
Operating Lease, Impairment Loss	740	$ 0
Restructuring and Related Cost, Accelerated Depreciation	200
Restructuring reserve	1,336		$ 1,792	$ 2,911
Employee Severance [Member]
Restructuring Charges [Abstract]
Restructuring reserve	253		443	443
Office Space Reductions [Member]
Restructuring Charges [Abstract]
Restructuring reserve	1,083		$ 1,349	$ 2,468
Corporate, Non-Segment [Member] | Employee Severance [Member]
Restructuring Charges [Abstract]
Restructuring charges	200
Huron Legal [Member] | Discontinued Operations [Member]
Restructuring Charges [Abstract]
Restructuring charges	$ 100

XML

Restructuring Charges Restructuring Liability Rollforward (Details) - USD ($) $ in Thousands		3 Months Ended
	Jan. 01, 2019	Mar. 31, 2019	Dec. 31, 2018
Restructuring Cost and Reserve [Line Items]
Restructuring reserve	$ 1,792	$ 1,336	$ 2,911
Restructuring and Related Cost, Incurred Cost		536
Payments for Restructuring		(806)
Restructuring Reserve, Accrual Adjustment		63
Noncash Restructuring Adjustments		(249)
Employee Severance [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring reserve	443	253	443
Restructuring and Related Cost, Incurred Cost		247
Payments for Restructuring		(435)
Restructuring Reserve, Accrual Adjustment		(2)
Noncash Restructuring Adjustments		0
Office Space Reductions [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring reserve	1,349	1,083	$ 2,468
Restructuring and Related Cost, Incurred Cost		289
Payments for Restructuring		(371)
Restructuring Reserve, Accrual Adjustment		65
Noncash Restructuring Adjustments		$ (249)
Accounting Standards Update 2016-02 [Member]
Restructuring Cost and Reserve [Line Items]
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification	(1,119)
Accounting Standards Update 2016-02 [Member] | Employee Severance [Member]
Restructuring Cost and Reserve [Line Items]
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification	0
Accounting Standards Update 2016-02 [Member] | Office Space Reductions [Member]
Restructuring Cost and Reserve [Line Items]
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification	$ (1,119)

XML

Derivative Instruments and Hedging Activity - Additional Information (Detail) - USD ($)		3 Months Ended
	Jun. 22, 2017	Mar. 31, 2019
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Interest rate swap agreement, effective date	Aug. 31, 2017
Interest rate swap agreement, end date	Aug. 31, 2022
Interest rate swap agreement for a notional amount	$ 50,000,000
Duration of LIBOR	1 month
Percentage of fixed rate	1.90%
Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred		$ 200,000
Gain (loss) reclassification from accumulated OCI to income, estimate of time to transfer		12 months

XML

Derivative Instruments and Hedging Activity - Fair Value Interest Rate Swaps Designated as Cash Flow Hedging Instruments (Detail) - USD ($) $ in Thousands	Mar. 31, 2019	Dec. 31, 2018
Prepaid Expenses and Other Current Assets [Member]
Fair Value interest rate swaps designated as cash flow hedging instruments
Fair Value (Derivative Asset and Liability)	$ 240	$ 302
Other Noncurrent Assets [Member]
Fair Value interest rate swaps designated as cash flow hedging instruments
Fair Value (Derivative Asset and Liability)	$ 192	$ 451

XML

Fair Value of Financial Instruments - Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) - Fair Value, Measurements, Recurring - USD ($) $ in Thousands	Mar. 31, 2019	Dec. 31, 2018
Fair Value, Asset/Liability
Assets, fair value	$ 78,388	$ 69,387
Liabilities, fair value	11,129	11,441
Contingent consideration for business acquisitions
Fair Value, Asset/Liability
Liabilities, fair value	11,129	11,441
Interest Rate Swap [Member]
Fair Value, Asset/Liability
Assets, fair value	432	753
Convertible debt investment
Fair Value, Asset/Liability
Assets, fair value	54,038	50,429
Level 2
Fair Value, Asset/Liability
Assets, fair value	24,350	18,958
Liabilities, fair value	0	0
Level 2 | Interest Rate Swap [Member]
Fair Value, Asset/Liability
Assets, fair value	432	753
Level 3
Fair Value, Asset/Liability
Assets, fair value	54,038	50,429
Liabilities, fair value	11,129	11,441
Level 3 | Contingent consideration for business acquisitions
Fair Value, Asset/Liability
Liabilities, fair value	11,129	11,441
Level 3 | Convertible debt investment
Fair Value, Asset/Liability
Assets, fair value	54,038	50,429
Deferred Compensation Plan Assets [Member]
Fair Value, Asset/Liability
Assets, fair value	23,918	18,205
Deferred Compensation Plan Assets [Member] | Level 2
Fair Value, Asset/Liability
Assets, fair value	$ 23,918	$ 18,205

XML

Fair Value of Financial Instruments - Additional Information (Detail) - USD ($)	3 Months Ended
	Mar. 31, 2019	Dec. 31, 2018	Sep. 30, 2014
Fair Value of Financial Instruments [Abstract]
Investments in notes	$ 54,038,000	$ 50,429,000
Closing price of common stock	$ 47.22
1.25% convertible senior notes due 2019
Fair Value of Financial Instruments [Abstract]
Aggregate principal amount	$ 250,000,000	250,000,000	$ 250,000,000
Carrying value of equity component	39,287,000	$ 39,287,000
Convertible debt investment | Shorelight Holdings LLC
Fair Value of Financial Instruments [Abstract]
Investments in notes	$ 27,900,000
Debt Instrument, Maturity Date	Jul. 01, 2020

XML

Fair Value of Financial Instruments - Summary of Carrying Amount and Estimated Fair Value of Convertible Notes (Detail) - USD ($) $ in Thousands	Mar. 31, 2019	Dec. 31, 2018
Carrying Amounts And Estimated Fair Values Of Financial Instruments [Line Items]
Net carrying amount	$ 325,291	$ 296,985
1.25% convertible senior notes due 2019
Carrying Amounts And Estimated Fair Values Of Financial Instruments [Line Items]
Net carrying amount	245,051	242,617
Estimated Fair Value	$ 246,190	$ 242,940

XML

Fair Value of Financial Instruments Fair Value of Financial Instruments - Contingent Consideration Reconciliation (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Dec. 31, 2018
Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial and Nonfinancial Liabilities, Fair Value Disclosure	$ 11,129	$ 11,441
Contingent consideration for business acquisitions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)	(391)
Contingent consideration for business acquisitions | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial and Nonfinancial Liabilities, Fair Value Disclosure	11,129	$ 11,441
Foreign Currency Gain (Loss) [Member] | Contingent consideration for business acquisitions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)	$ 79

XML

Fair Value of Financial Instruments Fair Value of Financial Instruments - Convertible Debt Investment Reconciliation (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Dec. 31, 2018
Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure	$ 78,388	$ 69,387
Convertible senior notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss)	3,609
Convertible senior notes | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure	$ 54,038	$ 50,429

XML

Other Comprehensive Income (Loss )- Components of Other Comprehensive Loss, Net of Tax (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Equity [Abstract]
Foreign currency translation adjustment, before taxes	$ 316	$ 34
Foreign currency translation adjustment, taxes	0	0
Foreign currency translation adjustment, net of taxes	316	34
Unrealized gain on investment, before taxes	3,609	2,927
Unrealized gain on investment, tax (expense) benefit	(952)	(761)
Unrealized gain on investment, net of taxes	2,657	2,166
Change in fair value, before taxes	(247)	545
Change in fair value, tax (expense) benefit	65	(141)
Change in fair value, net of taxes	(182)	404
Reclassification adjustments into earnings, before taxes	(74)	38
Reclassification adjustments into earnings, tax (expense) benefit	19	(10)
Reclassification adjustments into earnings, net of taxes	(55)	28
Net unrealized gain (loss), before taxes	(321)	583
Net unrealized gain (loss), tax (expense) benefit	84	(151)
Net unrealized gain (loss), net of taxes	(237)	432
Other comprehensive income (loss), before taxes	3,604	3,544
Other comprehensive income (loss), tax (expense) benefit	(868)	(912)
Accumulated Other Comprehensive (Income) Loss, Current period change	$ 2,736	$ 2,632

XML

Other Comprehensive Income (Loss )- Components of Accumulated Other Comprehensive Loss, Net of Tax (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Equity [Abstract]
Foreign Currency Translation Adjustments, Beginning balance	$ (665)
Foreign currency translation adjustments, net of tax	316	$ 34
Foreign Currency Translation Adjustments, Ending balance	(349)
Net Unrealized Gain (Loss) on Investment, Beginning balance	16,584
Unrealized gain on investment, net of tax	2,657	2,166
Net Unrealized Gain (Loss) on Investment, Ending balance	19,241
Net Unrealized Losses on Derivatives, Beginning balance	576
Unrealized gain (loss) on cash flow hedging instruments, net of tax	(237)	432
Net Unrealized Losses on Derivatives, Ending balance	339
Accumulated Other Comprehensive Income (Loss), Beginning balance	16,495
Accumulated Other Comprehensive (Income) Loss, Current period change	2,736	$ 2,632
Accumulated Other Comprehensive Income (Loss), Ending balance	$ 19,231

XML

Income Taxes - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Income Tax Disclosure [Line Items]
Effective Income Tax Rate Reconciliation, Percent	29.00%	(14.70%)
Income tax expense	$ 1,365	$ 413
Income (loss) from continuing operations before taxes	$ 4,715	$ (2,809)
Effective Income Tax Rate Reconciliation, at Statutory Rate, Inclusive of State Income Tax, Percent	26.40%	26.00%
Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent	2.90%
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent	1.80%
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Compensation Cost, Percent	1.80%	43.70%
Loss on continuing operations Foreign [Member]
Income Tax Disclosure [Line Items]
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount	$ 500
Executive Compensation [Member]
Income Tax Disclosure [Line Items]
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount	100
Share-based Compensation [Member]
Income Tax Disclosure [Line Items]
Income tax expense	$ 100

XML

Commitments, Contingencies and Guarantees - Additional Information (Detail) - USD ($) $ in Thousands	Mar. 31, 2019	Dec. 31, 2018
Fair Value, Measurements, Recurring
Commitments And Contingencies [Line Items]
Liabilities, fair value	$ 11,129	$ 11,441
Fair Value, Measurements, Recurring | Contingent consideration for business acquisitions
Commitments And Contingencies [Line Items]
Liabilities, fair value	11,129	11,441
Senior secured credit facility
Commitments And Contingencies [Line Items]
Guarantees in the form of letters of credit	$ 1,600	$ 1,600

XML

Segment Information - Additional Information (Detail)	3 Months Ended
	Mar. 31, 2019 Segment
Segment Reporting [Abstract]
Number of Operating Segments	3

XML

Segment Information - Components of Segment Information (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Components of Segment Information
Revenues	$ 204,445	$ 193,679
Operating income (loss)	6,756	2,322
Reimbursable expenses	18,617	17,619
Total revenues and reimbursable expenses	223,062	211,298
Gain (Loss) Related To Litigation Settlement And Other Operating Gains	456	(830)
Depreciation and amortization	7,172	8,803
Other expense, net	(2,041)	(5,131)
Income from continuing operations before income tax expense	4,715	(2,809)
Healthcare
Components of Segment Information
Revenues	93,682	89,895
Business Advisory
Components of Segment Information
Revenues	58,806	55,895
Education [Member]
Components of Segment Information
Revenues	51,957	47,889
Operating Segments
Components of Segment Information
Revenues	204,445	193,679
Operating income (loss)	50,050	44,883
Reimbursable expenses	18,617	17,619
Total revenues and reimbursable expenses	223,062	211,298
Operating Segments | Healthcare
Components of Segment Information
Revenues	93,682	89,895
Operating income (loss)	$ 27,851	$ 24,460
Segment operating income as a percentage of segment revenues	29.70%	27.20%
Operating Segments | Business Advisory
Components of Segment Information
Revenues	$ 58,806	$ 55,895
Operating income (loss)	$ 9,581	$ 8,998
Segment operating income as a percentage of segment revenues	16.30%	16.10%
Operating Segments | Education [Member]
Components of Segment Information
Revenues	$ 51,957	$ 47,889
Operating income (loss)	$ 12,618	$ 11,425
Segment operating income as a percentage of segment revenues	24.30%	23.90%
Segment Reconciling Items
Components of Segment Information
Other operating expenses	$ 36,578	$ 32,928
Gain (Loss) Related To Litigation Settlement And Other Operating Gains	(456)	830
Depreciation and amortization	7,172	8,803
Other expense, net	$ 2,041	$ 5,131

XML

Segment Information Segment Information - Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Disaggregation of Revenue [Line Items]
Sales Revenue, Services, Net	$ 204,445	$ 193,679
Healthcare
Disaggregation of Revenue [Line Items]
Sales Revenue, Services, Net	93,682	89,895
Business Advisory
Disaggregation of Revenue [Line Items]
Sales Revenue, Services, Net	58,806	55,895
Education [Member]
Disaggregation of Revenue [Line Items]
Sales Revenue, Services, Net	51,957	47,889
Transferred over Time [Member]
Disaggregation of Revenue [Line Items]
Sales Revenue, Services, Net	202,159	190,821
Transferred over Time [Member] | Healthcare
Disaggregation of Revenue [Line Items]
Sales Revenue, Services, Net	91,642	88,341
Transferred over Time [Member] | Business Advisory
Disaggregation of Revenue [Line Items]
Sales Revenue, Services, Net	58,806	55,895
Transferred over Time [Member] | Education [Member]
Disaggregation of Revenue [Line Items]
Sales Revenue, Services, Net	51,711	46,585
Transferred at Point in Time [Member]
Disaggregation of Revenue [Line Items]
Sales Revenue, Services, Net	2,286	2,858
Transferred at Point in Time [Member] | Healthcare
Disaggregation of Revenue [Line Items]
Sales Revenue, Services, Net	2,040	1,554
Transferred at Point in Time [Member] | Business Advisory
Disaggregation of Revenue [Line Items]
Sales Revenue, Services, Net	0	0
Transferred at Point in Time [Member] | Education [Member]
Disaggregation of Revenue [Line Items]
Sales Revenue, Services, Net	246	1,304
Full-time Billable Consultants [Member]
Disaggregation of Revenue [Line Items]
Sales Revenue, Services, Net	167,919	154,321
Full-time Billable Consultants [Member] | Healthcare
Disaggregation of Revenue [Line Items]
Sales Revenue, Services, Net	64,818	59,273
Full-time Billable Consultants [Member] | Business Advisory
Disaggregation of Revenue [Line Items]
Sales Revenue, Services, Net	57,094	53,416
Full-time Billable Consultants [Member] | Education [Member]
Disaggregation of Revenue [Line Items]
Sales Revenue, Services, Net	46,007	41,632
Full-time Equivalents [Member]
Disaggregation of Revenue [Line Items]
Sales Revenue, Services, Net	36,526	39,358
Full-time Equivalents [Member] | Healthcare
Disaggregation of Revenue [Line Items]
Sales Revenue, Services, Net	28,864	30,622
Full-time Equivalents [Member] | Business Advisory
Disaggregation of Revenue [Line Items]
Sales Revenue, Services, Net	1,712	2,479
Full-time Equivalents [Member] | Education [Member]
Disaggregation of Revenue [Line Items]
Sales Revenue, Services, Net	5,950	6,257
Fixed-price Contract [Member]
Disaggregation of Revenue [Line Items]
Sales Revenue, Services, Net	97,639	93,995
Fixed-price Contract [Member] | Healthcare
Disaggregation of Revenue [Line Items]
Sales Revenue, Services, Net	63,584	60,269
Fixed-price Contract [Member] | Business Advisory
Disaggregation of Revenue [Line Items]
Sales Revenue, Services, Net	21,672	22,420
Fixed-price Contract [Member] | Education [Member]
Disaggregation of Revenue [Line Items]
Sales Revenue, Services, Net	12,383	11,306
Time-and-materials Contract [Member]
Disaggregation of Revenue [Line Items]
Sales Revenue, Services, Net	83,430	77,568
Time-and-materials Contract [Member] | Healthcare
Disaggregation of Revenue [Line Items]
Sales Revenue, Services, Net	12,763	12,789
Time-and-materials Contract [Member] | Business Advisory
Disaggregation of Revenue [Line Items]
Sales Revenue, Services, Net	35,309	31,337
Time-and-materials Contract [Member] | Education [Member]
Disaggregation of Revenue [Line Items]
Sales Revenue, Services, Net	35,358	33,442
Performance-based [Member]
Disaggregation of Revenue [Line Items]
Sales Revenue, Services, Net	12,474	11,100
Performance-based [Member] | Healthcare
Disaggregation of Revenue [Line Items]
Sales Revenue, Services, Net	11,810	10,191
Performance-based [Member] | Business Advisory
Disaggregation of Revenue [Line Items]
Sales Revenue, Services, Net	664	909
Performance-based [Member] | Education [Member]
Disaggregation of Revenue [Line Items]
Sales Revenue, Services, Net	0	0
Software Service, Support and Maintenance Arrangement [Member]
Disaggregation of Revenue [Line Items]
Sales Revenue, Services, Net	10,902	11,016
Software Service, Support and Maintenance Arrangement [Member] | Healthcare
Disaggregation of Revenue [Line Items]
Sales Revenue, Services, Net	5,525	6,646
Software Service, Support and Maintenance Arrangement [Member] | Business Advisory
Disaggregation of Revenue [Line Items]
Sales Revenue, Services, Net	1,161	1,229
Software Service, Support and Maintenance Arrangement [Member] | Education [Member]
Disaggregation of Revenue [Line Items]
Sales Revenue, Services, Net	$ 4,216	$ 3,141